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ABSTRACT 
The phosphoinositide 3-kinase (PI3K) enzymes are well known for their 
regulation of pro-survival signalling cascades that result in increased cell 
survival and proliferation. However, most of what we understand is based 
on Class I PI3K enzymes and much less is understood about the Class II 
enzymes.  
Loss of PI3K C2 in mice results in embryonic lethality, or severe glomerular 
injury with increased morbidity. In contrast, PI3K C2 deficient mice display 
no apparent phenotype and are healthy and viable. Previous work in our 
laboratory revealed that administration of a sub-nephritogenic dose of 
nephrotoxic serum led to an augmented immune response resulting in 
glomerular damage and impaired renal function, which was associated with 
T-cell infiltration. Elucidating the immunological basis of this sensitivity was 
the basis of my project. 
In response to a subcutaneous injection of sheep IgG in complete Freund’s 
adjuvant, the spleens of PI3K C2 mice showed prominent germinal 
centre associated cell proliferation that was absent in the controls. Analysis 
of splenocyte populations revealed that PI3K C2 mice had an increased 
population of CD4+ T-cells and when cultured in vitro within a total 
splenocyte population, the increased CD4+ T-cell population was 
maintained. However, this effect was lost when T-cells were purified and 
maintained ex vivo. These data suggest that the increased PI3K C2 CD4+ 
proliferation may be due to additional factors within the total splenocyte 
population. 
B-cell populations from the spleens of PI3K C2 mice had higher CD19 
expression compared to B-cells from control mice. Elevated levels of CD19 
are associated with a reduced activation threshold. In response to 
stimulation with a sub-optimal dose of LPS and IL-4 PI3K C2 B-cells 
underwent increased class switch recombination, displayed increased 
metabolic activity and remained viable for longer than B-cells from control 
mice.   B-cell lysates from PI3K C2 mice also revealed increased levels 
of phosphorylated MEK1/2. These data indicate that PI3K C2may serve as 
a negative regulator of B-cell function and that loss of this PI3K enzyme 
isoform activity produces a heightened immune response which may lead 
to a predisposition to associated pathologies.  
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1 Introduction 
1.1 Overview of the innate and adaptive immune systems 
There are two arms of the immune system, innate and adaptive, although 
there is an interdependent relationship between the two (Hancock et al., 
2012; Iwasaki and Medzhitov, 2015). The innate immune system is present 
from birth and is the first line of defence against invading pathogens, it 
consists of immune cells that are specialized in recognising molecular 
patterns, such as lipopolysaccharides and dsRNA, which are expressed by 
many bacteria, viruses and fungi. These pathogen associated molecular 
patterns (PAMPs) are recognised by pattern recognition receptors (PRRs) on 
host immune cells, and importantly are able to distinguish self from non-self 
(Janeway and Medzhitov, 2002). The response to infectious agents is 
carefully coordinated and is dependent on the location and the nature of 
the pathogen, and maybe initiated by non-immune cells such as PRR 
expressing epithelial cells. For example, a breach in the epithelium causes 
epithelial cells to release chemokines that recruit leukocytes to the area. 
Following stimulation of PRRs, dendritic  cells    release chemokines, 
cytokines and antimicrobial peptides, if this is insufficient and the pathogen 
is detected in the circulation a systemic response may be triggered. This 
includes recruitment of monocytes and neutrophils which release cytotoxic 
chemicals and phagocytose the pathogen (Iwasaki and Medzhitov, 2015). 
In addition to eliminating infection, the innate immune system initiates the 
inflammatory response. While apoptosis is a normal physiological event 
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that occurs in a highly controlled manner, necrosis is typically the result of 
cell trauma and is associated with tissue damage, resulting in the loss of 
membrane integrity. As a result of necrosis, the contents of the cell escape 
into the local environment, releasing molecules that contain damage 
associated molecular patterns (DAMPs), which are thought to be recognised 
by PRRs on innate immune cells. These cells induce an inflammatory 
response and also engage the adaptive immune system (Kono and Rock, 
2008). 
The adaptive (also referred to as acquired) immune system is not present at 
birth and is developed over time in response to antigen exposure. 
Lymphocytes provide incredible antigen specificity via unique receptors that 
are produced by gene rearrangement during cell development. The adaptive 
response also provides immunological memory, which allows the immune 
system to recognise pathogens that it has previously encountered, 
facilitating a rapid response and mediating damage (Janeway and 
Medzhitov, 2002). Initiation of the adaptive response is largely dependent 
on signals from the innate immune system, such as chemokines and 
cytokines as well as the presentation of antigen by dendritic cells and 
macrophages (Hancock et al., 2012). However, the relationship between 
innate and adaptive immune systems is interdependent, including the 
recruitment of basophils, neutrophils and eosinophils by CD4+ T-cells, to 
sites of inflammation and infection. T-cells also induce microbicidal activity 
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by macrophages in response to infection (Zhu and Paul, 2015). Lymphocytes 
will be discussed later in the chapter. 
1.2 Cell Signalling 
Cell fate is controlled by a multitude of signalling pathways, which ultimately 
allow the cell to respond appropriately to the intracellular and extracellular 
environment. Under physiological conditions the downstream result is 
either of direct benefit to the cell (growth, proliferation, repair), or to the 
surrounding environment (secretion of cytokines). Alternatively, to protect 
the organism as a whole the cell can receive instruction to undergo 
programmed cell death (apoptosis). Signal transduction can be initiated 
when a receptor binds with a ligand, generating second messenger 
molecules such as Ca2+, cAMP or phosphoinositides. The role of second 
messengers is to amplify the original signal to produce a response. 
1.2.1 Phosphoinositides 
Phosphoinositides (PtdIns) are a phosphorylated form of 
phosphatidylinositol, which is derived from phospholipid within the plasma 
membrane. The third, fourth and fifth positions of the hydroxyl ring can be 
phosphorylated by different kinases to produce a combination of 
phosphoinositides (Figure 1.1); phospsoinositide-3-phosphate (PI3P), 
phospsoinositide-3,4-phosphate (PI3,4P2), phospsoinositide-3,4,5-
phosphate (PI3,4,5P3) and phosphoinositide-3,5-phosphate (PI3,5P2) 
(Vanhaesebroeck and Waterfield, 1999), phospsoinositide-4-phosphate 
(PI4P), (Hammond et al., 2012) and phospsoinositide-5- phosphate (PI5P) 
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(Nunès and Guittard, 2013). Phosphatases also have an important role in 
the regulation of phosphoinositide signalling by dephosphorylating the 
inositol ring. Signalling pathways mediated by PI3P and PI3,4,5P3 are 
regulated by the lipid phosphatases; phosphatase and tensin homologue 
(PTEN), myotubulin (MTM) and Src homology 2 (SH2) containing tyrosine 
phosphatase-1 (SHP-1)  (Majerus and York, 2009). The importance of 
phosphoinositides as second messengers is highlighted by the many human 
diseases that have been linked to their dysregulation, either through 
increased production or lack of phosphatase activity. Such diseases include 
cancer, autoimmune disorders including multiple sclerosis MS, systemic 
lupus erythematosus (SLE), asthma, chronic obstructive pulmonary disorder 
(COPD), rheumatoid arthritis and myopathies such as Charcot-Marie Tooth 
disease (Foster et al., 2012; Nicot and Laporte, 2008). 
 
 
 
 
 
 
1.2.2 The phosphoinositide 3-kinases (PI3K) 
There are eight members of the PI3K family, separated into three classes, 
which are responsible for phosphorylating phosphoinositide at the 3’ 
 
A B 
Inositol ring 
Glycerol moiety 
Fatty acid 
Figure 1.1 Schematic of A; phosphatidylinositol (PtdIns) and B; phosphoinositide-3-
phosphate (PI3P) 
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position of the inositol ring (Figure 1.1). Classification is based on structural 
properties and substrate specificity (Domin and Waterfield, 1997). 
The class I enzymes are heterodimers consisting of a catalytic unit and an 
adaptor unit, and have been further divided into class IA and IB (Figure 1.2). 
In vivo, the class I enzymes phosphorylate PI3,4P2 to generate PI3,4,5P3, 
although in vitro they can also phosphorylate PI4P to produce PI3,4P2  . 
PI3,4,5P3  and PI3,4P2  bind to downstream effector proteins via the 
pleckstrin homology (PH) domain (Vanhaesebroeck and Waterfield, 1999). 
Both p110 and p110 have ubiquitous expression, while p110 and p110 
are expressed predominantly in haematopoietic cells. As regulators of cell 
proliferation, differentiation and survival their dysregulation plays a role in 
diseases such as cancer   and autoimmunity (Domin, 2006). 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Classification of PI3K enzymes. There are eight isoforms of PI3K which have been 
separated into three classes depending on their structure and substrate specificity. 
Adapted from Domin and Waterfield (1997). 
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The class III PI3Ks consist of a single enzyme which is the homologue of 
Vps34p found in yeast, and like the class I enzymes it is a heterodimer. It is 
widely expressed and plays a role in maintaining cellular levels of PI3P 
required for vesicle trafficking (Cockcroft, 2000). It is also attributed as the 
source of PI3P within the endoplasmic reticulum, which is required for the 
regulation of autophagy. Although recently it has been demonstrated that 
class II PI3Ks may also play a role in this process (Devereaux et al., 2013). 
1.2.3 Class II PI3K 
Class II PI3Ks contain three members; PI3K C2, PI3K C2 and PI3K C2, all 
of which are large monomeric proteins (>170kD). PI3K C2 and PI3K C2 
show a wide distribution (El Sheikh et al., 2003), whereas PI3K C2 expression 
is restricted to the liver (Ono et al., 1998). Recently, a requirement for PI3K 
C2 has been described in the regulation of glycogen synthase production, 
and mice deficient in PI3K C2 were unable to store glycogen which led to 
obesity and insulin resistance (Braccini et al., 2015). 
Historically wortmannin and LY2094002 are thought of as pan-inhibitors of 
PI3K activity. However, the discovery of PI3K C2 led to the re-evaluation of 
both wortmannin and LY2094002, as their effect on PI3K C2 is greatly 
reduced (Domin et al., 1997). Similarly, PI3K C2 shows limited inhibition 
following treatment with LY2094002 (Ciraolo et al., 2014). 
Both PI3K C2 and PI3K C2 appear to share a substrate specificity for 
PtdIns (Falasca and Maffucci, 2007) and they are structurally similar with 
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the exception of their N-terminus, however, it has been demonstrated that 
they can mediate different functions. PI3K C2 appears to play a critical role 
in cell survival, whereas this does not appear to be the case for PI3K C2. 
For example, in over twenty cancer cell lines, knock down of PI3K C2 using 
siRNA was found to cause a six-fold increase in apoptosis compared to the 
controls, while the knockdown of PI3K C2 had no effect (Elis et al., 2008). 
Different roles have also been observed in HUVECs (human umbilical vein 
endothelial cells), knockdown of PI3K C2 using siRNA induced apoptosis 
suggesting a role in cell survival, whereas knock down of PI3K C2 had no 
effect on cell survival but did inhibit sphingosine-1-phosphate (S1P) 
dependent migration (Tibolla et al., 2013). In vivo experiments have 
highlighted the differences between the two isoforms. In mice, loss of PI3K 
C2 was found to be embryonically lethal due to severe vascular defects. 
The study went on to show that an endothelial cell specific knockdown led 
to impaired endosomal trafficking, signalling and defective receptor 
internalization (Yoshioka et al., 2012), indicating the importance of PI3K C2 
in cell survival. PI3k C2 deficient mice have previously been described as 
viable, fertile with  no pathological phenotype (Harada et al., 2005). 
 PI3K C2
Like the other class II isoforms, PI3K C2 is a monomeric protein with 
extensions at both the amino and carboxyl termini.   Differences within the 
N-terminus differentiate it from   the other class II members. 
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 Despite the lack of obvious phenotype in PI3K C2 deficient mice, PI3K C2 
is involved in the regulation of a diverse range of cellular functions (Table 
1.1). It has also been suggested that PI3K C2 may be required to optimize 
activation of downstream pathways in association with class I PI3Ks. For 
example, in small cell lung cancer cancer (SCLC) cells stimulated with 
polypeptide growth factors,  Akt activation by p110 was enhanced by the 
addition of PI3K C2   (Arcaro et al., 2002).   
 
 
 
 
 
 
In addition, a potentially cooperative role has been described for PI3K C2 in 
S1P dependent migration in HUVECs. While knockdown of P110 reduced 
S1P induced migration, simultaneous knockdown led to a greater reduction 
in S1P dependent migration (Tibolla et al., 2013). More recently, studies 
have revealed a role for ceramide in suppressing metastasis in ovarian 
cancer via its effect on PI3K C2 function (Kitatani et al., 2015). Ceramide is 
a bio-active lipid that contains sphingosine which can be metabolised to 
Figure 1.3 Schematic of PI3K C2 and PI3K C2. Although structurally similar they differ at 
the N-terminus. The class II members have a PX and an additional C2 domain at the C-
terminus.  
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produce S1P, and while S1P is associated with cell survival, ceramide has 
been shown to induce apoptosis (Ponnusamy et al., 2010). The efficacy of 
ceramide was due to interaction with the PIK domain (Figure 1.3), which 
appears to effect the localization of PI3K C2. By drawing PI3K C2 away 
from lamellipodia cell motility is inhibited. P110 was also shown to be 
redirected away from lamellipodia in the presence of ceramide, which also 
affected motility, which may indicate either a functional overlap or possibly 
a cooperative role (Kitatani et al., 2015).  
Of particular interest was the discovery of a possible role for PI3K C2 in the 
negative regulation of the GTPase Ras. Although previous in vitro studies 
indicated that Ras and PI3K C2 do not interact (Arcaro et al., 1998), a more 
recent study has revealed that PI3K C2 can interact with nucleotide free 
Ras via the Ras binding domain (RBD). The nucleotide free Ras/PI3K C2 
complex appears to stabilize Ras and also inhibit PI3K C2 catalytic activity. 
Intersectin 1 (ITSN1) was also shown to interact with PI3K C2 via proline 
rich residues and this binding of ITSN1 was thought to release nucleotide 
free Ras, allowing activation by GTP loading and re-establishing PI3K C2 
catalytic activity  (Wong et al., 2012b). 
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Table 1.1 Signalling events involving PI3K C2
 
 
 
Table 1.1. Signalling events involving PI3K C2
Cell Line Function Reference 
HEK293 The C-terminus C2 domain was shown to 
negatively regulate catalytic activity by 
competitively binding substrate. PI3K C2 was 
found not to bind with either the class I p85 
regulatory subunit or GTP-bound Ras. 
(Arcaro et al., 
1998) 
LNCaP, 
HEK293, A431 
PI3K C2 was shown to bind to Grb2 and Shc. 
Binding of Grb2 was via the proline rich domain 
and increased PI3K C2 catalytic activity. 
(Wheeler and 
Domin, 2001) 
A431 PI3K C2 and C2 were found to be  activated 
by EGF, and were shown to co-IP with the EGFR 
and ErbB-2. 
(Arcaro et al., 
2000) 
Hela , SKOV-3, 
COS7 
LPA was shown to activate PI3K C2 and 
knockdown inhibited LPA dependent migration. 
(Maffucci, 2005) 
A431 cells, 
HEK293, NIH-
3T3 
PI3K C2 was shown to interact with clathrin at 
the N-terminus and catalytic activity was 
increased. 
(Wheeler and 
Domin, 2006) 
A431 cells Following EGF activation PI3K C2 was shown to 
form a complex with Abi1, Eps8 and SOS, 
regulating Rac activity. This resulted in 
increased motility and cytoskeleton reorganisation 
(Katso et al., 
2006) 
Neuroblastoma 
cells, primary 
cortical 
neurons 
ITSN1 was found to interact with PI3K C2 via 
the proline rich domain, increasing kinase 
activity and Akt signalling. Loss of ITSN1 
increased apoptosis, independently of its role in 
vesicle trafficking. 
(Das et al., 2007) 
HEK293 cells PI3K C2 translocates to the nuclear matrix 
following EGF activation, by way of a nuclear 
localization signal within the C-terminus C2 
domain. 
(Banfic et al., 
2009) 
EC9706 , EC-1, 
Eca109 
and 
Eca109 
Knockdown of PI3K C2 increased sensitivity to 
cisplatin mediated apoptosis. Possibly by 
interrupting the Akt pathway. Examination of 
patient samples appeared to show a correlation 
between PI3K C2 and metastasis. 
(Liu et al., 2011a) 
NIH3T3 cells PI3K C2 was shown to form a complex with 
Grb2 and Dbl and was also shown to co-IP with 
Grb2 and Src. 
(Błajecka et al., 
2012) 
COS7 cells PI3K C2 is shown to bind to Ras in its 
nucleotide free form, preventing GTP loading 
and activation. This reveals a potential role in 
negative regulation. 
(Wong et al., 
2012) 
HUVEC PI3K C2 involvement in S1P dependent 
migration was demonstrated. 
(Tibolla et al., 
2013) 
 
 
LNCaP prostate cancer cell line; HEK293 human embryonic kidney cells; A431 epithelial carcinoma 
cells; Hela cervical epithelial cancer cells; SKOV-3 ovarian epithelial cancer cells, COS7 kidney 
fibroblasts from African green monkey; NIH-3T3 murine embryonic kidney cells; EC9706 , EC-1, 
Eca109 , Eca109 oesophageal squamous cell carcinoma cell lines; Co-IP co-immunoprecipitation; LPA 
Lysophosphatidic acid; EGF epidermal growth factor; EGFR epidermal growth factor receptor; S1P 
sphingosine-1-phophsphate; ITSN intersectin. 
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1.2.5 PI3K C2 in the immune  system 
Class I PI3Ks are known to play an important role in the immune system, in 
particular PI3K and PI3K are both highly expressed in leukocytes, and the 
involvement of p110 has also been recognised (Blunt and Ward, 2012). 
Their dysregulation has been observed in many immune related disorders 
and as such the function and regulation of the class I PI3Ks have been 
extensively studied, which has recently led to the first FDA approved 
inhibitor targeting p110 (Okkenhaug et al., 2014). 
Until recently the role of PI3K C2 has received little attention. However, 
studies have identified several signalling pathways in which PI3K C2 plays 
a regulatory role, including a potential function within the immune system 
(Figure 1.4). A role for PI3K C2 has been described in human T lymphocytes 
(T-cells) involving regulation of calcium influx by regulating the calcium 
(Ca2+) activated potassium (K+) channel KCa3.1. PI3K C2 is recruited to the 
T-cell receptor (TCR), following activation, which leads to PI3P synthesis and 
stimulation of KCa.3.1 via nucleoside diphosphate kinase B (NDPK-B), the 
efflux of K+ ensures a negative membrane potential which allows 
extracellular Ca2+ to enter the cell (Srivastava et al., 2009). Increased 
intracellular Ca2+ is required for effective T-cell activation. KCa3.1 mediated 
Ca2+ entry is negatively regulated by tripartite motif containing protein 27 
(TRIM27). TRIM27 ubiquinates PI3K C2 which inhibits the production of 
PI3P. In the absence of PI3P, NDPK-B is unable to activate KCa3.1 (Cai et al., 
2011). Due to differences in KCa3.1 expression between T-cell subsets, this 
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method of TCR activation affects type 1 helper T-cells (Th1) and type 2 
helper T-cells (Th2), whereas type 17 helper T-cells (Th17) and regulatory T- 
cells (Tregs) are unaffected (Ohya and Imaizumi, 2014). 
In addition, Ca2+ regulation by PI3K C2 and TRIM27 has also been observed 
in primary murine bone marrow derived mast cells (BMMCs) via the 
activation of the high affinity IgE receptor FcRI. In mast cells activation of 
the FcR1 leads to the release of cytokines, proteases and histamine, it also 
induces the synthesis of additional cytokines. Knockdown of PI3K C2 in 
BMMCs using siRNA resulted in a reduction in mRNA for interleukin 6 (IL-6), 
IL-13 and tumour necrosis factor 6 (TNF). Conversely, mRNA from these 
cytokines were upregulated in BMMCs from TRIM27  mice (Srivastava et 
al., 2012). While blocking KCa3.1 in T-cells and mast cells appears to 
negatively regulate activation, in human natural killer (NK) cells inhibition of 
KCa3.1 increases their cytotoxicity and proliferation which has been shown 
to increase their ability to kill tumour cells (Koshy et al., 2013). As 
dysregulation of Ca2+ signalling through KCa3.1 is implicated in various 
pathologies including multiple sclerosis, rheumatoid arthritis, 
atherosclerosis, asthma and transplant rejection, identifying mechanisms of 
activation would be of interest (Ohya and Imaizumi, 2014). 
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Figure 1.4 Schematic of potential ways in which PI3K C2 influences cell function. A; following 
activation via the EGFR, PI3K C2 was shown to interact with ITSN1. The binding of ITSN1 was 
shown to increase the lipid kinase activity of PI3K C2, resulting in increased AKT activation. This 
pathway was shown to regulate survival of N1E-115 (neuronal) cells (Das et al., 2007). B; Activation 
of PI3K C2 via the EGFR was shown to activate MEK1/2 and ERK1/2, which contributed to cell 
migration in a prostate cancer cell line. Following inhibition of PI3K C2, downregulation of the 
transcription factor Slug was observed which was independent of MEK / ERK activation. The 
reduction of Slug was found to inhibit cell invasion (Mavrommati et al., 2016). C; the Grb2/Sos 
complex causes GDP to disassociate from Ras, PI3K C2 was shown to bind to nucleotide free (nf) 
Ras competitively, preventing nf Ras binding GTP. This is believed to stabilize nf Ras, preventing 
GTP binding and activating Ras. Binding of ITSN1 with the PI3K C2/nf Ras complex, releases nf 
Ras allowing GTP to bind with Ras. Activated Ras is then able to recruit effector molecules, 
activating downstream signalling pathways (Wong et al., 2012a). D; In T-cells, activation via the T-
cell receptor (TCR) leads to up regulation of KCa3.1 and increased channel activity. Knockdown of 
PI3K C2 resulted in a reduction of KCa3.1 mediated Ca2+ influx. PI3K C2 was shown to co-localise 
with Zap70 and the TCR at the immunological synapse. It is suggested that PI3K C2 is required for 
full activation of KCa3.1 channels and activation of NFAT signalling pathways (Srivastava et al., 
2009). E; Activation of FceR1 results in Ca2+ influx followed by degranulation in mast cells. PI3K 
C2 was found to be necessary for activation of KCa3.1. Trim27 was shown to negatively regulate 
this process (Srivastava et al., 2012). 
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1.3 The Spleen 
The spleen is a secondary lymphoid organ and is located within the 
abdominal cavity, underneath the diaphragm in mice and humans. It has an 
unusual structure and complex vasculature, consisting of both open and 
closed circulation, which are essential for its primary functions; blood 
filtration and immunity. In addition to red blood cells, it contains immune 
cells from both the innate and adaptive immune systems (Mebius and Kraal, 
2005). 
 
 
 
Blood enters the spleen via the splenic artery, which branches off ending up 
as central arterioles. Lymphoid tissue surrounds the central arterioles, 
referred to as the white pulp (WP). Some of these arterioles branch off 
Figure 1.5 Mouse spleen. A; section from a mouse spleen showing areas of white pulp 
(WP) and red pulp (RP). Original magnification 10x. Length bar represents 500μm. B; 
section of mouse spleen stained with anti-B220 (brown), to identify the B-cell rich follicles 
(Fo), the periarterial lymphoid sheaths (PALS) contain predominantly T-cells. The marginal 
zone (MZ) separates the white pulp from the red pulp. Arrowheads show the central 
arteries. Arrows highlight the marginal sinus that separates the white pulp from the 
marginal zone. Original magnification 10x, section counter stained with haematoxylin. 
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further, supplying nutrients to the WP, others terminate within the marginal 
sinus. Arterioles that do not terminate within the WP continue into the red 
pulp (RP) becoming penicillar arteries and finally arterial capillaries which 
terminate in the RP. The RP has a largely open circulation and blood from 
the arterial capillaries empties into a sponge-like mesh, which is made up of 
reticular fibres, reticular cells and splenic cords (sometimes referred to as 
the cords of Billroth). Red blood cells (RBCs) and other circulating cells filter 
through this network and eventually re-enter the circulation via the 
sinusoids, which lead to the trabecular vein before leaving the spleen (Cesta, 
2006). 
1.3.1 Marginal Zone (MZ) 
In mice, the MZ forms a ring around areas of WP and is separated from the 
lymphoid tissue by the marginal sinus. Blood from the circulation empties 
into the marginal sinus, before migrating towards the RP, making cells 
within the MZ the first line of defence against blood borne pathogens. The 
MZ provides an important link between innate and adaptive immunity. The 
MZ is populated predominantly by non-circulatory B-cells, macrophages 
(metalophillic and MZ) and dendritic cells (Cesta, 2006; den Haan and Kraal, 
2012). MZ B-cells are specialized in T-cell independent responses, in part, by 
recognising particular molecular patterns (PAMPs) that are often associated 
with bacteria and viruses. Interaction with such antigens causes the B-cell 
to become activated resulting in proliferation, cytokine production and the 
excretion of antibodies (typically IgM) (Tsolaki, 2011). In addition to 
phagocytosing bacteria and viruses, macrophages gathered at the marginal 
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sinus play an important role in clearing apoptotic cells, as they arrive from 
the circulation. Disruption of this function has led to the development of 
autoimmune disorders in both mice and humans. High concentrations of 
cellular antigen can lead to a loss of self-tolerance and the production of 
autoantibodies (den Haan and Kraal, 2012). Dendritic cells specialize in 
antigen presentation and a population of MZ dendritic cells have been 
shown to be efficient at presenting to B-cells in addition their usual target, 
naïve T-cells (Chappell et al., 2012). 
1.3.2 Periarteriolar Lymphoid Sheaths (PALS) 
The PALS form around the central artery, the inner PALS are predominantly 
made up of CD4+ T-cells, CD8+ T-cells (also referred to as cytotoxic T-cells 
or CTLs) are also present but in fewer numbers and interdigitating dendritic 
cells which present antigen to naïve T-cells (Cesta, 2006). The outer PALS 
contain a mixture of T-cells and migrating B-Cells passing through from the 
MZ to the follicles (Steiniger et al., 2005). The outer PALS also contain 
populations of dendritic cells that have migrated from the MZ to present 
antigen to T-cells. It is also thought that some macrophage populations may 
also activate T-cells via antigen presentation (den Haan and Kraal, 2012). 
1.3.3 Follicles 
The predominant population of cells within the follicles are re-circulating B 
cells. B-cells leaving the circulation pass through the MZ and PALS and into 
the follicles, during this migration they interact with antigen presenting 
dendritic cells. If they are exposed to antigen that is specific to their B-cell 
37 
 
receptor (BCR), they are retained within the follicle where they proliferate 
and initiate a germinal centre reaction, which is the major source of long 
lived antibody secreting plasma cells and memory B-cells. Follicles that 
contain a germinal centre are known as secondary follicles. Germinal 
centres are only generated in response to a B-cell interacting with its 
cognate antigen, they are transient structures and disappear once the 
immunological challenge has been eliminated (Steiniger, 2005). In addition 
to B-cells and dendritic cells, there are populations of CD4+ T-cells and 
specialized tingible body macrophages whose function is to clear apoptotic 
B-cells. This is particularly important during the germinal centre reaction, 
when there are high numbers of proliferating B-cells. Many of these B-cells 
undergo apoptosis if they fail to produce a high affinity antigen receptor. 
Clearance of these cells prevents the release of potential self-antigen and 
autoreactive B-cells into the periphery (den Haan and Kraal, 2012). 
1.3.4 Red Pulp 
Within the open circulation of the red pulp (RP), dead and dying red blood 
cells (RBCs) get caught in the splenic cords, where they are phagocytosed by 
strategically placed RP macrophages (Cesta, 2006). In addition to 
maintaining the RBC population, RP macrophages are essential for iron 
metabolism and recycling (den Haan and Kraal, 2012). There is also a large 
reservoir of monocytes in the RP, where they reside until recruitment in 
response to acute inflammation. Although more typical in young animals, 
extra medullary haematopoiesis (EMH) is not uncommon in the rodent 
spleen (Suttie, 2006), as such the RP may also contain a variety of erythroid, 
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myeloid, and megakaryocytic cells (Cesta, 2006). Plasmablasts dependent 
on dendritic cells for survival are also located in the RP, as are differentiated 
long lived plasma cells, it is thought that this positioning in the spleen allows 
easy access to the circulation (den Haan and Kraal, 2012; Mebius and Kraal, 
2005). 
1.3.5 Micro-environment of the spleen 
In addition to the physical structure of the spleen, cellular 
compartmentalization and function of the splenic environment is largely 
governed by the milieu of cytokines and their complex interactions. These 
chemical messengers ensure correct localization to allow function, they 
regulate cell differentiation and can modulate the expression of the 
receptors required to mediate an appropriate cellular response  (Lund, 
2008; Stein and Nombela-Arrieta, 2005; Steiniger and Barth, 1999). 
Chemotaxis is mediated by chemokines and select bio-active molecules 
such as sphingosine-1-phosphate (S1P). Within the germinal centres of the 
spleen (Section 1.8), for example, by modulating the expression of the 
chemokine receptors CXCR4 and CXCR5 B-cells shuttle between the dark 
zone, in response to CXCL12, and the light zone, in response to CXCL13 
(Allen et al., 2004). This allows germinal centre B-cells to interact with 
follicular helper T-cells (Tfh) and receive the appropriate signals to maintain 
the germinal centre reaction (Gitlin et al., 2014). The lymphocyte response 
to S1P within the spleen is primarily regulated by the expression of the S1P 
receptors S1P1, S1P2 and S1P3. T-cells in the spleen predominantly express 
S1P1 (M Graeler and E J Goetzl, 2002), while, depending on their function 
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and location B-cells can express any of the S1P receptors (Cinamon et al., 
2004; Green et al., 2011).  
The concentration gradient of S1P differs between splenic compartments 
and also between the spleen and the periphery (Sic et al., 2014). As such, 
S1P1 expression allows lymphocytes to leave lymphoid organs where S1P 
concentrations are low, and enter the circulation  (Maceyka et al., 2012; 
Stein and Nombela-Arrieta, 2005). Within the spleen, expression of S1P2 
retains GC B-cells within the germinal centre, by inhibiting the response to 
chemoattractants produced in follicles (Green et al., 2011). The expression 
of S1P1 and S1P3 are required for the correct localization of MZ B-cells 
(Steiniger, 2015). 
In addition to directing cells to the correct location, a myriad of cytokines 
modulate the cellular responses. For the purpose of this thesis, cytokines 
affecting the lymphocyte populations within the spleen GCs and follicles will 
be discussed. Cellular function is closely linked to the cytokines they 
produce, and as such lymphocyte subsets are often distinguished by their 
cytokine expression profile. Frequently cytokines are characterized as either 
pro-inflammatory or anti-inflammatory, although this would appear to be a 
broad generalization as many cytokines mediate various responses (Raphael 
et al., 2014). The combination of cytokines produced, and the relative level 
of expression also determines the effect on the cellular environment. Table 
1.2 provides a non-exhaustive list of cytokines within the spleen, the cells 
that produce them and the associated physiological effect. 
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Cytokine Sources Known functions References 
TGF- Breg, Tregs Suppression of the  immune response (Lund, 2008) 
IFN pDC Induces S1P1 activity, induction of GCs, 
induces BAFF production 
(Mountz et al., 2011) 
(Vincent et al., 2013) 
IFN Be-1, Fo B-cells, 
Th1, Th17 
Increases expression of TLRs, , B-cell 
CSR to IgG, upregulation of MHCI and 
MHCII on APCs, suppression of Th17 
differentiation 
(Raphael et al., 2014) 
TNF Be-1, Be-2, 
memory B-cells, 
Th1 
Formation of B-cell follicles, TD 
antibody responses 
(Lund, 2008) 
(Raphael et al., 2014) 
BLys 
(BAFF) 
Tfh, monocytes Selection of high affinity GC B-cells, 
promotes B-cell survival 
(Goenka et al., 2014) 
(Vincent et al., 2013) 
APRIL Moncocytes/ 
macrophages, 
DCs 
Lymphocyte proliferation, promotes TI 
response 
(Medema et al., 
2003) 
LT Memory B-
cells, 
ILCs 
Formation of B-cell follicles, DC 
development 
(Lund, 2008) 
(Magri et al., 2014) 
IL2 Be-2, Th1 Induces Th2 differentiation (Lund, 2008) 
(Raphael et al., 2014) 
IL-4 Be2, Th2, Tfh GC response, B-cell CSR to IgG/IgE, B 
and T-cell survival, Induces PC and Th2 
differentiation 
(Mountz et al., 2011) 
(Raphael et al., 2014) 
IL-5 Th2 TD antibody responses (Raphael et al., 2014) 
IL-6 Be2, DC, 
monocytes, MZ 
B-cells 
Induces Th17, Tfh and B-cell 
differentiation 
(Lund, 2008) 
(Mountz et al., 2011) 
(Eto et al., 2011) 
IL-10 B-reg, MZ B-
cells, T2 B-cells, 
Fo B-cells, 
Th17, Tregs 
Suppression of  immune response (Lund, 2008) 
(Raphael et al. 2014) 
IL-12 Be2, memory B-
cells, Th2 
Induces Th1 differentiation (Lund, 2008) 
(Raphael et al., 2014) 
IL-13 Be2, Th2, DC, 
Tregs 
Humoral immune response (Lund, 2008) 
(Raphael et al., 2014) 
IL-17 Th17, Tfh Increased ICAM-1 (Raphael et al., 2014) 
IL-21 Tfh, Th17 GC response, induces Tfh and  PC 
differentiation 
(Mountz et al., 2011) 
(Raphael et al., 2014) 
(Eto et al., 2011) 
IL-23 ILCs, DCs, 
macrophages, 
Induces Th17 differentiation (Raphael et al., 2014) 
(Magri et al., 2014) 
 
1.4 T-cells 
T-cells originate in the bone marrow, but migrate to the thymus as precursor  
DC dendtric cells; pDC plasmacytoid dendritc cell; GC germinal centre; Breg regulatory B-cells; Be-1 
type 1 effector B-cells; Be2 type 2 effector B-cells; MZ marginal zone; T2 transitional type 2 B-cells; 
LT lymphotoxin;  Fo B-cell Follicular B-cells; ICAM intracellular adhesion molecule; TLR toll-like 
receptors; MHC major histocompatibility complex; CSR  class switch recombination; TD T-cell 
dependent, Th helper T-cells, Treg regulatory T-cell, ILC innate lymphoid cell; APC antigen presenting 
cell; BLys B lymphocyte stimulator; BAFF B cell activation factor; APRIL a proliferation inducing 
ligand; TI T-cell independent. 
Table 1.2 Selection of cytokines within the spleen 
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T-cells to develop over the course of approximately three weeks (Figure 
1.6). There are two T-cell lineages that develop from these precursors; a 
small population of γδ T-cells and the major population which are αβ T-cells. 
These distinctions are based on the development of different types of T-cell 
receptor (TCR). Interaction with stromal cells within the thymus stimulates 
development and commitment to the T-cell lineage. Initially, T-cells do not 
express a TCR or either of the co-receptors associated with mature T-cells 
(CD4 and CD8), they express CD44, and are referred to as double negative, 
stage 1 (DN1). As cells move to stage 2 (DN2), they also express CD25 and 
begin gene rearrangement of the diverse β (Dβ) and joining β (Jβ) loci. 
Rearrangement of variable β (Vβ) and diverse-joining β (DJβ) indicates that 
the T-cell has progressed to DN3. CD44 is downregulated and cells that have 
failed to produce a successfully rearranged β-chain are arrested in DN3 and 
eventually undergo apoptosis. CD25 and CD44 expression is lost and the 
successfully rearranged β-chain is expressed in addition to a surrogate α-
chain, which with CD3 makes up the pre-T-cell receptor. The expression of 
the pre-TCR marks the transition to DN4 and further rearrangement of the 
β-chain is stopped. Gene rearrangement and expression of CD4 and CD8 is 
followed by proliferation, which produces the double positive (DP) 
population (CD4+ and CD8+). DP cells undergo positive and negative 
selection at this point, and approximately 98% fail to transition to single 
positive CD4 or CD8 T-cells. T-cells that survive the selection process 
rearrange the α-chain, after which a functioning TCR is expressed and T-cells 
lose expression of either the CD4 or CD8 co-receptor. Commitment to either 
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CD4 or CD8 expression is determined as part of the selection process, 
depending on whether T-cells interact with major histocompatibility 
complex class one (MHC I), or MHC II (Janeway et al, 2001). 
Following expression of a functional TCR and single co-receptor, T-cells 
upregulate expression of S1P1 (Section 1.3.5) and migrate to secondary 
lymphoid organs, such as the spleen (Chen, 2004; Weinreich and Hogquist, 
2008) 
 
The predominant population of naïve T-cells entering the spleen are CD4+ 
and upon arrival they home to the PALS (Section 1.3.2), in response to 
chemokines CCL19 and CCL21 produced by stromal cells and also dendritic 
cells. Subsequent interactions with accessory cells and the local cytokines 
produced leads to differentiation into specific subsets, thereby governing 
their function (Mebius and Kraal, 2005). Naïve T-cells survive in the 
periphery in response to low affinity TCR interactions, until they are 
DN1 
CD44+ 
CD25- 
DN2 
CD44+ 
CD25+ 
DN3 
CD44
low
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CD44- 
CD25- 
DP 
CD4+ 
CD8+ 
DP 
TCR 
CD4+ 
CD8+ 
SN 
TCR 
CD4+ 
SN 
TCR 
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negative selection 
V

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
 V

-J
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-chain 
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Pre-TCR 
Figure 1.6 T-cell development in the thymus. T-cell precursors arrive in the thymus from 
the bone marrow and develop into functioning T-cells over approximately three weeks. The 
developmental stages are shown with gene rearrangements to produce a functioning T-cell 
receptor (TCR) and a single co-receptor. DN double negative; DP double positive; SN single 
negative. Adapted from Parham (2014). 
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activated. For T-cell activation, antigen presenting cells (APCs) expressing 
the co-stimulatory molecules CD80 and CD86 (B7.1 and B7.2) are required 
to present antigen displayed on MHC I (CD8+ T-cells) or MHC II (CD4+ T-
cells). Activation results in proliferation and differentiation into an effector 
subset (Broere et al., 2011). Development of these subsets is carefully 
regulated by cytokines and cell to cell interactions within the local 
environment to maintain a balance, loss of homeostasis is associated with 
immune pathologies such as chronic inflammation and autoimmunity (Zhu 
and Paul, 2015). 
1.4.1 T-cell subsets 
Although there are additional subsets, the principle CD4+ subsets in the 
spleen are helper T-cell type 1 (Th1), helper T-cell type 2 (Th2), helper T-cell 
type 17 (Th17), follicular T-cell helper (Tfh) and regulatory T-cells (Tregs) 
(Table 1.3). 
1.4.2 Type 1 and type 2 helper T-cells 
Differentiation from a naïve T-cell into a Th1 or Th2 cell is dependent on 
whether they are required for a type 1 or type 2 immune response. Type 
one responses are associated with infection that require pathogens to be 
cleared from the system, while a type two response occurs in response to 
infection by large pathogens that cannot be cleared by phagocytosis. 
Although a type one response will result in antibody production, the type 
two function is to generate a robust humoral response. Factors that 
determine which subset is produced are predominantly governed by the 
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cytokines in the local environment (Table 1.2). High levels of IL-12 produced 
by innate immune cells in response to bacteria, in addition to IFN-γ and IL-2 
will induce Th1 differentiation. Th1 cells, in turn, secrete IFN-γ which 
stimulates phagocytosis, intracellular killing by innate immune cells. They 
also induce upregulation of MHC I and MHC II on other cell types, which are 
required for antigen presentation to T-cells thereby maintaining the 
response. Both naïve and Th1 can differentiate into Th2 cells in response to 
IL-4, IL-25 and IL-33. Secretion of IL-4, IL-12, and IL-13 by Th2 cells induces 
B-cell proliferation and antibody production. In particular Th2 cells are 
associated with inducing IgG and IgE production in B-cells (Spellberg and 
Edwards, 2001).  
1.4.3 Type 17 helper T-cells 
The Th17 subset is a more recent discovery and are so named due to their 
production of IL-17. IL-17 is a family of six cytokines, two of which are known 
to be produced by Th17 cells; IL-17A and IL-17F. Although they play an 
important role in protection from bacterial and fungal pathogens, they are 
implicated in a range of immune pathologies (Raphael et al., 2014). 
Cytokines known to induce Th17 differentiation include IL-23, transforming 
growth factor-β (TGF-β), IL-21 and IL-6 and in response, Th17 cells produce 
IL-17A, IL-17F, IL-21, IL-22, TNF-α, IL-9, IL-10, IFN-γ (Singh et al., 2014). 
Although Th17 cells are largely associated with pathogenic outcomes, 
production of the anti-inflammatory cytokine IL-10 indicates that they may 
also have the ability to reduce inflammation. The pathogenic role of the 
Th17 subset is partly attributed to a positive feed-back loop in which innate 
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immune cells are recruited to the area in response to cytokines released by 
Th17 cells, they then release cytokines that induce increased cytokine 
production by Th17 cells. This scenario leads to tissue damage and further 
exacerbates the inflammatory response (Raphael et al., 2014). 
1.4.4 Regulatory T-cells 
At least two types of Treg have been identified, natural Tregs (nTreg), which 
develop in the thymus as a distinct lineage and upon entering the periphery 
their role is to suppress auto-reactive T-cells. Inducible Tregs (iTreg), leave 
the thymus as naïve T-cells and differentiate into iTregs in response to TGF-
β. Their role is to suppress the immune response and regulate inflammation 
by producing cytokines such as TGF-β and IL-10 (Noack and Miossec, 2014). 
IL-10 has been shown to act on antigen presenting cells (APCs) by causing 
them to down regulate MHC II and the co-stimulatory molecules CD80 and 
CD86, which reduces their ability to activate CD4+ T-cells via antigen 
presentation. IL-17 production, associated with Th17 cells is suppressed by 
TGF-β (Raphael et al., 2014). As such, iTregs are believed to have a function 
in counteracting Th17 mediated diseases (Noack and Miossec, 2014). 
1.4.5 Follicular helper T-cells (Tfh) 
Follicular helper T-cells are involved in initiating and regulating the B-cell 
germinal centre reaction. The induction of Tfh differentiation is still subject 
to investigation, but it is thought to be dependent on interactions with 
dendritic cells. Cytokines produced by dendritic cells vary depending the 
nature of antigen encountered and the subset, which is also thought to be 
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important. For example IL-6 leads to expression of the cytokine receptor 
CXCR5, which allows homing to the germinal centre (Ballesteros-Tato and 
Randall, 2014; Yu and Vinuesa, 2010). 
(Raphael et al. 2014; Yu & Vinuesa 2010; Ballesteros-Tato & Randall 2014) 
1.5 B-cells 
B-cells have a diverse range of functions within the immune system, 
although they are most well-known for providing immunological memory as 
memory B-cells, and also the production of highly specific antibodies, as 
differentiated plasma cells. Following development in the bone marrow and 
migration into secondary lymphoid organs such as the spleen, they continue 
Subset + 
markers 
Factors promoting 
differentiation 
Cytokine 
production 
Effects 
Th1 IFN-y, IL-2, IL-12, 
strong TCR signals 
IFN-y, TNF Pro-inflammatory 
Increased TLR expression, B-cell CSR 
to IgG, increased MHCI and MHCII 
antigen presentation 
 
Th2 IL-4, IL-25, IL-33 IL-4, IL-12, 
IL-13 
Anti-inflammatory 
Defence against parasites, B-cell CSR 
to IgG1 and IgE, suppression of Th1 
differentiation 
 
Th17 IL-23, TGF-b, IL-21, 
IL-6 
IL-17, IL-10, 
IFN-y 
Pro-inflammatory and anti-
inflammatory 
GC induction, enhances PC 
differentiation, reduces B-cell 
apoptosis 
 
T-regs TGF- TGF-b, IL-10 Anti-inflammatory  
Down regulates MHCII and co-
stimulatory molecules on APCs, 
activates B-cells, inhibit IL-17 
production, may suppress allergic 
responses mediated by Th2, 
enhances PC differentiation. 
 
Tfh IL-21, IL-6 
possibly IL-12 
IL-21, IL-4 Initiating and regulating the GC 
reaction. Positive selection of 
proliferating B-cells. 
Table 1.3 T-cell subsets 
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to differentiate in response to their environment. Differentiation into one 
of the B-cell subsets, is associated with changes in cytokine profile, 
expression of surface markers and specific effector or regulatory functions 
(Allman and Pillai, 2008; Lund, 2008). 
1.5.1 B-cell development and the B-cell receptor 
The pro-B-cell is the earliest cell of the B-lineage within the bone marrow 
(Figure 1.7) and is defined by gene rearrangement of the immunoglobulin 
heavy chain (IgH). Gene rearrangement occurs following the induction of 
the variable (V), diversity (D), joining (J) recombinases known as RAG-1 and 
RAG-2 (recombination activating gene).  
 
 
 
 
 
 
Successful V (D) J recombination results in the expression of the μ heavy 
chain which signals the B-cell to produce a pre-B-cell receptor (pre-BCR), if 
IgHμ is not produced the pro-B-cell undergoes apoptosis (negative 
selection). 
Early pro-B Late pro-B Large pre-B Small pre-B Immature 
T1, T2, T3 
Mature 
CD19 
B220/ CD45R 
Surrogate light chains 
Pre-BCR 
BCR (IgM) 
BCR (IgD) 
CD23 D-JH V-DJH V-J 
V

-J

 Gene rearrangement 
Figure 1.7 B-cell development. B-cells are produced in the bone marrow and undergo a 
series of developmental stages, including gene rearrangement of the B-cell receptor 
(BCR) to produce an antigen receptor with unique specificity. Upon expression of a 
functional BCR, immature B-cells enter the periphery and migrate to secondary lymphoid 
organs such as the spleen as immature transitional (T) B-cells. There are three stages of 
transition; T1, T2 and T3. Adapted from Parham (2014). 
48 
 
In addition to the IgH-μ, assembly of the pre-BCR involves production of 
surrogate light chains (λ5 and VpreB) and Igα (CD79α) and Igβ (CD79β). 
Expression of the pre-BCR signifies the B-cells’ transition into a large pro-B-
cell, and it undergoes proliferation before transitioning into a small pre B-
cell. Rearrangement of the light chain occurs following re-expression of the 
RAG proteins, which results in each of the clones having a different antigen 
specificity due the variation in light chain rearrangement. The rearranged 
light chains, Igα and Igβ assemble with IgHμ to form the BCR, which is a 
membrane bound IgM. The expression of membrane bound IgM signifies 
the transition from late pre-B-cell to immature B-cell. (Janeway et al., 2001). 
 
 
1.5.2 Selection of immature B-cells 
The diversity of the BCR created by random gene arrangements during BCR 
development increases the number of pathogenic antigens recognised with 
Figure 1.8 Schematic of the mature BCR. Following V (D) J rearrangement of heavy chain, 
rearrangement of the light chain and production of Ig and Ig, the mature B-cell antigen 
assembled and expressed of the cell surface. Adapted from Berry et al (2011). 
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extreme specificity, allowing an effective immune response to occur. 
However, it also has the potential to create a BCR that recognises self-
antigens, thereby triggering an inappropriate response as seen in 
autoimmune diseases (Ireland et al., 2012; Montes et al., 2007; 
Vossenkämper et al., 2012). Therefore, before being released into the 
periphery, immature B-cells are subject to rigorous positive and negative 
selection processes. To maintain self-tolerance, immature B-cells that 
recognise self-antigens can be directed to undergo apoptosis, known as 
clonal deletion (Chung et al., 2003). If self-antigen binding to the BCR is weak 
the B-cell can be rescued by a process known as receptor editing, which 
involves additional rearrangement of the light chain, providing an 
opportunity to produce a BCR that no longer recognises self-antigen (Edry 
and Melamed, 2004). Evidence of receptor editing, by identifying secondary 
rearrangements in the light chain locus, have been observed in more than 
half of immature B-cells within the bone marrow (Melchers, 2006). B-cells 
can also be rendered anergic following recognition of self-antigen, which 
renders the cell unable to respond to activation via antigen binding (Sandel 
and Monroe, 1999). Anergic B-cells have a reduced lifespan, and altered 
signalling that results in arrested development, therefore minimising the 
risk of releasing autoreactive cells into the periphery (Merrell et al., 2006). 
Immature B-cells also undergo positive selection to allow them to continue 
differentiating. This involves the BCR providing low level, antigen 
independent survival signals. However, in order to generate these ‘tonic’ 
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survival signals, the BCR must be expressed at sufficient levels. Failure to 
express a sufficient number of BCRs to provide ‘tonic’ signalling results in 
arrested differentiation and apoptosis (Pelanda and Torres, 2012). 
1.5.3 Immature transitional B-cells 
Following the expression of functional BCR and survival of initial selection 
processes in the bone marrow, immature B-cells migrate towards the spleen 
to continue the maturation process (Carsetti et al., 1995; Loder et al., 1999) 
B-cell maturation in the periphery is typically described as a sequential 
process. Immature B-cells arrive in the spleen from the bone marrow as 
Transitional 1 (T1) where they reside in the red pulp before developing into 
Transitional 2 (T2) B-cells and from T2 to mature B-cells. Transitional B-cells 
undergo additional negative and positive selection before maturation. In 
response to BCR engagement T1 B-cells are subject to negative selection, as 
transitional B-cells cells do not engage in receptor editing, this leads to 
apoptosis (Luning Prak et al., 2011; Wang et al., 2007). It is thought that T2 
cells are no longer sensitive to negative selection in response to BCR 
engagement. However, they undergo positive selection which is thought to 
be regulated by B-cell activating factor (BAFF). In response to BCR 
engagement, T2 cells upregulate expression of the BAFF receptor (BAFF-R), 
in order to compete for BAFF in the local environment. Failure to upregulate 
BAFF-R in response to BCR engagement also leads to apoptosis (Tussiwand 
et al., 2012; Wang et al., 2007). 
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A third immature transitional stage has also been described (T3) (Allman et 
al., 2001). It is thought that T3 B-cells arrive in the spleen having been 
rendered anergic as a method of silencing autoreactivity, which suggests 
that T3 are not actually transitional, as they are not undergoing maturation. 
T3 cells have been identified in unimmunized wild type mice, which might 
indicate that they are a normal physiological occurrence (Cambier et al., 
2007; Merrell et al., 2006), and although anergy is a method to silence 
autoreactivity, it has been shown to be reversible (Cambier et al., 2007). The 
hyporesponsive phenotype is maintained by chronic BCR engagement and 
can be reversed if the BCR is no longer bound to autoantigen, which under 
specific conditions may provide a source of self-reactive antibodies (Yarkoni 
et al., 2010). Studies in mice have shown that disruption of Src homology-2 
(SH2)-containing inositol 5-phosphatase (SHIP-1) signalling, which is 
involved in maintaining anergy, leads to the production of self-reactive 
antibodies and development of a lupus-like autoimmune disease (O’Neill et 
al., 2011). In a comparative study of four different strains of lupus prone 
mice and four different strains of wild type mice, there was a significant 
reduction of T3 B-cells in the lupus prone strains (Teague et al., 2007). 
1.6 B-cell markers: Cluster of differentiation (CD) 
The development of monoclonal antibodies (mAb) recognising different 
epitopes of the same surface antigen gave rise to various names being 
attributed to the same molecule. The cluster of differentiation (CD) 
nomenclature was designed to provide clarity by grouping together mAbs 
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based on the antigen rather than the specific epitope (Chan et al., 1988). 
Although originally designed for human antigens, the CD nomenclature is 
also applied to mouse antigens. When a mouse antigen is identified as a 
human homologue it is assigned the same CD identification (Lai et al., 1998). 
Identification of CD markers is useful in many aspects of cell biology, but 
plays a particularly important role for immunophenotyping. 
1.6.1 B220 (CD45R) 
Alternatively spliced isoforms of the tyrosine phosphatase CD45 are 
expressed on cells of myeloid lineage (Loder et al., 1999). B220, also known 
as CD45R is the isoform expressed on the surface of B-cells, from the pre-B-
cell developmental stage through to B-cell maturity (Hardy and Hayakawa, 
2001). Although minor subsets of Natural Killer (NK) cells and T-cells can be 
B220+, it is generally considered as a pan B-cell marker. 
In B-cells, B220 is primarily associated with positive regulation during BCR 
activation. Experiments using splenic B-cells from CD45 knock out mice 
revealed hyper-phosphorylation of Lyn following BCR activation. Lyn’s role 
in negative regulation via activation of CD22 (Sections 1.6.3 and 1.6.4), 
indicates that B220 serves as a positive regulator in B-cell activation, which 
is further supported by the observation that overexpression of CD45 leads 
to inactivation of Lyn (Shrivastava et al., 2004; Zikherman et al., 2012). A 
potential role in B-cell development in the bone marrow was uncovered by 
showing that upregulation of CD45 could increase BCR signal strength 
leading to increased populations of immature B-cells with secondary 
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rearrangements of the BCR light chain (Section 1.5.1), suggesting that CD45 
might be involved in receptor editing (Zikherman et al., 2012). 
1.6.2 The CD19 complex 
CD19 is a transmembrane receptor protein that controls the threshold 
required to induce B-cell activation (Inaoki et al., 1997; Tedder et al., 1997). 
CD19 expression is present on follicular DCs, however, it is predominantly 
found on the surface of B-cells from the pro-B stage of development until 
differentiation into a plasma cell (Tedder et al., 1997) and as such it is 
considered a pan B-cell marker (Wang et al., 2012). 
CD19 has been shown to bind, internalize and present antigen to CD4+ T-
cells in vivo, in doing so the co-stimulatory proteins CD80 and CD86 (also 
known as B7.1 and B7.2, respectively) are upregulated ensuring effective 
CD4+ T-cell activation (Yan et al., 2005). Although CD19 has been shown to 
elicit other independent functions (Chung et al., 2012; Hampel et al., 2011), 
its role is typically associated as part of a larger complex that can associate 
with the BCR. 
The CD19/CD21 complex, as it is frequently known, includes CD21, 
(complement receptor 2), CD225 known as Leu-13 or IFITM (Interferon-
induced transmembrane protein) and CD81, which is also referred to as 
TAPA1 (target of the anti-proliferative antibody 1). As CD81 and CD225 are 
found in a complex in several cell types, it is thought that the presence of 
additional signalling proteins, such as CD19 produce lineage specific 
signalling effects (Tedder et al., 1997). 
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CD19 activity is regulated by phosphorylation of tyrosine residues within the 
cytoplasmic tail. Of the nine tyrosine residues (Y), differential 
phosphorylation of three particular residues (CD19-Y513, CD19-Y482 and 
CD19-Y391) have been shown to be important for regulating CD19 function. 
The location of CD19, either within or outside of lipid rafts has also been 
shown to impact on the phosphorylation profile (Ishiura et al., 2010; Wang 
et al., 2002). Following activation, the BCR clusters within lipid rafts and 
CD19 has been shown to maintain the BCRs localisation and prolong the BCR 
signal by preventing BCR internalisation (Cherukuri et al., 2001). 
CD19 regulates the response to LPS stimulation via toll-like receptor 4 (TLR4) 
and is attributed with production of IL-6, IL-10 and TGF-β (Iwata et al., 2009), 
which suggests a role in the innate immune response. Phosphorylation of 
CD19 following LPS stimulation, leads to the formation of a complex with 
the tyrosine kinase; Lyn, and Vav (Yazawa et al., 2003). It has also been 
suggested that this complex is constitutively expressed, and is important for 
regulating tonic signalling (Fujimoto et al., 1999). 
The role of CD19 is typically linked to positive regulation including 
proliferation and increased survival (Hasegawa et al., 2001b). As such, over 
expression of CD19 has been shown to lead to a break in tolerance and 
predispose B-cells to autoantibody production (Hasegawa et al., 2001a; 
Inaoki et al., 1997). In addition to the production of antibodies, B-cells play 
an important role in T-cell activation (Yan et al., 2005), and cytokine 
secretion via CD19 (Fujimoto and Sato, 2007). 
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1.6.3 Lyn 
Src family protein tyrosine kinases (SFKs) have six functional domains and 
share a strong structural and functional homology (Gauld and Cambier, 
2004). In B-cells Lyn is constitutively associated with lipid rafts (Gupta and 
DeFranco, 2007) and has been shown to mediate several cell fates, including 
negative selection of immature transitional B-cells that exhibit a strong BCR 
signal, by phosphorylating Syk which activates apoptotic pathways. 
Independently of Syk, Lyn is also thought to induce B-cell anergy following 
a weak interaction with self-antigen. Lyn exerts control on positive and 
negative signalling following BCR activation by phosphorylating both CD19 
and CD22 and a hyper-responsive phenotype has been observed in Lyn 
deficient B-cells (Gauld and Cambier, 2004). Negative signalling attributed 
to Lyn includes the phosphorylation of immunoreceptor tyrosine-based 
inhibition motifs (ITIMs) in negative regulatory co-receptors such as CD22 
and FcyRIIB (Tsubata, 2012). In addition Lyn mediates negative regulation 
by phosphorylating an immunoreceptor tyrosine-based activation motif 
(ITAM) on CD79a (Figure 1.8), which although is normally associated with 
positive regulation, also activates the phosphatase SHIP-1. Dysregulation of 
this regulatory pathway has been linked to a loss of anergy, resulting in 
autoimmunity (O’Neill et al., 2011). 
1.6.4 CD22 
CD22 is a negative regulatory co-receptor of the BCR. Binding with its ligand 
α2, 6-linked sialic acid (2,6sia) results in the formation of homo-oligomers 
which are distinct from the BCR until activation. Recruitment of CD22 to the 
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BCR follows BCR activation at which point CD22’s two cytoplasmic 
immunoreceptor tyrosine-based inhibition motifs (ITIMs), are 
phosphorylated by Lyn (Nitschke, 2014). ITIM phosphorylation leads to the 
recruitment of phosphatases such as Src homology 2 domain containing 
protein tyrosine phosphatase-1/2 (SHP-1), SHP-2 and SH-2-containing 
inositol phosphatase (SHIP). The resulting dephosphorylation of 
downstream effectors inhibits signalling pathways triggered by BCR 
activation (Tsubata, 2012). Targets for dephosphorylation include CD19 and 
Vav-1 (Walker and Smith, 2008). 
Using primary splenic B-cells from wild-type mice, CD22 has been shown to 
co-immunoprecipitate with Grb2, in addition to SHIP and Shc. It has been 
proposed that CD22 acts as a scaffold to mediate docking and that the 
complex negatively regulates calcium influx (Poe et al., 2000). CD22 may 
also play a role in regulating the strength of tonic signalling by moderating 
the strength of the signal generated by the BCR. Although the majority of 
mature peripheral B-cells express CD22, expression is downregulated in 
germinal centre B-cells, which are proliferating and in an activated state. 
This is thought to be a result of stimulation via CD40 which is necessary for 
the T-cell dependent (TD) activation required for the induction and 
maintenance of the germinal centre reaction (Section 1.8) (Poe et al., 2012). 
1.6.5 CD23 
CD23 is the low affinity receptor for IgE, also known as FcεRII. Surface 
expression is absent from immature, and T1 B-cells, and with the exception 
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of MZ B-cells which are CD23 negative, it is expressed on mature naïve B-
cells (Best et al., 1995). The differential expression of CD23 makes it useful 
for identifying the maturational state of B-cells. Following BCR activation, 
CD23 expression is briefly increased before being down-regulated until 
expression is lost on B-cells following class switch recombination  (Rabin et 
al., 1992). The microenvironment has been shown to influence CD23 
expression and IL-4 has been shown to upregulate CD23, whereas the 
presence of IFN-γ inhibits expression (Sukumar et al., 2006). 
Surface CD23 is thought to negatively regulate IgE synthesis, which is 
supported by the observation that loss of CD23 in mice is associated with 
increased IgE production (Gould and Sutton, 2008). It has also been 
proposed that antigen/IgE complexes can be presented to naïve T-cells via 
surface CD23, leading to T-cell proliferation (Carlsson et al., 2007). However, 
more recent findings suggest that CD23+ B-cells transport the IgE/antigen 
complex to dendritic cells, which activate CD4+ T-cells (Henningsson et al., 
2011). 
While binding of surface CD23 inhibits production of IgE, soluble CD23 has 
been shown to both negatively and positively regulate IgE production. This 
appears to be due to differences in oligomerization that occur depending 
on how CD23 is cleaved from the cell surface (Acharya et al., 2010). Cleavage 
by the dust mite related protease der p1 produces a monomeric soluble 
CD23 which inhibits IgE synthesis (Hibbert et al., 2005) When cleaved by the 
metalloproteinase ADAM10 (Lemieux et al., 2007), soluble CD23 forms a 
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trimer, which has been found to increase IgE production (Acharya et al., 
2010). 
Given its potential regulation of IgE, CD23 has become a target for research 
into allergy and asthma (Gould and Sutton, 2008). In particular the 
stabilization of surface CD23, which would reduce soluble CD23 (Bowles et 
al., 2011). 
1.6.6 Toll like receptors (TLRs) 
While the highly antigen specific BCR is the key to an adaptive humoral 
immune response, TLRs link B-cells to the innate immune system. TLRs are 
a type of pattern recognition receptor (PRR) that recognise a unique 
molecular pattern that is typically found in a bacteria but not in the host, 
and individual TLRs are specific for a particular pathogen-associated 
molecular pattern (PAMP) (Pone et al., 2010). The range of PAMPs 
recognised by TLRs include polysaccharides, lipoproteins, lipids, and 
proteins from bacteria, viruses and parasites. In mice, lipopolysaccharide 
(LPS) is recognised by TLR4, and upon activation a complex is formed with 
the adapter protein MD2. This triggers a MyD88 dependent pathway, the 
complex is then internalized which triggers a second signalling pathway. 
Both pathways are required to activate NF-κΒ which results in the 
production of inflammatory cytokines (Kawai and Akira, 2010). 
1.7 B-cell subsets in the spleen 
B-cell subsets in mice are typically separated into B1 and B2. In the spleen 
the predominant population is B2 B-cells, which can be further separated 
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into transitional B-cells (Section 1.5.3), follicular (Fo), marginal zone (MZ) 
and regulatory B-cells (Bregs) (Baumgarth, 2011). 
1.7.1 Follicular B-cells 
Follicular B-cells (Fo) (Section 1.3.3) are the major population in the spleen, 
accounting for approximately 70% of total B-cells (Baumgarth, 2011). B-cells 
enter the spleen from the circulation and migrate towards the follicles in 
response to the chemokine CXCL13 (Shen and Fillatreau, 2015). The Fo 
population predominantly consists of recirculating naïve B-cells (Fillatreau 
et al., 2008), and are the primary population to take part in the germinal 
centre reaction following T-cell dependent (TD) activation. T-cell dependent 
activation is necessary for Fo B-cells to differentiate into either short lived 
plasma or long lived antibody secreting plasma cells (Lund, 2008). Fo B-cells 
have an interdependent relationship with follicular dendritic cells (FDCs) via 
production of LTα1β2, which induces FDCs to produce CXCL13 and the 
presence of CXCL13 results in further production of LTα1β2. Fo B-cell 
derived LTα1β2 is also required to support stromal cells in the T-cell rich 
PALS (Section 1.3.2), as such they play an important role in maintaining the 
local environment (Shen and Fillatreau, 2015). 
1.7.2 Marginal zone B-cells 
Due to their location, marginal zone (MZ) B-cells provide a link between 
innate and adaptive immunity (Section 1.3.1). Mouse MZ B-cells are 
typically non-circulating and account for between 5-10% of the splenic B-
cell population (Loder et al., 1999). Although this population is non-
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circulating, MZ B-cells have been shown to be highly motile and migrate 
between the MZ and the follicles to present antigen to FDCs (Arnon et al., 
2013). Unlike Fo B-cells, MZ B-cells can be activated in a TD or a T-cell 
independent (TI) manner via interaction with innate antigen presenting 
cells, and in response are able to rapidly differentiate into antibody 
secreting plasmablasts (Cerutti et al., 2013). Production of IL-10 indicates 
that MZ B-cells have regulatory properties and recently it has been 
proposed that Bregs may be derived from Transitional 2 MZ precursors 
(T2MZP) (Lund, 2008; Mauri and Bosma, 2012). 
1.7.3 Regulatory B-cells 
Regulatory B-cells (Bregs) account for 1-2% of the splenic B-cell population. 
There may be more than one subset of regulatory B-cell, as some studies 
suggest that the only regulatory cytokine produced is IL-10 (Matsushita et 
al., 2010), while others have described the production of both IL-10 and 
TGF-β (Lund, 2008). Bregs have been shown to indirectly suppress T-cell 
activation by inhibiting antigen presentation of monocytes and dendritic 
cells. They have also been studied during the induction of experimental 
autoimmune encephalomyelitis (EAE), which is a mouse model of multiple 
sclerosis (MS). By suppressing the production of IFNγ and TNFα by CD4+ T-
cells, disease severity was moderated (Matsushita et al., 2010). Bregs are 
thought to be derived from T2 marginal zone pre B-cells (T2-MZP) (Mauri 
and Bosma, 2012). 
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1.8 Germinal centre reaction 
Germinal centres (GCs) are the source of long lived plasma cells that 
produce high affinity antibodies following class switch recombination (CSR) 
and somatic hypermutation (SHM) (Section 1.8.1), memory B-cells are also 
a product of the GC reaction. Within the follicles B-cells interact with a 
network of antigen presenting dendritic cells and upon interaction with 
their cognate antigen, naïve B-cells migrate to the edge of the periarterial 
lymphoid sheath (PALS). This area is rich in helper T-cells (Th), and 
interaction with Th via costimulatory molecules CD40, expressed by B-cells 
and CD154 (also known as CD40L) which is expressed by T-cells results in B-
cell activation. At this point the B-cell can either differentiate into a short 
lived plasma cell outside of the follicle, or re-enter the follicle and initiate 
the GC reaction (Klein and Dalla-favera, 2008). It is thought that class switch 
recombination (CSR) is initiated at this point, following the initial B-cell-Tfh 
interaction (Vinuesa et al., 2009). Re- entry to the follicle is dependent on 
the expression of the chemokine receptor CXCR5, which is upregulated in 
response to Th interaction (Allen et al., 2007). In the follicle, activated B-
cells undergoes rapid proliferation, cell cycle can occur in as little as 6-12 
hour (Klein and Dalla-favera, 2008), and a preliminary GC can be identified 
approximately four days post initiation. 
Following initial proliferation, B-cells migrate to the light zone (LZ) in 
response to the chemokine CXCL12 by upregulating the receptor CXCR4 
(Klein and Dalla-favera, 2008). As they enter the LZ, interaction with FDCs 
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expressing integrin vascular adhesion molecule 1 (VCAM1) helps to increase 
contact, providing the best chance for B-cells to bind antigen (Gatto and 
Brink, 2010). Antigen is then presented to Tfh via MHC II. Germinal centre 
B-cells are highly susceptible to apoptosis following down-regulation of 
factors such as BCL-2, and they rely on survival signals provided by Tfh and 
FDCs. B-cells that fail to present antigen to Tfh undergo apoptosis in the 
absence of these signals (Vinuesa et al., 2009). B-cells that are most 
successful at binding antigen with high affinity receive survival signals and 
are directed back to the dark zone (DZ) to undergo SHM to produce a BCR 
with even higher antigen affinity, and CSR which defines antibody isotype 
(De Silva and Klein, 2015). This cycle of shuttling back and forth between the 
DZ and LZ is thought to happen repeatedly, producing B-cells with 
increasingly high affinity antigen receptors. It also allows successive rounds 
of CSR. It is currently unknown what causes cessation of the GC reaction and 
the release of newly differentiated plasma cells and memory cells into the 
circulation (De Silva and Klein, 2015; Oropallo and Cerutti, 2014). Although 
it is thought that modulation of the sphingosine 1-phosphate receptors may 
play a role (Green et al., 2011). 
1.8.1 Class switch recombination (CSR) and somatic hypermutation 
(SHM) 
CSR, also known as isotype switching involves rearrangement of the genes 
that encode the heavy chain constant region (CH) of the immunoglobulin, 
and is influenced by cytokines in the environment, such as IL-4 which 
produces a switch to IgG1 and IgE (Deenick et al., 2005). Murine B-cells can 
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switch heavy chain from Cμ to Cγ1, Cγ2a, Cγ2b, Cγ3, Cα and Cε, producing 
IgG1, IgG2a, IgG2b, IgA and IgE (Figure 1.9). Antigen specificity is 
unchanged, but differences in isotype allows for a broader range of effector 
functions to a single antigen. The process of SHM modifies the antigen 
binding site which requires rearrangement of the variable regions of both 
the immunoglobulin heavy chain (IgH) and the immunoglobulin light chain 
(IgL). Although these processes can occur at the same time and require 
activation-induced cytidine deaminase (AID), they are independent events 
(Chaudhuri and Alt, 2004). 
Germinal centre CSR occurs in a TD manner by way of antigen engagement 
and CD40, which is expressed on B-cells and CD40 ligand (CD40L), expressed 
by Tfh (Durandy et al., 2013). However, CSR can also occur following TI 
activation, , which is also independent of CD40/CD40L (Castigli et al., 2005; 
Cerutti et al., 2013; Kim et al., 2011). This is associated with the induction of 
AID by the transmembrane activator and calcium-modulator and cytophilin 
ligand interactor (TACI) and also B-cell activation factor (BAFF) (Castigli et 
al., 2005; Kim et al., 2011). 
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CSR requires the generation of double stranded breaks in the switch region 
of the transcript which is initiated by AID. The double stranded breaks are 
repaired by a process known as non-homologous end joining (NHEJ) during 
G1 of the cell cycle. The excision of the region between the two switch 
regions results in the production of an alternative isotype (Chaudhuri and 
Alt, 2004). B-cells have been shown to undergo both direct CSR, as shown 
in Figure 1.9 and sequential class switching, in which regions are removed 
separately, which, for example, could produce IgG1 and then IgE following 
additional CSR. It has been shown that sequential switching to IgE can result 
in high affinity antibodies that have been associated with anaphylaxis in 
mice (Xiong et al., 2012). 
  
AID
AID AID
AID
Figure 1.9 Schematic of class switch recombination (CSR). Activation-induced cytidine 
deaminase (AID) targets switch regions on the on the constant heavy (CH) chain. Following 
a double stranded break in the DNA, a non-homologous end joining (NHEJ) event 
recombines the DNA excluding the excised sequence. Depicted above is CSR from IgM to 
IgA. Adapted from Stavnezer et al. (2008). 
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1.9 Hypothesis 
The Class II Phosphoinositide 3-kinase enzyme PI3K C2β has been linked to 
a variety of cellular processes. Recently a role for PI3K C2β was described in 
T-cells, where it mediates Ca2+ signalling via the potassium channel KCa3.1. 
The increased intracellular Ca2+ associated with the efflux of K+ following 
KC3.1 activation is required for full T-cell activation (Srivastava et al., 2009). 
Inhibition of KCa3.1 has been shown to ameliorate colitis in a mouse model 
of the disease, which was due to defective CD4+T-cell receptor signalling, 
resulting in a reduction in T-cell activation (Di et al., 2010). A recent study 
revealed that the bioactive lipid ceramide was effective at inhibiting PI3K 
C2β mediated metastasis in ovarian cancer cells (Kitatani et al., 2015), while 
in oesophageal squamous cell carcinoma, loss of PI3K C2β was shown to 
increase the efficacy of cisplatin mediated apoptosis (Liu et al., 2011). 
However, mice deficient in PI3K C2β do not appear to be negatively affected 
by its loss. The mice are viable and fertile, with no obvious health defects 
(Harada et al., 2005). In our laboratory, PI3K C2β mice were rederived 
and also found to be viable and fertile. However, when provided with an 
immune challenge PI3K C2β mice displayed a heightened immune 
response that was not observed in the control mice (Balakrishnan, 2012).  
My hypothesis was that mice deficient in PI3K C2β are predisposed to a 
heightened immune response.  
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1.10 Aim 
The aim of my project was to identify whether splenocytes from PI3K 
C2 mice could predispose the mice to an altered immune response. 
1.11 Objectives 
Chapter 3 
Question: Does the loss of PI3K C2 result in a specific phenotype? 
Following an immunological challenge, can a change be identified between 
the spleens of PI3K C2 and control mice?  
Data were collected over an eighteen month period to determine whether 
PI3K C2 mice displayed an altered phenotype compared to the control 
mice, this included breeding data, animal weight and spleen weight. To 
study the effect of an immunological challenge, the spleens from control 
and PI3K C2 mice were examined using either mice kept under basal 
conditions or following immunization with sheep IgG and complete Freund’s 
adjuvant (CFA). Immunohistochemistry was performed to compare 
germinal centre reactions, between PI3K C2 and control mice under 
both conditions. Differences in spleen weight as a percentage of animal 
weight were also recorded. 
Chapter 4 
Question: Under basal conditions, are there any differences in lymphocyte 
populations from PI3K C2 mice that might predispose them to a 
heightened immune response?  
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Lymphocyte populations from PI3K C2and control mice were 
quantified. T-cell populations were examined at 0 hr and within splenocyte 
cultures following stimulation. B-cells were also examined at 0 hr and as part 
of a total splenocyte culture following stimulation. Splenocyte viability was 
examined, as differences may provide insight into the previously observed 
heightened immune response seen in PI3K C2mice. 
Chapter 5 
Question: Could the differences between the control and PI3K C2 
splenic B-cells identified in chapter 4 provide a mechanism for an altered 
immune response? 
 B-cell population analysis was performed using isolated B-cells at 0 hr post 
isolation and following stimulation. To identify whether PI3K C2 B-cells 
exhibited an altered activation threshold in comparison to control B-cells, 
isolated B-cell cultures were stimulated with optimal and sub-optimal 
concentrations of lipopolysaccharide (LPS) and IL-4.  Viability, activation 
state and class switch recombination were assessed. 
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2 Materials and methods 
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Product  Product number Company 
10% neutral buffered formalin #HT501320 Sigma 
Agarose #A9539 Sigma 
Ammonia #A/3240/PB15 Fisher Scientific 
Ammonium acetate #09691 Sigma 
Ammonium persulphate #248614 Sigma 
Annexin V-FITC Apoptosis Detection Kit #ab14085 Abcam 
Antibiotic-antimycotic #152-062 Gibco 
Anti-CD19 (Rabbit) #3574 CST 
Anti-CD45R (Rat) #Ab64100 Abcam 
Anti-CD45R (Rat) isotype control #Ab18450 Abcam 
Anti-PCNA (Rabbit) #Ab2426 Abcam 
Anti-PCNA IgG (Rabbit) isotype control #Ab27472 Abcam 
Anti-phospho-MEK1/2 #9121 CST 
Anti-PI3K C2 (rabbit)  #sc-134766 Santa Cruz 
Anti-rabbit secondary antibody (HRP) #P0448 Dako 
Anti-mouse secondary antibody (HRP) #P0447 Dako 
 mercaptoethanol #11508916 Fisher Scientific 
(Gibco) 
BCA protein assay kit #23225 Pierce 
Blue Juice #10816-015 Fisher Scientific 
Bromophenol blue #403140100 Sigma 
BSA #A7030 Sigma 
Chloroform #C/4920/15 Fisher Scientific 
Complete Freund’s adjuvant #F5881 Sigma 
Dako Envision+ System-HRP/DAB #K4010 Dako 
DPX mounting media #06522 Sigma 
EDTA # 03690 Sigma 
Ethanol (absolute) #E/0650DF/17 Fisher Scientific 
Ethanol (IMS) #M/4450/17 Fisher Scientific 
FBS #EU-000F (150201) Sera Labs 
Glycine #G/0800/600 Fisher Scientific 
Harris haematoxylin #HHS80 Sigma 
LPS #L4392 Sigma 
Lympholyte M #CL5030 Cedarlane  
Lyophilised sheep IgG #I5131 Sigma 
Methanol #10284580 Fisher Scientific 
MTT #15224654 Fisher Scientific 
(Acros) 
NaCl #10112640 Fisher Scientific 
Non-essential amino acids #12084947 Gibco 
Table 2.1 Details of the reagents used during the project. 
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Product Product number Company 
Pan B-cell isolation kit #130-095-813 Miltenyi Biotec 
Pan T-cell isolation kit #130-095-130 Miltenyi Biotec 
Propidium Iodide #ABIN412371 eBioscience 
Proteinase-K #P2308 Sigma 
Protoscript First Strand cDNA Synthesis Kit #E6300S NEB 
QIAquick Gel Extraction Kit #28104 Qiagen  
ReadyMix #P4600 Sigma 
Recombinant IL-2 #402-ML-020 R&D Systems 
Recombinant IL-4 #404-ML-010 R&D Systems 
RNAse A #R6513 Sigma 
RPMI 1640 media #11879020 Fisher Scientific 
(Gibco) 
SDS #10607443 Fisher Scientific 
Seroblock #BUF041B AbD Serotec 
Sodium azide #12695107 Fisher Scientific 
(Acros) 
Sodium citrate #10787024 Fisher Scientific 
Sterile PBS #10388739 Fisher Scientific 
T-cell activation/expansion kit #130-093-627 Miltenyi Biotec 
TEMED #T9281 Sigma 
Tris base #10724344 Fisher Scientific 
Tris HCl #10001223 Fisher Scientific 
Triton-X-100 #X100 Sigma 
Tween-20 #P9416 Sigma 
Xylene #534056 Sigma 
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2.1   PI3K C2β   and control mice 
Previously generated PI3K C2β mice (Harada et al., 2005) were rederived 
in our lab (Balakrishnan, 2012), and maintained at Burlington Danes unit, 
Central Biomedical Services (CBS) facility, Hammersmith Campus, Imperial 
College, London. All procedures were carried out within British Home Office 
regulations and ethical guidelines (Animals (Scientific Procedures) Act 1886) 
under Home Office project licence PPL70 7104 (Professor Charles Pusey) 
and my personal licence PIL 70/25001.  
2.1.1 Housing conditions of experimental animals 
Control and PI3K C2 mice were caged separately and kept in a pathogen 
free environment with air filtering technology, which is designed to prevent 
pollutants and particles from entering the facility. In addition, animals were 
kept in individually ventilated cages (IVCs), which results in air being 
ventilated twice. The mice had free access to the standard autoclaved chow, 
and autoclaved water and were re-caged weekly into clean IVCs.  Stocking 
density within the facility is seven mice, up to a weight of 30g. However, 
post weaning, mice were typically housed at a maximum of five animals per 
IVC. The cages were stacked, with the roofs of the top row being covered so 
that all mice experienced the same level of lighting. Rooms in which the 
mice are housed are programmed with ambient lighting, to reflect dusk and 
dawn. Individual experiments used groups of three mice, which were 
typically housed together. Repeat experiments would therefore use mice 
from different cages (Table 2.2). 
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3.1 Genotyping 20 26 
     
3.2 Breeding data 
(see Appendix 1) 
       
3.3 Animal weight 29 36 
     
3.4 Spleen weight as a 
percentage of bodyweight 
(IgG/CFA and basal) 
27 31 
 
F_18-35 
wk 
F_18-35 
wk 
  
3.5 PCNA and B220 
immunostaining of spleen 
from control and PI3K 
C2β   mice kept under 
basal conditions. 
4 6 
 
F_18-35 
wk 
   
3.6 PCNA and B220 
immunostaining of spleen 
from control and PI3K 
C2β mice treated with 
IgG/CFA. 
4 5 
 
F_18-35 
wk 
F_18-35 
wk 
  
3.7 Quantification of germinal 
centre associated 
proliferation. 
8 11 
 
F_18-35 
wk 
F_18-35 
wk 
  
4.1 Splenocyte population 
breakdown at 0 hr (B220, 
CD19) 
9 9 1,4,6 m_33-
35 wk 
m_31-33 
wk 
m_31-33 
wk 
 
4.1 Splenocyte population 
breakdown at 0 hr (CD4, 
CD8) 
12 12 1,4,6,7 m_33-
35 wk 
m_31-33 
wk 
m_31-33 
wk 
m_15-17 
wk 
4.2 Confirmation of T-cell 
populations within total 
splenocytes (CD3, CD4 dual 
staining) 
6 6 5,6 m_8-9  
wk 
m_31-33 
wk 
  
4.3 CD19 and B220 expression 
levels 
9 9 2,4,3 f_32-35 
wk 
m_31-33 
wk 
f_22-24 
wk 
 
4.4 Isolation of T-cells 
       
4.5 CD8+ cells within isolated T-
cell population at 72 hr 
3 3 8 m_16-
18 wk 
   
4.6 T-cell viability at 72 hr 4 4 5,8 m_8-9  
wk 
m_16-18 
wk 
  
4.7 T-cell populations (CD3, CD4, 
CD8) within total splenocyte 
cultures at 86 hr 
6 6 7,8 m_15-
17 wk 
m_16-18 
wk 
  
Table 2.2. Details of the experimental animals used in this project. 
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4.8 CD19+ populations within 
total splenocyte cultures at 
86 hr 
6 6 8,5 m_16-
18 wk 
m_8-9 wk 
  
4.9 Propidium iodide staining of 
splenocytes after 80 hr 
stimulation with LPS (20 
μg/ml) and IL-4 (50 ng/ml) 
6 6 4,6 m_31-
33 wk 
m_31-33 
wk 
  
5.1 Isolation of B-cells 
       
5.2 Presence of PI3K C2 in 
control mice 
3 3 
     
5.3 CD19 expression on isolated 
B-cells at 0 hr 
9 9 13,10,12 f_25-30  
wk 
f_28-31 
wk 
f_16-20 
wk 
 
5.4 B-cell viability at 24 hr 
(Annexin V and propidium 
iodide) 
6 6 11,10 f_24-26 
wk 
f_28-31 
wk 
  
5.5 B-cell viability at 72 hr 
(Annexin V and propidium 
iodide) 
9 9 11,10 f_24-26 
wk 
f_28-31 
wk 
  
5.6 B-cell metabolic activity 
(MTT assay) 
6 6 9,14 m_20-
24 wk 
m_16-18 
wk 
  
5.7 Cell cycle analysis at 0 hr, 24 
hr and 72 hr 
6 6 10,11 f_28-31 
wk 
f_24-26 
wk 
  
5.8 Analysis of the sub G0/G1, 
and G0/G1 populations 
6 6 10,11 f_28-31 
wk 
f_24-26 
wk 
  
5.9 IgM expression at 0 hr 12 12 10,11,7, 
13 
f_28-31 
wk 
f_24-26 
wk 
m_15-17 
wk 
f,25-30 
wk 
5.1 IgM expression profile at 0 hr 12 12 10,11,7, 
13 
f_28-31 
wk 
f_24-26 
wk 
m_15-17 
wk 
 
5.11 IgG expression at 0 hr 9 9 2,11,7 f_32-35 
wk 
f_24-26 
wk 
m_15-17 
wk 
 
5.12 IgE expression at 0 hr 6 6 2,5 f_32-35 
wk 
m_8-9 wk 
  
5.13 CD23 expression at 0 hr 9 9 10,11,13 f_28-31 
wk 
f_24-26 
wk 
  
5.14 CD23 expression profile at 0 
hr 
9 9 10,11,13 f_28-31 
wk 
f_24-26 
wk 
  
5.15 CD19hi, CD23hi population 
at 0 hr 
6 6 11,13 f_24-26 
wk 
f_25-30 
wk 
  
5.16 CD19, CD23 expression 
profile at 0 hr 
6 6 11,13 f_24-26 
wk 
f_25-30 
wk 
  
5.17 CD23low and IgMlow 
expression profile 0 hr 
3 3 10 f_28-31 
wk 
   
5.18 CD23- and IgMhi population 
at 0 hr 
3 3 10 f_28-31 
wk 
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5.19 IgG expression at 86 hr 
following optimal stimulation 
7 7 4,7 m_31-
33 wk 
m_15-17 
wk 
  
5.19 IgE expression at 86 hr 
following optimal stimulation 
6 6 4,7 m_31-
33 wk 
m_15-17 
wk 
  
5.20 IgG expression at 86 hr 
following sub-optimal 
stimulation 
9 9 2,11,7 f_32-35 
wk 
f_24-26 
wk 
m_15-17 
wk 
 
5.21 IgE expression at 86 hr 
following sub-optimal 
stimulation 
12 12 2,11,7 f_32-35 
wk 
f_24-26 
wk 
m_15-17 
wk 
 
5.22 IgM expression at 86 hr 
following sub-optimal 
stimulation 
9 9 2,11,7,10 f_32-35 
wk 
f_24-26 
wk 
m_15-17 
wk 
f_28-31 
wk 
5.23 CD23 expression at 86 hr 
following sub-optimal 
stimulation 
9 9 10,11,13 f_28-31 
wk 
f_24-26 
wk 
f_25-30 
wk 
 
5.24 MEK 1/2 2 2 
     
 
 
 
 
 
 
 
 
 
 
Details of the animals used during this project, including sex (m or f) and age in weeks (wk) 
with the corresponding experiment and figure number. Group numbers have been provided 
to indicate when mice were used for multiple experiments. * total number of animals used. 
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2.2 Extracting genomic DNA from ear punches. 
Ear punches were digested in lysis buffer (50 mM Tris-HCl (pH 8.0), 0.1 M 
NaCl, 1% SDS (sodium dodecyl sulphate), 20 mM EDTA (ethylene diamine 
tetra acetic acid) autoclaved) and 10 mg/ml proteinase-K (Sigma #P2308) 
overnight at 50˚C.  1.8 M ammonium acetate (Sigma #09691) was added to 
the tissue, it was then vortexed and incubated on ice for at least 10 minutes.  
Chloroform was added, before being centrifuged at 14000 rpm for 10 
minutes at 4˚C. Supernatant transferred to a tube containing 100% ethanol.  
After centrifugation at 14000 rpm for 5 minutes at room temperature, DNA 
was re-suspended in molecular grade water. 
2.3 Polymerase chain reaction (PCR) 
PCR was used to amplify gDNA from control and PI3K C2 mice for 
genotyping: PCR reactions contained 25 l of ReadyMix (Sigma #P4600), 10 
pm of each of the forward and reverse primers (control: 74/75 or PI3K 
C2 76/77), 50 ng of gDNA, and the volume was brought to 50 l using 
molecular grade water. The thermo cycler was set to:  Denature 950C for 
2min,  melt 950C  for 40sec, anneal 600C for 40sec, extension 720C  for 40sec  
and final extension 720C for 4min followed by an indefinite  hold at 40C for 
35 cycles (melt, anneal and extension). Reverse transcription was used to 
confirm the presence of PI3K C2 mRNA in B-cells from control mice with 
an expected product size of 858bp. Primers were designed to cross exons so 
that gDNA contamination could be excluded. PCR parameters were the 
same as before.  
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Control primers (74/75) 
Designation: 74/75 (expected product 300bp) 
Forward: 5'-GGCACACACTAACCACAGCACC-3' 
Reverse:  5'-TCGATGCACGT CTCTCCGC-3'  
 
PI3K-C2 primers (76/76) 
Designation: 76/77 (expected product 404bp) 
Forward: 5'-TGTTAGAACCTGCCGCCTTTAC-3’ 
Reverse:  5'-CCGAATCAGCCTCATTTCCTCTC-3’ 
 
Primers 235/235 (expected product size 858bp) 
Forward: 5'-TGTTAGAACCTGCCGCCTTTAC-3’ 
Reverse:  5'-CCGAATCAGCCTCATTTCCTCTC-3’ 
 
2.3.1 Agarose gel electrophoresis 
1.5% agarose gels were used to resolve PCR products (1.5% agarose (Sigma 
#A9539), in 1X TAE buffer), agarose powder was melted in 1x TAE buffer and 
allowed to cool to approximately 550C before adding ethidium bromide at 
0.5 g/ml. A DNA ladder and each of the samples in 10x loading buffer (Blue 
Juice ThermoFisher #10816-015)  were loaded on to the gel once set, and 
samples electrophoresed at 100V in TAE buffer for approximately 1hr 
before being visualized using UV light. 
2.3.2 DNA sequencing 
Following gel extraction (QIAquick Gel Extraction Kit; Qiagen #28104) of 
each PCR band, 100 ng of PCR product was resuspended 10 ml of molecular 
grade water and sent to Cambridge University for sequencing. 
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2.4 Sheep IgG and complete Freund’s adjuvant activation of mice 
Lyophilised sheep IgG (Sigma #I5131) was dissolved in saline (150 mM 
sodium chloride) to make a 10 mg/ml stock. For use, 20l of stock was 
diluted in l saline (per animal) and mixed with complete Freund’s 
adjuvant (CFA) in a 50:50 ratio (Sigma #F5881). Reagents were placed in a 
glass universal and mixed thoroughly using a hypodermic syringe until thick 
and opaque. Mice were given subcutaneous injections of 0.2 mg sheep 
IgG/CFA (400 l total volume) which were administered by technicians in 
Central Biomedical Services, Imperial College London. Mice were sacrificed 
after seven days by cervical dislocation. 
2.5 Measurement of spleen and body weight 
Body weight was measured at culling and spleens were excised and weighed 
immediately. To take into account the variability in animal weight, spleen 
weight was then calculated as a percentage of animal weight. 
2.6 Processing of spleens for histology and immunohistochemistry 
Freshly excised spleens were fixed overnight in 10% neutral buffered 
formalin (Sigma # HT501320), spleens were then transferred to 70% ethanol 
and taken to the Histology Department, South Kensington Campus, Imperial 
College London for paraffin embedding and sectioning (4m). 
2.6.1 De-waxing and rehydration 
Formalin fixed, paraffin embedded sections were de-waxed by immersion in 
xylene twice for 8min each, after which they were rehydrated by successive 
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immersing in 100%, 95% and 70% ethanol for 5min each. Sections were kept 
in distilled water for a minimum of 10min before antigen retrieval.  
2.6.2 Antigen retrieval 
Formalin fixation can result in the cross linking of proteins, resulting in the 
masking of antigenic epitopes and loss of immunoreactivity. Heat induced 
epitope retrieval (HIER) was performed by placing de-waxed, rehydrated 
sections in 400ml of  pre-heated sodium citrate buffer (0.1 M Sodium 
citrate, 0.05% Tween 20, pH 6.0, in distilled water) and microwaving for 15 
minutes at 400W. Slides were then placed in distilled water until processing. 
2.6.3 Immunohistochemistry 
IHC was performed using Dako Envision+ System-HRP/DAB (# K4010) to 
examine germinal centres within the spleen. Anti-CD45R (Rat) at 1:250 
(Abcam #64100) and anti-PCNA (Rabbit) at 1:100 (Abcam #Ab2426) and 
their isotype controls (Dako #P0450) and (Abcam #27478), were used. 
Following antigen retrieval, sections were treated with serum-free block 
(Dako) for 1 h in a humidified chamber, followed by a gentle wash in TBS-T 
(tris buffered saline; sodium chloride and tris-HCl at pH 7.6 + 0.1% TWEEN-
20). Primary antibody was applied to one tissue section and isotype control 
was applied to the second section (two sections per slide). Slides were 
incubated in a humidified chamber for 1hr, followed by 2X5 min washes in 
TBS-T (0.25%).  Peroxidase block (Dako) was added for 15 min before 
2x5min washes in TBS-T (0.025%).  Secondary antibody was applied (HRP 
labelled polymer) and slides were incubated in a humidified chamber for 
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45min, followed by 2x5min washes. DAB + buffer (1:50) (approximately 40l 
per section) was added for approximately 2min. Slides were then placed in 
distilled water before counterstaining. 
2.6.4 Counterstaining with haematoxylin 
Slides were dipped in Harris haematoxylin 3x5 seconds followed by washing 
under gently running tap water for 5min. Slides were briefly dipped in 1% 
acid alcohol before washing under gently running tap water for 5min. Slides 
were then immersed in 0.37 M ammonia for 1min followed by 5min wash 
under gently running tap water. Slides were allowed to dry before being 
rehydrated by sequential immersion in increasing concentrations of ethanol 
for 5min each; 70%, 95% and 100% followed by immersion in xylene twice 
for 8min each. Slides were then mounted using DPX mounting media (Sigma 
#06522).  
2.7 Microscopy 
The BX63 (Olympus) was used for imaging. Measurements for spleen area 
and germinal centre areas were made using CellSens software. 
2.8 Splenocyte isolation 
Mice were culled by cervical dislocation, weighed, and sprayed with 70% 
ethanol before spleen excision. Connective tissue was carefully removed 
and spleens were weighed. Spleens were then briefly immersed in 96% 
absolute ethanol before immersing in RPMI X2. Spleens were then 
transferred to individual 15 ml falcon tubes containing ‘travel’ media (RPMI 
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1640, 3% heat inactivated FBS, 2 mM Glutamine, 20 mM HEPES (pH 7), 50 
M -ME, antibiotic-antimycotic (Gibco #152-062), non-essential amino 
acids (Gibco #12084947), filter sterilized), before being placed on ice and 
transported to the University of Bedfordshire.  
Splenocyte isolation was carried out under aseptic conditions. Spleens were 
transferred through two additional RPMI washes before disaggregation. 
Using a plunger from a sterile 5 ml syringe, tissue was pressed through a 70 
m pre-wetted cell strainer into a 6 cm tissue culture dish containing 2 ml 
of B-cell media (RPMI 1640, 10% heat inactivated FBS, 2 mM glutamine, 20 
mM HEPES (pH 7), 50 M -ME, antibiotic-antimycotic (Gibco #152-062), 
non-essential amino acids (Gibco #12084947), filter sterilized), the strainer 
was rinsed with 2 ml of media and splenocytes were collected. 
2.9 Removal of red blood cells 
Red blood cells were removed from splenocyte suspensions using 
Lympholyte M cell separation media (Cedarlane #CL5030) as per 
manufacturer’s instructions. Briefly, collected splenocytes were carefully 
layered on top of 5 ml of Lympholyte M in a 15 ml falcon tube and 
centrifuges at 1200g for 20 min at room temperature. Lymphocytes were 
then collected and transferred to a fresh falcon tube, the cell suspension 
was made up to 10 ml using B-cell media. The cells were centrifuged at 300g, 
the supernatant was discarded and the splenocytes were resuspended in 10 
ml of B-cell media before being counted using a haemocytometer. 
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2.10 B-cell isolation 
B-cell isolation was carried out using a pan B-cell isolation kit from Miltenyi 
Biotec (#130-095-813), as per the manufacturer’s instructions. Cells were 
pelleted, supernatant discarded and resuspended at 107 cells per 40 l of 
Macs buffer (PBS, (pH 7.2), 0.5% bovine serum albumin (BSA), and 2 mM 
EDTA; all filter sterilized).  10 l of Pan B Cell Biotin-Antibody Cocktail was 
added to each 106 total cells and cells were incubated for 5min on ice. 30 μL 
of cold buffer was added per 106 total cells, followed by 20 μl of anti-Biotin 
MicroBeads per 106 cells, for 10 min on ice. The cell suspension was then 
made up to a minimum volume of 500 l. B-cells were then separated by 
negative selection using Macs columns (Miltenyi #LD130-042-901) and 
magnetic separators. Separation columns were prepared by adding 2 ml of 
Macs buffer and letting it flow through by gravity. The cells were then added 
to the column and cells were collected. 2 ml of Macs buffer was then passed 
through the column and collected. The enriched B-cell population was 
pelleted at 300 g and initially resuspended in 5 ml of B-cell media and 
counted. 
2.11 T-cell isolation 
T-cell isolation was carried out using a pan B-cell isolation kit from Miltenyi 
Biotec (#130-095-130). The process is the same as for B-cell separation with 
the exception of the antibody, which was 10 μL of Pan T Cell Biotin-Antibody 
Cocktail per 10⁷ total cells. 
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2.12 Cell culture and stimulation 
Following negative selection, splenocytes, B-cells and T-cells were plated in 
complete B-cell media at 1-2 x 106 per ml and allowed to ‘rest’ for one hour 
at 37oC, 5% C02 before stimulation. Stimulation for splenocytes and B-cells 
was provided by lipopolysaccharide (LPS) (Sigma #L4391) and recombinant 
IL-4 (R&D Systems #404-ML-010). LPS was dissolved in RPMI media at 1 
mg/ml, aliquoted and stored at -200C. Splenocytes and B-cells were 
stimulated with either 20 g/ml or 2 g/ml. IL-4 was dissolved in RPMI 
media at 0.01 mg/ml, aliquoted and stored at -200C. Splenocytes and B-cells 
were stimulated with either 50 ng/ml or 20 ng/ml. T-cells were stimulated 
using  recombinant IL-2 (R&S Systems #402-ML-020) and a T-cell 
activation/expansion kit (Milteni #130-093-627), as per manufacturer’s 
instructions. Anti-biotin MACSiBead particles and biotinylated antibodies 
against mouse CD3ε and CD28 were prepared in advance;  100 μL of CD3ε-
Biotin and 100 μL CD28-Biotin were mixed well in a sterile 2 ml centrifuge 
tube, 300 l of PBS (pH 7.2) containing 2 mM EDTA was added, followed by 
500 μL anti-biotin MACSiBeads (108 beads). The suspension was incubated 
for 2 hr at 40C, while being rotated.  40 l of resuspended beads were added 
to 1 ml of B-cell media and centrifuged at 300g for five minutes at 40C. 
Supernatant was aspirated and beads were resuspended in 1 ml B-cell 
media (approximately 4x106 beads) containing IL-2. Beads were used at a 
bead to cell ratio of 2:1. Following stimulation, cell cultures were 
maintained in a humidified 5% CO2 incubator at 370C.  
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2.13 Flow cytometry 
All flow cytometric analysis was carried out using the C6 cytometer (BD 
Accuri). Calibration was performed at the beginning of each session. 
Although the C6 is designed with predictable fluorescence overspill values, 
compensation was checked and adjusted as necessary when co-staining.  
2.13.1 Labelling cells for cytometric analysis 
The same procedure was used to prepare cells for flow cytometric analysis. 
However, some of the antibodies were used in different concentrations and 
were incubated for different periods of time as detailed in Table 2.3.  
Marker Volume per 106 
(to a final volume of 
50l in FACS buffer) 
Incubation time 
(on ice in the dark) 
Isotype control 
B220 (CD45R) 
AbD Serotec 
MCA1258A488T 
5l 40min rat anti-mouse IgG2a 
AbD Serotec 
#MCAA488 
CD19 
BD Pharmingen 
CD19 #557684 
5l 40min rat anti-mouse IgG2a 
BD Pharmingen 
#557690 
CD3 
BD Pharmingen 
555274 
5l 40min Rat IgG2b 
BD Pharmingen 
#553988 
CD4 
AbD Serotec 
#MCA1767A647T 
10l 40min rat anti-mouse IgG2b 
AbD Serotec 
 #MCA1125A647 
CD8 
AbD Serotec 
#MCA609A647T 
10l 40min rat anti-mouse IgG2a 
AbD Serotec 
#MCA1212A647 
CD23 
Miltenyi Biotech 
#130-102611 
5l 15min Rat IgG2a 
Miltenyi Biotec 
#130-102-654 
IgM 
Southern Biotech 
#1140-09 
1l 40min Rat IgM
SouthernBiotech 
#0120-09 
IgG1 
AbD Serotec 
#STAR132PE 
10l 40min Rat IgG1 
SouthernBiotech 
#0116-19 
IgE 
Southern Biotec 
#1130-09 
10l 40min Rat IgG1 
SouthernBiotech 
#0116-19 
Table 2.3. Fluorophore conjugated antibodies used for flow cytometry 
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Cells were counted prior to being washed twice in FACS buffer (PBS, 2% FBS, 
1 mM EDTA, 0.1% sodium azide) by centrifugation at 300g for 5 min at 40C. 
The supernatant was carefully removed and cell pellets were gently 
resuspended in FACS buffer containing Seroblock (AbD Serotec #BUF041B) 
and incubated for 10 min on ice, in the dark. Antibody dilutions were 
prepared to a final volume of 50 l/ 1x106 cells in FACS buffer and were 
aliquoted into individual round bottomed 2ml centrifuge tubes on ice at 50 
l/ 106 cells. After blocking cells were mixed gently and were added to the 
appropriate antibody (final concentration: 1x106 cells/ 100l). Cells were 
incubated on ice in the dark. Following incubation 1 ml of FACS buffer was 
added to each tube before centrifuging at 300g for 5 min at 40C. The 
supernatants were removed and cells were washed a further two times in 
FACS buffer. After the final wash cells were resuspended in 200 l of FACS 
buffer per 106 cells and were analysed on the flow cytometer. 
2.13.2 Median fluorescent intensity 
Fluorescent intensity was used as an indication of relative protein 
expression between fluorophore labelled cell populations from control mice 
and PI3K C2 mice. Fluorescent intensity data is sometimes presented 
using the mean fluorescent intensity. However, this may not be an accurate 
representation if fluorescence is recorded using a logarithmic scale, as the 
arithmetic mean does not take into account the skewed distribution of log-
amplified data. As such, to assess relative protein expression between 
samples, median fluorescent intensity (MFI) has been used. As the central 
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value is not as sensitive to the distribution of logarithmic data, the median 
is considered to be a more robust measure of relative fluorescent intensity 
(Demishtein et al., 2015; Givan, 2001). 
2.13.3 Cell cycle analysis 
Following isolation, the splenic B-cells were allowed to rest for 1 hr. 106 B-
cells were removed prior to stimulation for the 0 hr analysis. Cells being 
used for 24 hr and 72 hr analysis were then stimulated with 2 ug/ ml LPS 
and 20 ng/ ml IL-4. Cells were centrifuged at 300g for 5 min at 40C, the 
supernatant was aspirated and the pellet was resuspended in 1 ml of cold 
PBS and centrifuged for 5 min at 300g at 40c. The supernatant was removed 
and the pellet was resuspended, dropwise in ice-cold 70% ethanol (stored 
at -200C) while being vortexed to minimize cell clumping. Cells were then 
stored at 40C until cells for 24 hr and 72 hr had been collected. Following 
the final collection, cells were kept at 40C overnight to ensure sufficient 
fixation of the 72hr sample. Staining and analysis of all three timepoints was 
conducted at the same time. Cells were centrifuged at 850 g for 5 min at 
40C, supernatant was discarded and cells were washed twice in cold PBS. 
Following the final wash, pellets were treated with 50 l of RNase A (100 
g/ ml) to remove contaminating RNA. 400 l of propidium iodide (PI) was 
then added (50 g/ ml in FACs buffer) and cells were carefully resuspended 
and incubated at room temperature for 10 min before analysis using a C6 
cytometer (BD Accuri).  An initial plot of FSC (area) vs FSC (height) was used 
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to exclude doublets, which could lead to false positive readings in the G2/ 
M gate. PI was read in the FL-2 channel. 
2.13.4 Annexin V and propidium iodide staining (cell viability) 
Annexin V-FITC Apoptosis Detection Kit (Abcam #ab14085) was used to 
examine cell viability as per manufacturer’s instruction. 0.5 x 106 cells were 
collected and centrifuged at 300g for 5 min at room temperature. The pellet 
was resuspended in 500 l of binding buffer and 5 l of Annexin V-FITC and 
5 l of PI were added. Cells were then incubated in the dark for 5 min at 
room temperature before analysis by flow cytometry. Annexin V was 
analysed using the FL-1 channel and PI was read in FL-2. Compensation was 
set to eliminate fluorescence overspill between FL-1 and FL-2.  A minimum 
of 20,000 events were collected per sample. 
2.14 MTT assay 
Freshly isolated B-cells were plated in triplicate at 0.1 x 106 per well in a 96 
well plate, in 200 l of media and allowed to rest for two hr before being 
stimulated with LPS (2 g/ ml) and IL-4 (20 ng/ ml). 20 l of MTT (5 mg/ ml) 
was added to the wells being analysed at 0 hrs, and cells were returned to 
5% CO2 incubator at 37oC for four hr before adding the MTT solvent (20% 
SDS in 0.2 M HCl) (Young et al., 2005). Cells were returned to the incubator 
for a further two hr before reading the absorbance at 570 nm. This was 
repeated at 72 hr.  
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2.15 Cell lysis 
Total cell lysate was prepared by adding 2X sample buffer (500 mM tris base, 
25% v/v glycerol, 15% v/v SDS, 10% v/v -mercaptoethanol, 0.5 M EDTA and 
0.05% w/v bromophenol blue),  directly to prewashed cell pellets at a 1:1 
ratio. Total cell lysate was boiled and stored at -200C. 
Cell extract lysates were prepared using lysis buffer (1% Triton X-100, 10 
mM Tris-HCL, 5 mM EDTA, 50 mM sodium chloride, 30 mM sodium 
pyrophosphate, 1 mM phenylmethylsulfonyl (PMSF), 1:100 v/v aprotinin, 1 
g/ ml pepstatin and 5 g/ ml leupeptin. Cells were washed in ice-cold PBS 
before being incubated for 20 mins on ice with complete lysis buffer. Lysates 
were harvested, centrifuged at 14000rpm, at 4oC for 15 mins before storage 
at   -80oC. 
2.16 BCA assay 
Protein concentration of lysates was determined using a BCA protein assay 
kit (Pierce #23225) as per manufacturer’s instructions.  
2.17 SDS PAGE 
Proteins from cell lysates were separated using SDS-PAGE prior to western 
blotting. For detection of PI3K C2, lysates were separated using a 7% 
resolving gel, for CD19 and pMEK1/2 a 10% resolving gel was used topped 
by a 4% stacking gel.  Resolving gel; (31.75% v/v dH2O, 1.5 M Tris-base at pH 
8.8, 30% v/v acrylamide, 2% Bis, 0.5% v/v of 20% SDS, 0.33% v/v of 10% 
ammonium persulphate (APS) and 0.05% v/v TEMED) and 4% stacking gel 
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(46.5% v/v dH2O, 34% 1.5 M tris-HCl (pH 6.8), 13.5% v/v acrylamide, 3.5% 
v/v Bis, 0.7% v/v of 20% SDS, 0.35% v/v of 10% APS, 0.14% v/v TEMED). 
Proteins were denatured in sample buffer (Section 2.15) and gels were run 
at 65V overnight or for 1 hr at 190 V using  Mini-PROTEAN system (BioRad) 
in running buffer (25 mM tris-base, 200 mM glycine and 0.1%  SDS). 
2.18 Western blotting 
Following protein separation by SDS-PAGE, proteins were transferred to a 
polyvinyledine difluoride (PVDF) membrane. Gels were equilibrated in 
transfer buffer (25 mM tris-base, 192 mM glycine, 0.1% SDS and 10% v/v 
methanol) for 15mins prior to transfer, which was carried out at 24V for 5 
hrs at room temperature. Following transfer, the PVDF membrane was 
blocked in 5% non-fat dairy milk (NFDM) in TBS-T. Primary antibodies were 
diluted in TBS-T, 5% bovine serum albumin (BSA) and 0.005% sodium azide 
as per manufacturer’s instructions: anti-PI3K C2 (rabbit) at a 1:600 dilution 
(Santa Cruz #sc-134766), anti-CD19 (Rabbit) at a 1:1000 dilution (CST #3574) 
and anti-phospho-MEK 1/2 (Rabbit) at a 1:1000 dilution (CST #9121). 
Membranes were incubated in primary antibody overnight at 40C after 
which they were washed 2 X 5mins in TBS-T. Secondary antibody (anti-
rabbit) (DAKO), labelled with horseradish peroxidase was diluted as per 
manufacturer’s instructions in TBS-T and 5% NFDM. Incubation was carried 
out for 1 hour at room temperature. The membrane was then washed 3 x 5 
mins in TBS-T before exposure using the Medical Film Processor SRX-101A, 
Konica) and chemiluminescence (ECL, GE Life Sciences). 
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2.19 Statistical analysis 
Analysis was performed using GraphPad Prism version 6.01 for Windows, 
GraphPad Software, San Diego California USA. Where possible, normality of 
data was assessed using a Kolmogorov-Smirnov normality test. Data 
identified as having normal distribution were analysed using an unpaired, 
two-tailed Student t-test, with differences in variance being corrected for 
using Welch’s test (Figure 5.15). Results were considered statistically 
significant at p=0.05. This method of analysis has been previously used in 
the literature (Adachi et al., 2015; Allen et al., 2012; Hampel et al., 2011). 
When multiple t-tests were used, multiple comparisons were corrected for 
using the Sidak-Bonferroni method and results were considered significant 
at p=0.005 (Figure 4.1). For analysis of two or more experiments that were 
not combined (such as median fluorescent intensity) a two-way ANOVA was 
performed, corrected for multiple comparisons using Sidak’s multiple 
comparisons test (Figure 5.3). Preliminary experiments using very small 
sample sizes (n = 3), were analysed to detect whether they were powered 
to detect changes using an unpaired, two-tailed t-test (Figure 5.17), using; 
Java Applets for Power and Sample Size [Computer software], available at: 
http://www.stat.uiowa.edu/~rlenth/Power.  
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3 PI3K C2β mice 
The Class I PI3Ks are well established as mediators of signalling cascades 
within immune cells following activation via G protein coupled receptors 
(GPRCs), or antigen receptors such as the B-cells receptor (BCR) and the T-
cell receptor (TCR) (Werner et al., 2010). Augmented signalling has been 
linked to many human diseases and their inhibition is associated with 
reduced disease severity (Hawkins and Stephens, 2015). As such there is 
much interest in developing PI3K inhibitors for therapeutic purposes and 
several are being used in clinical trials (Westin, 2014). The use of genetically 
modified mice with distinctive phenotypes has played an important role in 
what has been learned so far (Hawkins and Stephens, 2015). However the 
role of the Class II PI3Ks is still to be elucidated. 
A mouse model deficient in PI3K C2β was previously established to study 
the role of PI3K C2β in epidermal differentiation. These mice did not display 
a specific phenotype under the conditions in which they were studied and 
were both viable and fertile (Harada et al., 2005). Our laboratory has been 
working with PI3K C2β   mice which were rederived to examine the role 
of PI3K C2β in the kidney, during which time a potentially dysregulated 
immune response was observed (Balakrishnan, 2012). 
The purpose of my project was to identify a potential role for PI3K C2β in 
the immune system, with a particular emphasis on the spleen. This chapter 
focuses on genotyping the mice and identifying any phenotypic differences 
in health, weight or breeding patterns. It will also show a basic examination 
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of spleens from control and PI3K C2β mice kept under basal conditions 
and also following stimulation with sheep IgG and complete Freund’s 
adjuvant (CFA). 
3.1 Genotyping 
All mice were genotyped prior to analysis of the spleen. Ear punches were 
collected and genomic DNA was extracted. The primers used to determine 
the genetic background of the mice had been previously designed (Harada 
et al., 2005). For the floxed control animals (B6.129.PIK3C2btm pkh/J) the 
primers, designated 74/75, had been designed to amplify a region of intron 
between exons two and three, encompassing the first LoxP site, with an 
expected product size of 300bp (Figure 3.1). The primers (designated 76/77) 
were used to confirm successful knock out of PI3K C2β (B6.129.PIK3C.KO), 
and generated a product of 404bp, if the region between the LoxP sites has 
successfully been excised. If this region was not excised it would span 
2673bp, resulting in no product under the conditions used. 
Following amplification by PCR, products were separated by agarose gel 
electrophoresis and imaged under UV light (Figure 3.1). Both strains 
generated a product of the expected size (300bp from control gDNA and 
404bp from PI3K C2β gDNA). Bands from three controls and three 
knockouts were extracted from the agarose gels, and following purification 
were sent for sequencing. Analysis of sequences, using Bio-Edit (Hall, 1999) 
confirmed that the intended sequences had been amplified. Comparison of 
the cDNA sequences generated by primers 74/75 (control) and 76/77 (PI3K 
92 
 
C2β) allowed identification of the LoxP sites. As previously described 
(Harada et al., 2005), these were located within intron three and intron six. 
Identification of the LoxP sites also confirmed that the sequence remained 
in frame, and therefore the generation of PI3K C2β protein in the control 
mice should remain unaffected. 
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Figure 3.1 Genotyping PI3K C2β knockout mice (B6.129.PIK3C.KO) and control mice 
(B6.129.PIK3C2btm pkh/J). Genomic DNA was extracted from ear punches and PCR was 
used to genotype the animals. A; schematic of knockout strategy. B; primers 74/75 
generated a product of approximately 300bp in the PI3K-C2βfloxed control mice. Primers 
76/77 generated a product of 404bp, PI3K-C2β mice. C and D; representative agarose 
gels showing PCR products following amplification using primers 74/75 (control) and 
76/77 (KO). Solid arrows; expected product, dashed arrows; positive control GAPDH 
(200bp). 
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3.2 Phenotypic differences displayed by PI3K C2β mice  
Consistent with earlier reports, under basal conditions PI3K C2β mice 
appear healthy and do not exhibit any obvious health issues. During the 
course of the project I noted that PI3K C2 to any increase in the G2/M 
phase mice appeared to be better breeders producing more female offspring 
than control animals. Also, PI3K C2β mice were slightly smaller than the 
controls.  
3.3 Breeding data  
While setting up breeding cages designed to produce age matched litters it 
was noted that the PI3K C2β−− mice produce more offspring than the 
control mice. To test this hypothesis, births were monitored over an 
eighteen month period. Data was collected from four breeding cages from 
each strain, which were matched for age, the date that they were 
established and the breeding period (Appendix 1). Data shown in Figure 3.2 
demonstrates that PI3K C2β mice successfully weaned 36% more 
offspring (158) than control mice (101). Of these pups the control mice 
produced 48 males and 53 females, which represents 9% more females 
compared to males. PI3K C2 mice produced 66 males compared to 92 
females, which represents 29% more females. These data indicate that PI3K 
C2 mice analysed not only weaned more pups, but that the sex ratio 
was skewed towards female offspring.  
The increased number of offspring produced by PI3K Cmice was not 
due to larger litters, as the average litter size was five pups, compared to 
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the control animals, which was six pups. However, the number of litters 
produced over the same period of time was higher in the PI3K C2 mice 
(41 litters), compared to the controls (31 litters).  
Data for pre-weaned mice is more limited, as disturbing female mice and 
their pups can cause undue stress and is therefore avoided. However, it was 
noted that there were more litters ‘found dead’ in the control breeding 
cages (9 litters), compared to the PI3K C2 breeding cages (6 litters). 
Excluding the litters that were found dead, PI3K C2 mice produced 167 
offspring compared to 128 from control mice. This suggests that fewer PI3K 
C2 pups died between birth and weaning (5%), compared to the 
controls (21%).   
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Figure 3.2 Breeding data from control and knockout mice, collected over an 
eighteen month period. Data was collected from four matched breeding cages 
from each strain, over the same time period. A; PI3K C2β mice successfully 
weaned 158 pups compared to 101 pups successfully weaned by the controls. 
B; control mice had a male to female ratio of 1:1.1 (48 and 53 pups 
respectively). The male to female ratio for PI3K C2β mice was 1:1.4 (66 male 
and 92 female pups). See also Appendix 1. 
A 
B 
 
 Control PI3K C2 Difference 
Percentage 
difference 
Male pups 
weaned 48 66 18 27% 
Female pups 
weaned 53 92 39 42% 
Percentage 
difference 
9% 29%   
 
PI3K C2 
Control 
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3.4 PI3K C2β mice weigh less than control counterparts over time  
Mice used during the project were weighed at culling and data were 
collected over the course of eighteen months. The range of age was chosen 
to represent young mice, prime breeding age (10-18 weeks), mature mice 
that were still within breeding age (19-35 weeks) and post-breeding age (36-
52 weeks) (Table 3.1 and Figure 3.3). 
Male PI3K C2βmice were of a comparable weight to the control mice at 
10-18 weeks (26.7g vs 27.0g respectively) and at 19-35 weeks (29.2g vs 
29.6g). PI3K C2βmales were 11.8% smaller than the controls at 36-52 
weeks (30.2g vs 34.2g). The overall difference in male animal weight was 
considered significant when calculated using a two-way ANOVA (p=0.02). 
The female PI3K C2β mice showed a more pronounced difference in 
weight (p=0.001), compared to control mice. At 10-18 weeks female PI3K 
C2 mice were 8.7% lighter and 10.1% lighter at 36-52 weeks.  
Gene knockout in mice can lead to a reduction in bodyweight in 
approximately one third of viable strains (Reed et al., 2008), and therefore 
the modest reduction in weight observed in the PI3K C2β mice was not 
considered any further at this point. However, it was taken into account 
when assessing spleen weight (Figure 3.4), and as such spleen weight was 
calculated as a percentage of bodyweight (Sellers et al., 2007).  
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Table 3.1 Analysis of mouse weight 
  Mouse age 
 10-18 weeks 19-35-weeks 36-52 weeks 
Control 
males 
27.1 (n=21) 29.6 (n=6) 34.2 (n=7) 
PI3K C2 
males 
26.7 (n=17) 29.17 (n=9) 30.2 (n=7) 
Difference 
between means 
0.03 0.5 4.0 
Percentage 
difference 
1.2% 1.5% 11.8% 
Control 
females 
22.7(n=14) 23.5 (n=7) 25.8(n=8) 
PI3K C2 
females 
20.7 (n=21) 24.4 (n=4) 23.2 (n=11) 
Difference 
between means 
2 0.9 2.6 
Percentage 
difference 
8.7% 3.7% 10.1% 
Weights are presented in grams and were collected over an eighteen month period. 
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Figure 3.3 Comparison of total bodyweight. Mice were weighed immediately after 
being culled over an eighteen month period. A; the weight of control mice and PI3K 
C2β male mice was comparable at 10-18 weeks and 19-35 weeks. Between the 
age of 36-52 weeks PI3K C2β males were on average 4.04g lighter. Overall the 
difference in weight was considered statistically significant (p=0.02). B; shows the 
number of male mice analysed within each age range. C; female mice also showed 
a difference in weight (p=0.04), with PI3K C2β mice being lighter at 10-18 weeks 
and 36-52 weeks, between 19-35 weeks the weights were comparable. D; shows 
the numbers of female mice weighed within each age range. Statistical analysis was 
calculated using a two-way ANOVA, * = p<0.05. Data represent mean values ± SEM. 
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3.5 Spleen overview  
Previous work from our laboratory had suggested that PI3K C2β mice 
exhibit an altered immune response following administration of a sub-
nephritogenic dose of nephrotoxic serum (NTS), and as a result PI3K C2β 
mice developed enlarged spleens (Balakrishnan, 2012). The spleen plays an 
important role in both the adaptive and innate immune response and is the 
largest lymphoid organ. Consequently, its analysis has been a longstanding 
focus for those researchers involved in studying the response of organisms 
to immunological challenge (Mebius and Kraal, 2005). 
3.6 Spleen weight as a percentage of animal weight (Basal and 
IgG/CFA) 
To examine the effect of an immune challenge on spleen morphology, 
female mice aged between 18-35 weeks were given a subcutaneous 
injection of a sheep IgG (0.2mg) in PBS with complete Freund’s adjuvant 
(CFA) in a 50:50 ratio. After seven days the mice were culled and the spleens 
were excised, weighed and fixed in 10% buffered formalin before being 
processed for immunohistochemistry (IHC). 
Spleens from mice treated with IgG/CFA and mice kept under basal 
conditions were examined (Table 3.2, Table 3.3 and Figure3.4). To take into 
account any variation in animal weight which might influence spleen weight, 
data for spleen weight are expressed as a percentage of animal weight. 
Statistical analysis was performed using unpaired multiple t-tests, corrected 
for multiple comparisons using the Sidak-Bonferroni method.  
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As a percentage of animal weight, spleens in PI3K C2β mice were slightly 
smaller than those of control mice that were untreated (basal). The 
difference between female PI3K C2β and control mice (0.3% ± 0.01 and 
0.4% ± 0.01, respectively) which equates to a 13.2% difference in spleen 
weight as a percentage of animal weight (p= 0.007). 
Following IgG/CFA treatment, spleen weight as a percentage of animal 
weight was greater in the PI3K C2β mice, compared to the controls (0.6% 
± 0.04 vs 0.4% ± 0.02, respectively), representing an increase of 29.5% 
(p=0.01). Although treatment with IgG/CFA increased spleen weight in both 
PI3K C2β mice and controls, it produced a greater effect in PI3K C2β 
mice. In control mice the difference in spleen weight between IgG/CFA 
treated and untreated mice was 0.1% ± 0.02 (p=0.005), representing a 
15.8% difference. In comparison, spleens from PI3K C2β mice treated with 
IgG/CFA were 72.7 % greater than spleens from untreated PI3K C2β mice 
(p=<0.0001). 
 
 Basal IgG/CFA Difference Significance 
Control 0.4% ± 0.01 
(n=14) 
0.4% ± 0.02 
(n=13) 
0.1 ± 0.02 p=0.005 
PI3K C2 0.3% ± 0.01 
(n=16) 
0.6% ± 0.04 
(n=15) 
0.2 ± 0.04 p=< 0.0001 
Difference 0.05 ± 0.02 0.1 ± 0.04   
Significance p=0.007 p= 0.01   
Table 3.2  Analysis of spleen weight as a percentage of animal weight. 
 
 
Table 3.3  Analysis of spleen weight as a percentage of animal weight. 
 
Female mice aged between 18-35 weeks were examined either under basal conditions or 
following treatment with sheep IgG and CFA. Spleen weight as a percentage of 
bodyweight was examined. Statistical analysis was performed using unpaired multiple t-
tests, corrected for multiple comparisons using the Sidak-Bonferroni method. Data 
represent mean values ± SEM. 
 
 
Female mice aged between 18-35 weeks were examined either under basal conditions or 
following treatment with sheep IgG and CFA. Spleen weight as a percentage of 
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Figure 3.4 Spleen weight as a percentage of animal weight from mice kept under basal 
conditions or mice treated with IgG/CFA. Female mice between 18-35 weeks of age were 
used in this experiment, and were culled after seven days, post subcutaneous injection 
with IgG and CFA. A; images of freshly isolated spleens from control and PI3K C2β mice 
kept under basal conditions. B; Spleen weight expressed as a percentage of animal weight 
in animals treated with (IgG/CFA) or without (Basal) sheep IgG and CFA. Under basal 
conditions the spleens of PI3K C2 mice were 0.3% ± 0.01 of the total body weight 
(n=15), compared to 0.4% ± 0.01 in the controls (n=14).  When treated with IgG/CFA this 
trend was reversed and PI3K C2 spleens were 0.6% ± 0.04 of the total body weight 
(n=15), while the spleens of control mice were 0.4% ± 0.02 (n=13).  Statistical analysis was 
performed using unpaired multiple t-tests, corrected for multiple comparisons using the 
Sidak-Bonferroni method, with p=<0.005 being considered statistically significant. Data 
represent mean values ± SEM 
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3.7 Immunohistochemistry (Basal vs IgG/CFA) 
Following stimulation with sheep IgG/CFA, PI3K C2β mice had shown a 
greater increase in spleen weight compared to control mice. As a reservoir 
for B-cells and T-cells and an important mediator of both innate and 
adaptive immune responses, I wanted to investigate whether the increase 
in spleen weight reflected an altered immune response in the PI3K C2β 
mice. Following excision, spleens were fixed in 10% neutral buffered 
formalin for approximately 16 hrs, transferred to 70% ethanol before 
processing at the Histology Department, Imperial College, London. 
3.8 Germinal centre associated proliferation in unimmunized and 
IgG/CFA treated mice 
As the PI3K C2β mice had shown a greater increase in spleen weight as a 
percentage of animal weight in response to IgG/CFA treatment, I initially 
examined whether there were any differences in the rates of splenocyte 
proliferation. Formalin fixed paraffin embedded sections were de-waxed, 
rehydrated and subjected to HIER before treatment with anti-PCNA 
(proliferating cell nuclear antigen), which is a marker of cell proliferation, 
and visualised with DAKO EnVision+ System-HRP. Following the addition of 
DAB substrate chromogen, sections were counterstained with 
haematoxylin, dehydrated and mounted prior to analysis. Greater numbers 
of PCNA positive cells were detected in the follicles of spleens from PI3K 
C2β mice compared to controls, both under basal conditions and 
following an immunological challenge with IgG/CFA (Figure 3.5 and Figure 
3.6). These areas appeared to be germinal centres, which are areas of B-cell 
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proliferation that occur in response to antigen activation. Immunostaining 
with the pan B-cell marker B220 confirmed that the germinal centres had 
been correctly identified. Measurements were performed using CellSens 
software (Olympus), on stitched images of whole spleens. Spleens from four 
control mice and five PI3K C2β mice were analysed from each group 
(Basal and IgG/CFA treated). 
The areas of PCNA positive germinal centres were compared to the area 
defined by B220 staining. Under basal conditions, the mean germinal centre 
area, as defined by B220 staining in PI3K C2β mice was 1.4 mm2 ± 0.1. In 
the control mice this value was 1 mm2 ± 0.02 (p=0.03). Following treatment 
with IgG/CFA the mean area of germinal centre associated proliferation was 
1.8 mm2 ± 0.1 in PI3K C2β mice and 0.8 mm2 ± 0.2 in controls (p=0.0001). 
Given the earlier concern that differences in animal weight might influence 
spleen size, the area of the germinal centres was expressed as a percentage 
of spleen area. The percentage of GC associated proliferation was increased 
in comparison to the controls, under basal conditions and following 
treatment with sheep IgG/CFA (Figure 3.7). Measurement of spleen area 
showed that under basal conditions PI3K C2β  spleen area was reduced 
in mice compared to the controls (17.2 mm2 vs 29.6 mm2) p=0.0002. Spleen 
area was comparable between control and PI3K C2β mice following 
IgG/CFA treatment (26.3 mm2 vs 26.3 mm2) p=0.4. 
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Area of Germinal Centre associated cell proliferation (mm2)  
Basal IgG/CFA 
Control  1 ± 0.02  
n=4  
0.8 ± 0.2  
n=4  
PI3K C2β 1.4 ± 0.1  
n=5  
1.8 ± 0.1  
n=5  
Difference  0.4 ± 0.1  
 
1.1 ± 0.2  
Significance  p= 0.03  p= 0.001  
 
Germinal Centre area expressed as a percentage of spleen area  
Basal IgG/CFA 
Control  0.1 ± 0.02  
n=4  
0.04 ± 0.01  
n=4  
PI3K C2β   0.3 ± 0.04  
n=5  
0.3 ± 0.1  
n=5  
Difference  0.2 ± 0.04  
 
0.2 ± 0.1 
Significance  p= 0.01  p= 0.03 
 
Total spleen area (mm2) 
Basal  IgG/CFA 
Control  29.6 ± 2.4  
n=4  
26.3 ± 2.02  
n=4  
PI3K C2β   17.2 ± 0.2  
n=6  
24 ± 1.6  
n=5  
Difference  12.4 ± 2.42  2.3 ± 2.6  
 
Significance  p=0.0002  p=0.4  
Cell proliferation in spleen germinal centres was determined after IHC 
analysis using anti-PCNA and anti-B220 antibodies. Statistical analysis 
was performed using unpaired multiple t-tests, corrected for multiple 
comparisons using the Sidak-Bonferroni method. Data represent mean 
values ± SEM. 
 
Table 3.4 Analysis of germinal associated cell proliferation.Cell 
proliferation in spleen germinal centres was determined after IHC 
analysis using anti-PCNA and anti-B220 antibodies. Statistical analysis 
was performed using unpaired multiple t-tests, corrected for multiple 
comparisons using the Sidak-Bonferroni method. Data represent mean 
values ± SEM. 
Table 3.3 Analysis of germinal associated cell proliferation. 
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Figure 3.5 PCNA and B220 immunostaining of spleen from control and 
PI3K C2β mice kept under basal conditions. Formalin fixed paraffin 
embedded serial spleen sections from control and PI3K C2β mice kept 
under basal conditions, were immunostained with anti-PCNA or an isotype 
control (A and C). B and D matched sections were stained with anti-B220 
or an isotype control to confirm that proliferation was associated with 
germinal centres. Increased areas of PCNA staining in PI3K C2β spleens, 
are highlighted (black arrows). Original magnification was at 10X. Size bar 
represents 100μm.  
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Control PCNA 
Control B220 
PI3K C2 PCNA 
PI3K C2 B220 
 
Negative control 
Negative control 
Negative control 
Negative control 
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Figure 3.6 PCNA and B220 immunostaining of spleen from control and PI3K 
C2β mice treated with IgG/CFA. Formalin fixed paraffin embedded serial 
spleen sections from control and PI3K C2β mice treated with IgG/CFA, 
were immunostained with anti-PCNA or an isotype control (A and C). B and 
D matched sections were stained with anti-B220 or an isotype control to 
confirm that proliferation was associated with germinal centres. Increased 
areas of PCNA staining in PI3K C2βspleens, are highlighted (black 
arrows).Original magnification was at 10X. Size bar represents 100μm. 
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Figure 3.7 Quantification of germinal centre associated proliferation using anti-PCNA. Spleens 
from control and PI3K C2β−/−mice kept either under basal conditions or treated with sheep 
IgG/CFA, were excised and stained with anti-PCNA or an isotype control. To confirm that the 
areas of proliferation were germinal centres, matched sections were also stained with anti-B220 
or an isotype control. Germinal centre proliferation was then measured using the Olympus BX63 
CellSens software. A; the mean area of germinal centre associated proliferation (PCNA positive) 
from the spleens of PI3K C2βmice was greater than the controls, both under basal conditions 
(1.4mm2 vs 1mm2) p=0.03,  and when treated with IgG/CFA, although the greatest increase was 
seen following IgG/CFA treatment (1.8mm2 vs 0.8mm2) p=0.001. B; as a percentage of the total 
spleen area, the area of GC related proliferation was also greater in PI3K C2βmice under both 
conditions, the greatest difference was observed under basal conditions (0.3% vs 0.1%) p=0.01 
C; measuring total spleen area showed that PI3K C2β mice had a smaller surface area than 
age matched, sex matched control mice under basal conditions (17.2mm2 vs 29.6mm2) 
p=0.0002. However, following treatment with IgG/CFA the difference in total spleen area was 
comparable (24mm2 vs 26.2mm2) p=0.4. Statistical analysis was performed using unpaired 
multiple t-tests, corrected for multiple comparisons using the Sidak-Bonferroni method. Data 
represent mean values ± SEM. 
 
B A 
C 
 M e a n  G C  a r e a  ( P C N A )
C o n tro l  
B a s a l
P I3 K  C 2
-/ -
B a s a l
C o n tro l
Ig G /C F A
P I3 K  C 2
-/ -
Ig G /C F A
0
1
2
3
4
P = P =
ar
ea
 (
m
m
2
)
0.0364 0.0016
T o t a l  s p le e n  a r e a
C o n tro l  
B a s a l
P I3 K  C 2
-/ -
B a s a l
C o n tro l
Ig G /C F A
P I3 K  C 2
-/ -
Ig G /C F A
0
1 0
2 0
3 0
4 0
5 0
P = P =
ar
ea
 (
m
m
2
)
0.0138 0.4134
G C  P C N A   p e r c e n t a g e  o f  t o t a l  s p le e n  a r e a
C o n tro l  
B a s a l
P I3 K  C 2
-/ -
B a s a l
C o n tro l
Ig G /C F A
P I3 K  C 2
-/ -
Ig G /C F A
0 .0
0 .2
0 .4
0 .6
P = P =
P
e
rc
e
n
ta
g
e
0.0092 0.0352
P=0.03 P=0.001 
P=0.01 P=0.03 
P=0.0002 P=0.4 
PI3K C2 
Basal 
Control 
Basal 
PI3K C2 
Basal 
Control 
Basal 
PI3K C2 
IgG/CFA 
Control 
IgG/CFA 
PI3K C2 
IgG/CFA 
Control 
IgG/CFA 
PI3K C2 
Basal 
Control 
Basal 
PI3K C2 
IgG/CFA 
Control 
IgG/CFA 
109 
 
3.9   Discussion 
These results show that the mean area of GC associated proliferation was 
greater in the spleens of unimmunized PI3K C2β−− mice, and the difference 
was increased following treatment with IgG/CFA, compared to controls. 
However, analysis of total GC related proliferation, calculated as a 
percentage of spleen area, indicates that unimmunized PI3K C2β−− mice 
have an increased background level of GC associated proliferation 
compared to control mice. Germinal centres are dynamic structures that 
occur in response to T-cell dependent (TD) activation with a cognate antigen 
and contain two distinct compartments referred to as the dark zone (DZ) 
and the light zone (LZ). The DZ is where rapid proliferation occurs (Vinuesa 
et al., 2009), which has been supported by gene array analysis showing the 
upregulation of genes involved in cell division and an increased population 
within the G2/M phase of the cell cycle, which was absent within the LZ. 
Cells within the LZ showed upregulation of genes associated with signalling 
and apoptosis (De Silva and Klein, 2015; Victora et al., 2010; Vinuesa et al., 
2009). 
The difference between GC associated proliferation in unimmunized PI3K 
C2β and control mice was intriguing because both strains were kept 
under the same conditions within a pathogen free environment. The 
interaction between the DZ and LZ is thought to be coordinated by CD4+ 
follicular helper T-cells (Tfh), residing mainly within the LZ. Following 
activation, B-cells migrate to the LZ where they present antigen to the Tfh 
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cells as part of an MHC II complex. B-cells with the highest affinity for their 
antigen, determined by the concentration of antigen presented, are 
signalled to return to the DZ and proliferate. B-cells with a low affinity for 
antigen remain in the LZ, and presumably undergo apoptosis (Victora et al., 
2010).  
The controlled environment in which the mice are kept make it unlikely that 
PI3K C2β B-cells encounter their cognate antigen more frequently, 
resulting in Tfh cells driving the GC reaction forward. It is possible that PI3K 
C2βmice mount a GC reaction in response to self-antigen, as 
spontaneous GC formation is associated with autoimmunity in mouse 
models (Luzina et al., 2001). However, although neither strain of mice have 
undergone examination by a professional pathologist, there have been no 
reports of health issues or reduced lifespan that might be expected if PI3K 
C2β mice were predisposed to spontaneous autoimmunity (Jolly et al., 
2001; Singh et al., 2007).  
The increased area of individual GCs may indicate that PI3K C2βB-cells 
are unable to exit the GC/DZ as efficiently as the controls. B-cells are highly 
motile within the GC, shuttling between the DZ and the LZ (De Silva and 
Klein, 2015; Oropallo and Cerutti, 2014). Fo B-cells have been observed 
entering and leaving the GC (Meyer-Hermann et al., 2012) and MZ B-cells 
regularly deliver antigen to follicles (Arnon et al., 2013). This movement is 
regulated by chemokines produced by accessory cells within the local 
environment, and changes in receptor expression, such as CXCR5 and 
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CXCR4. Dendritic cells within the LZ produce CXCL13, facilitating the 
migration of B-cells expressing CXCR5 from the DZ into the LZ. Upregulation 
of CXCR4 in response to CXCL12 allows B-cells to migrate from the LZ to the 
DZ (Allen et al., 2004). Research into GC maintenance and homeostasis has 
revealed a role for the extracellular signalling molecule Sphingosine-1-
phosphate (S1P), which mediates the exiting of B-cells from the GC via five 
specific G protein coupled receptors (GPCRs). These receptors referred to 
as S1P1-5, allow cells to respond to the S1P gradient, which is higher in the 
blood than in the spleen (Blaho and Hla, 2014; Maceyka et al., 2012). GC B-
cells express high levels of S1P2 which was shown to be important in 
mediating the egress of GC B-cells. S1P2 deficient mice develop chronically 
enlarged GCs over time, as GC B-cells are unable to respond to S1P and exit 
the GC (Green et al., 2011). In a previous experiment, loss of S1P2 led to a 
high incidence of age related diffuse large B-cell lymphoma (DLBCL) in mice 
(Cattoretti et al., 2009). PI3K C2β has recently been shown to have a 
contributory role in S1P dependent cell migration following gene knock 
down in human umbilical vein endothelial cells (HUVEC). siRNA gene 
targeting against PI3K C2α, PI3K C2β and Class I P110γ revealed that loss of 
PI3K C2α had little effect on migration, whereas loss of either P110γ or PI3K 
C2β resulted in significant inhibition of S1P dependent migration. Knock 
down of both of these genes led to the most significant effect on migration 
suggesting that the role of PI3K C2β is not redundant (Tibolla et al., 2013). 
A loss of S1P mediated migration from the GC provides a potential 
connection to the increased GCs in the PI3K C2βspleens. However, the 
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study by Tibolla (2013) did not investigate whether the specific S1P receptor 
influences the contribution of PI3K C2β to S1P mediated migration. The 
influence of S1P to B-cell function is dependent on the S1P receptor 
signalling pathway and could be a contributing factor in primary 
immunodeficiencies, such as chronic lymphocytic leukaemia (CLL) and 
multiple sclerosis (MS) (Sic et al., 2014). An additional complication is that 
S1P receptors appear to operate in a coordinated manner (Kono et al., 
2004), and appear to modulate the expression and function of other S1P 
receptors (Sic et al., 2014).   
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4 Splenocyte populations in control and PI3K 
C2mice. 
Immunohistochemistry data presented in the previous chapter 
demonstrated increased cell proliferation in the germinal centres of PI3K 
C2 spleens, both in unimmunized mice and following treatment with 
sheep IgG/CFA.  Consequently, I focused on B-cells and T-cells as the major 
leukocyte populations resident in the spleen. These were characterised 
using flow cytometry and fluorophore conjugated antibodies. T-cells were 
of particular interest given their role in the formation of germinal centres.  
4.1 Splenic T-cell population under basal conditions (0hr)  
The spleen is a major reservoir for T-cells, which are predominantly located 
in the periarteriolar lymphoid sheath (PALS) of the splenic white pulp (WP) 
and are associated with the adaptive immunity. Initial T-cell populations 
were quantified using anti-CD4 and anti-CD8 antibodies. CD4 is a T-cell co-
receptor associated with interactions involving major histocompatibility 
complex II (MHC II) molecules and are often referred to as regulatory T-cells 
or helper T-cells (Th). T-cells that are CD8+, referred to cytotoxic T-cells 
associate with major histocompatibility complex I (MHC I) molecules, 
differentiating them from CD4+ T-cells. 
Splenocytes were isolated from freshly harvested spleens and allowed to 
rest for between one and two hr, prior to labelling with fluorophore 
conjugated antibodies and analysis by flow cytometry.  
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My data (Figure 4.1) showed a significant increase in the PI3K C2 CD4+ 
splenocyte number compared to the controls (20.6% ± 1 vs 14.9% ± 0.4, 
respectively) (p=<0.0001). No difference was seen in the CD8+ populations 
(control 10.1% ± 0.4 vs PI3K C210.6% ± 0.4). These data were from four 
independent experiments, using a total of twelve control and twelve PI3K 
C2mice.  
Having observed a consistently elevated CD4+ population in the PI3K 
C2splenocytes, I next wanted to confirm that this increase was the 
result of increased T-cell numbers rather than increased numbers of 
dendritic cell or NK cells, as these cell types can also express CD4. Freshly 
isolated splenocytes were co-stained with the pan T-cell marker CD3 and 
CD4 (Figure 4.2). These results closely reflected my initial data. Spleens from 
PI3K C2 mice showed 5.2% more CD3+/CD4+ positive splenocytes than 
did spleens from control mice (18.8% ± 1.2 vs 13.6% ± 0.4). This increase 
was significant when analysed by student t-test (p=0.002). Data are from 
two independent experiments using six control and six PI3K C2mice. 
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Table 4.1 Lymphocyte populations at 0 hr. 
 
 
 
 
 
 
 
 
 
 
 
 
 B220 CD19 CD4 CD8 CD3+/CD4+ 
Control 62.7 % 
± 2.7  
65 %  
± 1.7 
14.9 %  
± 0.4  
10.1 %  
± 0.4 
13.6 %  
± 0.4 
PI3K C2 63.4 % 
± 3  
56.6 %  
± 2.7  
20.6 %  
± 1 
10.6 % 
± 0.4  
18.8 %  
± 1.2 
Difference 0.7  
± 4.0 
8.3  
± 3.2 
5.7  
± 1.1 
0.5  
± 0.6 
5.2  
± 1.2 
Significance p=0.9 p=0.02 p=< 0.0001 p=0.4 p=0.002 
A student t-test was used to determine whether the difference between populations 
was statistically significant. Results are from three independent experiments, using 
nine control and nine PI3K C2 mice (B220 and CD19), or four experiments using 
twelve control and twelve PI3K C2 mice (CD4 and CD8). Statistical analysis was 
performed using unpaired multiple t-tests, corrected for multiple comparisons using 
the Sidak-Bonferroni method, results were considered significant at p=< 0.005. Data 
represent mean values ± SEM. 
 
A student t-test was used to determine whether the difference between populations 
was statistically significant. Results are from three independent experiments, using 
nine control and nine PI3K C2mice (B220 and CD19), or four experiments using 
twelve control and twelve PI3K C2mice (CD4 and CD8). Statistical analysis was 
performed using unpaired multiple t-tests, corrected for multiple comparisons using 
the Sidak-Bonferroni method, results were considered significant at p=< 0.005. Data 
represent mean values ± SEM. 
116 
 
C 
B 
A 
CD8 
CD4 
  
B220  
FS
C
 
Is
o
ty
p
e 
Is
o
ty
p
e
 
P
I3
K
 C
2


 
C
o
n
tr
o
l 
Is
o
ty
p
e 
C
o
n
tr
o
l 
C
o
n
tr
o
l 
P
I3
K
 C
2


 
P
I3
K
 C
2


 
CD19 
  
Is
o
ty
p
e 
C
o
n
tr
o
l 
P
I3
K
 C
2


 
S p le n o c y t e  p o p u la t io n s  0 h r
C o n tro l
B 2 2 0 +
P I3 K  C 2
-/ -
B 2 2 0 +
C o n tro l
C D 1 9 +
P I3 K  C 2
-/ -
C D 1 9 +
C o n tro l
C D 4 +
P I3 K  C 2
-/ -
C D 4 +
C o n tro l
C D 8 +
P I3 K  C 2
-/ -
C D 8 +
0
2 0
4 0
6 0
8 0
1 0 0
P
e
rc
e
n
ta
g
e
 o
f 
p
o
p
u
la
ti
o
n
P = 0.8632 0.0193P =
< 0.0001P =
C D 4 C D 8C D 1 9B 2 2 0
0.3644P =
p=0.9 p=0.02 
p=< 0.0001 p=0.4 
D 
Control PI3K C2 Control PI3K C2 Control PI3K C2 Control PI3K C2 
 
 
  
Figure 4.1 Splenocyte population breakdown at 0 hr. Freshly isolated, unstimulated splenocytes 
were allowed to rest for 1-2 hr before each sample was labelled with fluorophore conjugated 
antibodies to anti CD19, anti B220, anti CD4, anti CD8 and the relevant isotype controls. A to D; 
representative plots for B220, CD19, CD4 and CD8 populations. Left to right; initial gating for 
highest viability cells, negative isotype control and labelled populations for control and PI3K C2 
splenocytes. A minimum of 30,000 events were recorded for each plot. E; analysis of results showed 
that PI3K C2 and control splenocytes had comparable populations of B220+ (63.4% ± 3 and 
62.7% ± 2.7 respectively) p=0.9, and CD8+ cells (10.6% ± 0.4 and 10.1% ± 0.4 respectively) p=0.4, 
there was a reduced CD19+ population in the PI3K C2 samples (56.6% ± 2.7 compared to 65% 
± 1.7 in controls) p=0.02. There was a small but significant increase in the PI3K C2 CD4+ 
population, compared to controls (20.6% ± 1 and 14.9% ± 0.4) p=< 0.0001. Results are from three 
independent experiments (B220 and CD19) and four independent experiments (CD4 and CD8). 
Statistical analysis was performed using unpaired multiple t-tests, corrected for multiple 
comparisons using the Sidak-Bonferroni method. Results were considered significant at p=< 0.005 
Data represent mean values ± SEM.  
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Figure 4.2 Confirmation of T-cell populations. Analysis of CD4+ splenocytes had 
shown a small but significant increase in the PI3K C2 population. To confirm 
that the increase was as a result of an expanded T-cell population freshly isolated 
splenocytes were labelled with fluorophore conjugated antibodies to the pan T-cell 
marker CD3, in conjunction with CD4. A minimum of 30,000 events were recorded 
for each plot. A; representative plot showing staining for the isotype control, used 
for gating. B and C; co-staining results from control and PI3K C2splenocytes, 
respectively. D; the significant increase in the PI3K C2 CD4+/CD3+ population 
correlated well with the previously seen increase in CD4+ T-cells  (18.8% ± 1.2 
compared to 13.6% ± 0.4) p=0.002. An unpaired, two tailed Student t-test was used 
to determine statistical significance. Data represent mean values ± SEM. 
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4.2 Splenic B-cell population 0 hr 
Identification of B-cell populations was performed using the pan B-cell 
markers B220 (CD45R) and CD19. Splenocytes were isolated from freshly 
harvested spleens and allowed to rest for one to two hr before being 
labelled with fluorophore conjugated antibodies and analysed by flow 
cytometry. To examine the relative level of antigen expression, median 
fluorescent intensity (MFI) was measured.  
Data from three independent experiments using the B-cell marker B220 
showed that both PI3K C2 and control splenocytes had comparable 
populations (62.7 % ± 2.7 vs 63.4% ± 3, respectively) (Figure 4.1). Use of the 
B-cell marker CD19 provided similar results for the control splenocytes, with 
65 % ± 1.7 splenocytes being positive for CD19. The mean CD19 positive cell 
population was 56.6 % ± 2.7 in PI3K C2 mice, a difference of 8.4% 
compared to the controls (p=0.02). However, as statistical analysis was 
performed using unpaired multiple t-tests, corrected for multiple 
comparisons using the Sidak-Bonferroni method, this result was not 
considered statistically significant.  MFI for CD19 was also measured and 
revealed a significant increase (p=0.0001) in the population within the PI3K 
C2splenocytes (Figure 4.3). Together, these data indicate that PI3K 
C2 mice had fewer CD19 positive splenocytes than control animals, but 
the level of CD19 expression within this CD19 positive cell population was 
increased. These data were obtained from three independent experiments 
using nine control and nine PI3K C2 mice.  
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Figure 4.3 Median fluorescence intensity (MFI) for B220 and CD19. Median 
fluorescent intensity was analysed following initial lymphocyte population 
analysis, using the BD Accuri C6 software. 30,000 events were recorded per 
plot. Representative overlaid histograms showing A; median fluorescent 
intensity for B220 and B; CD19 populations found in spleens of control (blue 
line) and PI3K C2β (red line) mice C; MFI is shown for B220 staining of 
control and PI3K C2β splenocytes. D; MFI is shown for CD19 staining for 
control and PI3K C2β splenocytes. Data for B220 are from two independent 
experiments, using a total of six control and six PI3K C2mice. CD19 data 
were generated from three independent experiments, using a total of nine 
control and nine PI3K C2 mice. Statistical analysis was calculated using a 
two-way ANOVA. 
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4.3 Isolated splenic CD4 positive T-cells 
To examine whether differences exist upon stimulation between CD4 
positive T-cells obtained from the spleens of control and PI3K C2 mice, 
isolated T-cells were stimulated with CD3/CD28 coated beads. This 
approach would exclude the possible influence of accessory cells found in 
the intact spleen or total splenocyte populations.  
T-cells were isolated from the spleens of age-matched and sex-matched 
control and PI3K C2mice by negative selection. T-cell purity was 
assessed using a FITC-conjugated antibody to the pan T-cell marker CD3, 
resulting in an enriched T-cell population which was shown to exceed 98% 
(Figure 4.4). 
4.4 The CD4/CD8 ratio appears to be unaffected in isolated T-cells 
Analysis of T-cell populations at 0 hr, within isolated splenocytes had shown 
that compared to the controls, PI3K C2 mice had an increased CD4+ T-
cell population (Figure 4.2). To assess whether CD4/CD8 populations would 
be affected differently when cultured in isolation, a preliminary experiment 
using isolated T-cells, stimulated with anti-CD3 and anti-CD28 coated 
beads was conducted. T-cells were cultured as recommended by the 
manufacturer of the ‘activation beads’ (Miltenyi Biotec), for 80 hr before 
analysis using flow cytometry. Results revealed no difference in the number 
of CD8 positive T-cells. The means were 50.3% ± 2.8 for the controls and 
49.9% ± 0.6 for PI3K C2 (Figure 4.5). These data indicate that when 
cultured under the same conditions the CD4+ and CD8+ populations 
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respond comparably. Three control and three PI3K C2 mice were used, 
these data are from a single experiment. Statistical analysis has not been 
applied as this experiment was not powered to detect a difference between 
the samples.   
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Figure 4.4 T-cell isolation. T-cells were harvested from the spleens of 
freshly culled control or PI3K C2 mice, using negative isolation. Flow 
cytometry using the pan T-cell marker CD3 was used to determine the 
purity of T-cell populations. A minimum of 10,000 events were recorded 
per plot. A; a representative plot showing gating strategy. Cells within the 
highest viability gate were analysed. B; representative plots showing 
results for the isotype control to exclude any non-specific binding. C; cells 
were labelled with anti-CD3 (FITC) and were found to be >98% positive 
for both control (left) and PI3K C2β−− cultures. 
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Figure 4.5 CD8+ T-cell populations at 72 hr. Following isolation, T-cell purity 
was examined. Cells were plated at 2x106/ml and stimulated with anti-CD3ε 
and anti-CD28 coated beads. A minimum of 10,000 events were recorded per 
plot. A; representative plots showing T-cell purity following isolation which 
were >98% CD3+. B; plots showing T-cells at 72 hr, cells were assessed from 
the highest viability population (upper left), cells were labelled with an 
isotype control (upper right), or anti CD8 (lower panels). C; analysis of results 
showed no difference between the percentage of CD8+ T-cell isolated from 
control and PI3K C2β−/− animals (50.3% ± 2.83 and 49.9% ± 0.6, respectively). 
Results are from a single experiment using three control and three PI3K 
C2β−/− mice.  
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4.5 Control and PI3K C2 T-cell viability is comparable 
Within isolated splenocytes, analysis of the T-cell populations had shown 
that while the CD8+ populations were comparable, PI3K C2 mice had 
an increased CD4+ population, compared to the control animals. However, 
following T-cell isolation and activation with anti-CD3 and anti-CD28 
coated beads, there was no difference in the T-cell populations (Figure 4.5).  
To analyse viability of control and PI3K C2 T-cells an Annexin V, 
propidium iodide assay was used.  The AnnexinV/ Propidium iodide (AnV/PI) 
assay is a widely used approach to analyse cell viability. AnV binds to the 
negatively charged phospholipid phosphatidylserine (PS), which under 
physiological conditions are present on the inner plasma membrane. During 
the early stages of apoptosis, loss of phospholipid asymmetry results in PS 
being externalized to the outer plasma membrane, which makes it useful 
for flow cytometric analysis (Koopman et al., 1994). Late stages of apoptosis 
are identified by the uptake of PI, which binds to nucleic acids. PI can only 
enter the cell in the late stages of apoptosis once membrane integrity has 
been lost (Darzynkiewicz et al., 1992). Therefore, cells can be separated into 
viable (AnV/PI negative), early apoptotic (AnV positive, PI negative), or late 
apoptotic/ necrotic (AnV positive/ PI positive). Finally, to avoid false positive 
readings, staining debris is gated out. 
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Isolated T-cells were assessed by flow cytometry at 72 hr post stimulation 
with CD3/CD28 beads (Figure 4.6). When plots were gated to exclude 
debris, no statistical difference was found between the percentage of 
control and PI3K C2 T-cells that were viable (AnV-/PI-), early apoptotic 
(AnV+/PI-) or late apoptotic (AnV+/PI+). However, when gated on the 
highest viability population, 5.4 % ± 1.8 fewer PI3K C2 T-cells were in 
the latest stage of apoptosis compared to controls (10.7% vs 16.1%) (Table 
4.2). These results are from two independent experiments, using four 
control and four PI3K C2 mice in total.  
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Figure 4.6 T-cell viability at 72 hr following stimulation with anti-CD3 and anti-CD28 
beads. T-cell viability was examined using AnnexinV/PI staining and analysis by flow 
cytometry, with a minimum of 30,000 events being recorded. A; plot showing FSC 
versus SSC following flow cytometry. B; typical plots showing AnnexinV/PI staining for 
control (left) and PI3K C2 (right) T-cells. Beads and debris were excluded from 
analysis to avoid false negative readings. C; analysis of results showed that there were 
no significant differences in viability between control and PI3K C2 T-cells at 72 hr 
post stimulation. D; gating on the highest viability population, showed that the 
percentage of late apoptotic (PI negative) PI3K C2 T-cells was slightly decreased 
compared to the control T-cells (10.7% vs 16.1%). Results are from two independent 
experiments using four control and four PI3K C2 mice in total. Statistical analysis 
was performed using unpaired multiple t-tests, corrected for multiple comparisons 
using the Sidak-Bonferroni method. Results were considered significant at p=< 0.005 
Data represent mean values ± SEM. 
Control PI3K C2 Control PI3K C2 PI3K C2 trol 
Control PI3K C2 Control PI3K C2 PI3K C2 Control 
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Table 4.2 T-cell viability at 72 hr following stimulation with anti-CD3 and anti-CD28 
beads 
 
4.6 Splenic T-cell populations at 80 hrs 
Characterisation of isolated T-cells revealed comparable CD4/CD8 ratios 
and viability, between control and PI3K C2β mice. However, having 
observed a difference in the PI3K C2β T-cell ratios in splenocytes at 0hr, 
their response within a splenocyte culture was examined. Within the total 
splenocyte populations, the presence of additional cell types has the 
potential to influence the population dynamics, both through cell-to-cell 
contact and through the production of cytokines. Although this mechanism 
is likely to be complex, an assessment of the CD4+ population within total 
splenocyte cultures might provide a useful insight into the effect of 
additional cell types on the CD4+ population.  
Lipopolysaccharide (LPS) and interleukin-4 (IL-4) are commonly used as B-
cell stimuli in vitro, T-cells also respond to both factors. IL-4 is required for 
the differentiation of naïve T-cells into CD4+ Th2 T-cells, which in turn 
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p=0.4 p=0.3 p=0.6 p=0.6 p=0.1 p=0.03 
Results are from two independent experiments using four control and four PI3K C2 mice. 
Statistical analysis was performed using unpaired multiple t-tests, corrected for multiple 
comparisons using the Sidak-Bonferroni method. Results were considered significant at p=< 
0.005. Data represent mean values ± SEM.in total 
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secrete IL-4 (Swain et al., 1990). LPS has been linked to CD4+ inhibition  
(González-Navajas et al., 2010; Srinivasan and McSorley, 2007). However, in 
the presence of additional accessory cells, which could be the case in the 
splenocyte cultures, LPS was shown to induce proliferation and cytokine 
production (Mattern et al., 1998). 
To assess the T-cell populations within the splenocyte cultures, splenocytes 
were cultured in LPS (20μg/ml) and IL-4 (50ng/ml) for approximately 80 hr 
before being stained with anti-CD4, anti-CD8 or anti-CD3 antibody and 
analysed by flow cytometry (Figure 4.7). Labelling with CD3 revealed that 
under these conditions a greater reduction in the overall T-cell population 
was observed in splenocytes from PI3K C2β mice compared to 
splenocytes prepared from control mice (50.4% ± 3.9 vs. 61.2% ± 4.4, 
respectively). However, the difference of 10.8 % was not statistically 
significant (p=0.04), as the statistical analysis was performed using unpaired 
multiple t-tests, corrected for multiple comparisons using the Sidak-
Bonferroni method. As such, the significance threshold was set at p=< 0.005, 
rather than p=0.05. Further analysis of the T-cell population showed that 
the number of CD8+ cells was reduced in the splenocyte population isolated 
from PI3K C2β mice compared to controls by 16.4% (25 % ± 3.8 vs 41.3 
% ± 2.5) (p=0.005). The CD4+ population also differed but the number of 
CD4+ cells increased in the cultures of PI3K C2β splenocytes (27 % ± 2) 
compared to cultures from control animals (16.9 % ± 0.8) (p=0.0007). Data 
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were derived from two independent experiments using six control and six 
PI3K C2β−− mice.  
These results suggest that the conditions within the splenocyte cultures 
preferentially supported CD4+ T-cells over CD8+ T-cells in cultures from PI3K 
C2β−− mice and that the overall reduction in T-cell number was a reflection 
of CD8+ cell loss, which was not observed in the control cultures.  
The increased CD4+ population in PI3K C2β−− splenocyte cultures and the 
link between CD4 T-cells and B-cell activation suggested a potential 
explanation for the increase in germinal centre associated proliferation 
observed in these knockout animals (Figure 3.5).  
4.7 Splenic B-cell population at 80hrs 
Under basal conditions splenic B220 positive cell populations were 
comparable within splenocyte populations isolated from control and PI3K 
C2β−/- mice, with no difference observed in median fluorescent intensity 
(MFI). Analysis of CD19+ cells within the splenocyte populations revealed 
that PI3K C2βmice had a slight reduction in the CD19+ splenic 
population (Figure 4.1). Further analysis of the CD19+ population showed 
that the MFI was consistently increased on the CD19+ PI3K C2βcells, 
indicating that the level of expression may be upregulated (Figure 4.3). 
Murine B-cells express CD19 from the pro-B stage until differentiation into 
plasma cells (Inaoki et al., 1997). The association with B-cell development, 
activation and survival is well established (Depoil et al., 2008; Engel et al., 
1995; Tedder et al., 1994) making the CD19 receptor an interesting target. 
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4.8 CD19 expression at 80hrs following treatment with LPS and IL-4 
Splenocyte cultures were stimulated with 20μg/ml lipopolysaccharide (LPS) 
and 50ng/ml IL-4. After 80 hr stimulation they were labelled with anti-CD19 
antibody (AlexaFluor-647) and analysed by flow cytometry. Results are from 
two independent experiments using a total of six control and six PI3K 
C2β−− mice (Figure 4.8). 
At 80 hr the mean CD19+ population within the control cells was 24.5 % ± 
2.1 and 38 % ± 1 in cells derived from PI3K C2βmice (p=0.0002). In 
addition to having an increased CD19+ cell number, the MFI was also slightly 
higher in CD19+ cells from PI3K C2β animals (p=0.03) indicating an 
increase in its expression on the cells. 
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Figure 4.7 T-cell populations within splenocyte cultures at 86 hr. Total splenocyte populations 
were stimulated with 20μg/ml LPS and 50ng/ml IL-4 for 80 hr. Cells were labelled with anti-
CD3, anti-CD4, anti CD8 or the relevant isotype control. Representative plots following analysis 
by flow cytometry are shown (Panels A-C). A minimum of 10,000 events were recorded per 
plot. In each case the left panel shows the staining pattern of the isotype controls, the middle 
column and right hand columns show positive staining for control and PI3K C2β splenocytes 
respectively. D; At 86 hr post-harvest (80 hr stimulation) the PI3K C2 there were 10.8% 
fewer CD3+ cells than in the control cultures (p=0.03). The percentage of CD4+ cells was 10.1% 
higher in PI3K C2 cultures compared to the controls (p=0.0007) while the population of 
CD8+ cells was 16.3% lower in the PI3KC2β cultures (p=0.005). Data are from two 
independent experiments using six control and six PI3K C2βmice. Statistical analysis was 
performed using unpaired multiple t-tests, corrected for multiple comparisons using the Sidak-
Bonferroni method. Results were considered significant at p=< 0.005. Data represent mean 
values ± SEM. 
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Figure 4.8 Response of CD19+ populations to LPS / IL-4. A; from left to right, 
representative plots showing the highest viability gate from which cells were analysed, the 
isotype control and representative plots from control and PI3K C2β splenocytes 
stimulated with LPS (2μg/ml) and IL-4 (20ng/ml). 30,000 events were counted, per sample. 
B; analysis of data showed that stimulated splenocytes from PI3K C2β mice had a 
significantly higher number of CD19+ cells compared to splenocytes from control animals 
(p=0.0002). C; analysis of MFI showed a slight increase in PI3K C2β CD19+ populations. 
D; A representative histogram shows the difference in MFI. Data are from two independent 
experiments, using a total of six control and six PI3K C2 mice. A Student’s t-test was 
used for statistical analysis (B), or a two-way ANOVA (C). 
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Figure 4.9 Propidium iodide (PI) staining of splenocytes after 80 h stimulation with 
LPS (20 μg/ml) and IL-4 (50 ng/ml). A; from left to right, representative plots show 
the total splenocyte population, centre and right-hand plots show PI staining for 
control and PI3K C2β splenocytes respectively. 30,000 events were analysed from 
each culture and plots were gated to exclude debris. B; following stimulation with 
LPS and IL-4 splenocyte cultures from PI3K C2βmice had a higher population of 
live cells (PI negative) than splenocytes isolated from control animals (27.1 % ± 1.7, 
compared to 22.1 % ± 0.8, respectively) (p=0.02). Data are from two experiments 
using six control and six PI3K C2β mice. Analysis was performed using an 
unpaired, two-tailed Student’s t-test. Data represent mean values ± SEM. 
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4.9 Splenocyte viability following stimulation with LPS/IL-4  
As a mechanism to maintain immunological homeostasis both B-cells and T-
cells are highly susceptible to apoptosis, and as such dysregulation of 
apoptotic pathways is linked to a pathological outcome. Following 
stimulation with LPS (20μg/ml) and IL-4 (50ng/ml) for 80 hr, splenocytes 
were stained with PI and analysed by flow cytometry. Excluding debris 
ensured that non-staining artefacts were not included in the analysis, which 
may otherwise have led to an increased false negative reading (Figure 4.9). 
Results showed that splenocytes from PI3K C2β−− mice had a live 
population (PI negative) of 27.1 % ± 1.7, compared to 22.1 % ± 0.8 from 
controls (p=0.02). These data are from two independent experiments each 
using six control and six PI3K C2βmice. Statistical analysis was performed 
using a Student’s t-test.  
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4.10 Discussion 
Analysis of total splenocyte populations revealed consistently higher 
numbers of CD4 positive T-cells in PI3K C2β−− mice spleens compared to 
spleens from control mice. However, when T-cells were isolated from 
splenocyte preparations and stimulated for 80 hr with anti-CD3ε and anti-
CD28 antibody, CD4/ CD8 T-cell ratios were equivalent and there was no 
difference in cell viability between the control and PI3K C2βpopulations. 
These data indicated that a different cell type within the total splenocyte 
population may be responsible for the increased number of T-cells observed 
in PI3KC2β mouse spleens.  
Splenocyte populations were then stimulated with LPS and IL-4, factors 
often used to stimulate B-cells in vitro. Under these conditions the numbers 
of CD4+ cells increased and the numbers of CD8+ cells decreased. However, 
LPS and IL-4 can stimulate other cell types present within splenocyte 
cultures, both directly and indirectly. In a study examining isolated CD4+ T-
cells from murine model of experimental colitis, LPS activation via toll-like 
receptor 4 (TLR4) led to CD4+ T-cell inhibition (González-Navajas et al., 
2010). Conversely, T-cell proliferation and cytokine production was 
observed when T-cells were cultured with monocytes displaying bound LPS 
(Mattern et al., 1998), and although the study did not discriminate between 
CD4+ and CD8+ T-cell populations, monocytes would be present within the 
total splenocyte cultures (Drutman et al., 2012; Strauss-Ayali et al., 2007; 
Swirski et al., 2009). In the presence of accessory antigen presenting cells 
(APCs), increased CD4+ T-cell survival was reported following LPS treatment 
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(McAleer and Vella, 2008), while Xu (2008) describes how LPS treated B-cells 
mediate T-cell differentiation into a Th2 phenotype. The effect of IL-4 on T-
cells appears less controversial and has been shown to direct CD4+ T-cells 
towards a Th2 phenotype in an autocrine manner (Le Gros et al., 1990; 
Swain et al., 1990). 
An additional consideration regarding the differences between control and 
PI3K C2β−− cultures is the role PI3K C2β has in calcium signalling. For 
example, in human T-cells PI3K C2β activates the K+ channel, KCa3.1, 
following stimulation of the T-cell receptor (TCR) (Srivastava et al., 2009). 
Functional studies in KCa3.1−− mice have shown that while CD4+ T-cell 
differentiation was not affected by loss of KCa3.1, cytokine production and 
proliferation following TCR stimulation was impaired in Th1 and Th2 subsets 
while Th17 and Tregs remained unaffected (Di et al., 2010).  
In a mouse model of autoimmunity, Th17 cells, which are CD4+, were found 
to promote the generation of spontaneous autoreactive germinal centres 
through the production of IL-17. Increased IL-17 was found to initiate 
germinal centre (GC) formation and size by increasing cell numbers, and 
reducing B-cell migration (Hsu et al., 2008). Furthermore, expression of the 
IL-17 receptor (IL-17RA) by follicular helper T (Tfh) cells appears to be 
necessary for retention of Tfh cells within the light zones (LZ) of the GC and 
loss of IL17RA led to loss of Tfh from the LZ (Ding et al., 2013). 
Within total splenocyte cultures, the presence of different subsets 
belonging to several cell types is likely to result in variations between 
cultures, both as a result of cell interactions and the production of cytokines. 
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However, the consistent increase in CD4+ population and increased viability 
of splenocyte cultures, indicated that loss of PI3K C2β−− was not 
necessarily inhibitory when in a mixed cell culture. Results obtained from 
the isolated T-cell cultures suggest that when provided with the same 
stimuli, PI3K C2β−− and control T-cells react in a comparable manner. 
However, the slightly increased CD4+ population at 0 hr and results from 
total splenocyte cultures may indicate that conditions within the total 
splenocyte cultures preferentially maintain the PI3K C2β−− CD4+ 
population both ex vivo and in vitro. Maintenance of the CD4+ population 
could be due to the increased CD19+ population within the PI3K C2β−− 
cultures. B-cells are efficient APCs and in addition to mediating immune 
responses via the B-cell receptor (BCR), they can stimulate T-cells by 
binding, processing and presenting antigen via CD19, and in doing so 
upregulate the co-stimulatory molecules CD80 and CD86 (also known as 
B7.1 and B7.2) (Yan et al., 2005).  
Examination of B-cells within the splenocyte populations had shown that 
CD19 expression at 0 hr was elevated in the PI3K C2β cultures, compared 
to control cultures. Analysis at 80 hr following stimulation with LPS and IL-4 
had shown that not only was CD19 MFI increased in PI3K C2βsplenocyte 
cultures, but also the percentage of CD19+ cells was higher, compared to 
control cultures. This was of particular interest because increased CD19 
expression has been linked to a hyper-responsive phenotype in B-cells and 
increased cell survival (Hasegawa et al., 2001a; Sato et al., 1996). 
Splenocytes from PI3K C2βspleens had shown a small increase in the 
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percentage of live cells at 80 hr, which would be consistent with an 
increased CD19+ population and increased expression. As such, a more 
detailed examination of the B-cell population was conducted (Chapter 5). 
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5 B-cells 
Histological examination revealed that PI3K C2β−− mice had larger 
germinal centres (GC), as a percentage of total spleen area compared to 
control mice and that their number was also greater (Chapter 3). This 
difference was exaggerated in mice treated with sheep IgG/CFA to induce 
an immunological response. PI3K C2β splenocytes had shown increased 
viability following LPS/IL-4 stimulation. Examination of isolated T-cells, 
suggested that T-cell viability was comparable between PI3K C2β and 
control T-cells, suggesting that increased viability may not be due to the T-
cell population. Increased CD19 MFI on PI3K C2β−− CD19+ cells, indicated 
that CD19 was upregulated. As such, isolated B-cells were examined in more 
detail. Initially, I wanted to establish the presence of PI3K C2β in murine B-
cells and to confirm that CD19 upregulation was B-cell related. 
5.1 Isolation of splenic B-cells 
B-cells were isolated via negative selection from the spleens of control mice 
and PI3K C2βmice. Following a resting period of 1-2 hr splenocytes were 
labelled with either anti-B220 (Alexa-Fluor 648), or an isotype control 
before B-cell purity was analysed by flow cytometry. Negative selection 
resulted in >96% B220+ population (Figure 5.1). 
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Figure 5.1 Isolation of B-cells from spleens of control and PI3KC2β mice. B-cells 
were isolated from freshly harvested splenocytes by negative selection. A minimum 
of 10,000 event were recorded per plot. Cells were then labelled with either anti-
B220 (Alexa-Fluor 648), or an isotype control before B-cell purity was analysed by 
flow cytometry. A; plots show typical FSC vs SSC of B-cells isolated from spleens of 
control (upper) and PI3KC2β mice (lower). B; a negative isotype control was used 
to exclude non-specific staining control (upper) and PI3KC2β mice (lower). C; cells 
labelled with anti-B220 used to determine B-cell purity control (upper) and 
PI3KC2βmice (lower). Over the course of the project the percentage of B220+ 
cells isolated in this way was >96%. 
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5.2 PI3K C2β expression in murine B-cells  
The expression of PI3K C2β in T-cells has been previously reported 
(Balzarotti et al., 2015; Ohya and Imaizumi, 2014; Srivastava et al., 2009). 
PI3K C2β is reported to be expressed in human B-cells based on gene 
expression analysis (Jelinek et al., 2003; McCarthy et al., 2015), but its 
expression in murine B-cells has not been described. Cells of the immune 
system are greatly affected by the micro environment, including cell to cell 
contact as well as their exposure to various cytokines and chemokines. As 
such, a cell may be indirectly affected by the loss of PI3K C2β without 
expressing the enzyme itself. However, determining whether PI3K C2β is 
expressed in murine B-cells would allow a better understanding of its role 
and provide insight into its effect on B-cell biology.  
Expression of PI3K C2β in B-cells from control mice was confirmed using 
reverse transcription PCR (RT PCR) and Western blot analysis (Figure 5.2). 
The forward primer (235) was designed to anneal to the end of exon 26 and 
the start of exon 27, and the reverse primer should anneal within exon 33. 
Successful PCR amplification produced a cDNA product of 858bp from 
control B-cells, which was absent in cells isolated from PI3K C2β mice. 
The presence of the protein was then confirmed using Western blot analysis 
on B-cell lysates.   
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Figure 5.2 Expression of PI3K C2β in murine B-cells. Reverse transcription PCR 
and Western blot. A; cDNA was isolated and PCR was used to identify the 
presence of PI3K C2β mRNA in B-cells from control mice (expected product size 
of 858bp), and its absence from PI3K C2β mice. Primers were designed to 
straddle exons 26 and 27 so that gDNA contamination could be excluded. B; 
following the fractionation of B-cell lysates by SDS PAGE, proteins were 
immunoblotted with anti-PI3K C2 antibody and visualised using ECL. A band 
was seen at approximately 170kD, in B-cells from control mice which was 
absent from PI3K C2β mice. Actin was used to determine loading. 
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5.3 B-cells isolated from PI3K C2β−− mice have an increased level of 
CD19 expression compared to controls  
Differences in CD19 expression had been observed within total splenocyte 
populations both basally and following their stimulation with LPS/ IL-4. A 
strong association between CD19 expression and B-cell activation 
thresholds has been previously reported making increased CD19 expression 
of particular interest (Fujimoto et al., 2000; Inaoki et al., 1997). 
Following B-cell isolation, cells were labelled with anti-CD19 (Alexa-Fluor 
647) and analysed by flow cytometry. The cell populations assessed were 
within the highest viability gate as determined by PI staining. In each 
experiment CD19+ MFI was increased by >25% on B-cells isolated from PI3K 
C2β mice, compared to the controls (p=<0.0001). Results are from three 
independent experiments using nine control and nine PI3K C2βmice, 
statistical analysis was calculated using a two way ANOVA.  
To further validate the increased levels of CD19 expression on PI3K C2β 
B-cells, lysates from freshly isolated B-cells were fractionated by SDS-PAGE, 
immunoblotted and probed with anti-CD19 antibody. Anti- β-actin antibody 
was used to confirm loading. Chemiluminescent detection confirmed that 
PI3K C2β B-cell lysates, expressed higher levels of CD19 protein 
compared to the control lysates (Figure 5.3).  
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  Expt 1 Expt  2 Expt 3 Mean ± SEM 
Control 2.3 ± 0.1 2.6 ± 0.04 3.3 ± 0.2 2.7 ± 0.2 
PI3KC2 3.3 ± 0.2 3.4 ± 0.1 4.67 ± 0.2 3.8 ± 0.4  
Difference 1 0.9 1.4      1.1 
 
Data shown is shown as arbitrary units and was collected over three independent 
experiments, using nine control and nine PI3K C2β mice. The increased MFI on 
PI3K C2 B-cells was considered statistically significant (p=<0.0001). Statistical 
analysis was calculated using a two-way ANOVA. Data are presented ± SEM. 
Table 5.1 CD19 expression on isolated B-cells at 0 hr. 
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Figure 5.3 CD19 expression is increased in PI3K C2 B-cells. A; following 
the fractionation of B-cell lysates by SDS PAGE, proteins were 
immunoblotted with anti-CD19 antibody and visualised by ECL. 40μg of total 
protein was loaded and β-actin was used as a loading control B; B-cells 
isolated from spleen of either control or PI3K C2β mice were labelled with 
anti-CD19 antibody conjugated to alexa-fluor 647 and median fluorescent 
intensity (MFI) was analysed. In each experiment MFI was higher on PI3K 
C2β B-cells compared to control B-cells (see Table 5.1). A minimum of 
10,000 events were recorded per experiment. A two-way ANOVA was used 
to determine statistical significance (p=< 0.0001). The results are from three 
independent experiments using a total of nine control mice and nine PI3K 
C2β mice. 
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5.4 B-cell viability 
Previously, PI staining of total splenocyte populations demonstrated that 
cells isolated from the spleens of PI3K C2β−− mice survived longer ex vivo 
than splenocytes from control mice (Figure 4.9), and that CD19 expression 
was elevated in the PI3KC2β splenocytes (Figure 4.3). Previous 
unpublished work from our laboratory showed that a marked immune 
response was generated in PI3K C2β−− mice following a sub-nephritogenic 
dose of NTS. Analysis of splenocyte populations had indicated that PI3K 
C2−− mice had a slightly expanded CD4+ population upon isolation which 
was still apparent after 80hr in culture (Table 4.2 and Figure 4.7). However, 
a preliminary examination of isolated T-cells had shown that viability was 
comparable between control and PI3K C2β cultures. Since these data 
suggested that the increased splenocyte survival may not be T-cell mediated 
B-cell viability was examined. 
B-cells have a tightly regulated lifecycle and undergo apoptosis if they do 
not receive the appropriate stimuli. These stimuli can be provided by 
cytokines in the local environment and interactions with other cell types 
including T-cells, and professional antigen presenting cells (APCs), such as 
dendritic cells. In turn, B-cells can activate T-cells through antigen 
presentation in addition to producing cytokines that support and regulate 
the T-cell immune response (Baumjohann et al., 2013; Wollenberg et al., 
2011). If the B-cell population is not kept under strict control, B-cell related 
pathologies result and dysregulation of the T-cell response may occur 
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(González-Navajas et al., 2010; Singh et al., 2014; Zhu and Paul, 2015). My 
earlier analysis of splenocyte viability had used stimulation with LPS at 
20μg/ml and IL-4 at 50ng/ml, which are concentrations that had previously 
been optimised in our lab and that are often utilised for B-cell culture (Heise 
et al., 2014; Lin and Calame, 2004; Omori et al., 2006). As LPS has been 
shown to induce B-cell activation and proliferation in a dose-dependent 
manner (Xu et al., 2008), and having identified increased CD19 expression 
(Figure 5.3) which is associated with a reduced activation threshold (Carter 
and Fearon, 1992; Inaoki et al., 1997), isolated B-cell cultures were 
stimulated with reduced doses of LPS and IL-4.  A preliminary experiment 
was conducted in which B-cells from control and PI3K C2 mice were 
stimulated with 10g/ml LPS and 5g/ml (Appendix 2). The results 
indicated that the B-cells remained alive at the lower concentrations and 
that the PI3K C2 B-cells were more responsive to the reduced stimuli, 
they appeared to form more foci and had an increased population of live 
cells at 72 hr. A final concentration of 2g/ml LPS and 20ng/ml was tested 
and used. 
5.5 Analysis of B-cell viability using AnnexinV and propidium iodide 
(AnV/PI)  
Initial analysis following stimulation with 2g/ml LPS and 20ng/ml, using  PI 
only showed that PI3K C2β cultures had an increased percentage of live 
cells compared to controls at 24 hr, which was greater at 72 hr. Two distinct 
populations were identified as highest viability and mixed viability, and were 
analysed individually. PI3K C2β B-cells appeared to remain within the 
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high viability gate for longer than B-cells from control mice, which 
underwent a shift into the mixed viability gate more quickly (Appendix 3 
and Appendix 4). This analysis was performed using propidium iodide (PI), 
which is useful for identifying cells in late apoptosis, however PI cannot 
identify cells at the early stages of apoptosis when the cell membrane is still 
intact. To identify cells in the early stages of apoptosis AnnexinV was used, 
as it binds to the cell membrane via phosphatidylserine which is exposed on 
the surface of apoptotic cells (Koopman et al., 1994).  
Cells were analysed after 24 hr and 72 hr stimulation with LPS (2μg/ml) and 
IL-4 (20ng/ml) (Table 5.2, Figure 5.4 and Figure 5.5). After 24 hr stimulation 
both control and PI3K C2β B-cells had comparable percentages of cells 
that were PI negative/AnV negative (54 % ± 2.6 and 55.1 % ± 1.80), they also 
had comparable populations of AnV positive/PI negative (early apoptotic) 
B-cells (11.1 % ± 0.9 and 13 % ± 0.7). However there was a smaller 
population of PI3K C2β B-cells that were PI positive/AnV positive (late 
apoptosis), compared to the controls (14 % ± 1 compared to 21.7 % ± 2.04, 
respectively). The difference of 5.7 % ± 1.2 was significant (p=0.001).  
After 72 hr stimulation the percentage of AnV negative /PI negative B-cells 
from control and PI3K C2β mice were again comparable (7.2 % ± 1.2 and 
6.9 % ± 1.4). The percentage of B-cells that were AnV positive/PI negative 
was significantly higher (p=0.003) in the PI3K C2β−/− population compared 
to the controls (36.4 % ± 2.4 and 25.2 % ± 2.2, respectively). However, the 
percentage of B-cells that were PI positive/AnV positive was now higher in 
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the control samples (64.5 % ± 3.5) compared to B-cells from PI3K C2β−− 
mice (51.9 % ± 1.7), (p=0.005). 
The AnV negative/PI negative results showing comparable populations at 
both time points suggest that the earliest stage of apoptosis occurs at a 
similar time in both control and PI3K C2β−− B-cells. However, the build-up 
of PI3K C2β−− B-cells in the AnV positive/PI negative (early apoptosis) gate, 
in conjunction with the reduction in the AnV positive/ PI positive (late 
apoptosis) at 72 hr might indicate that PI3K C2β−− B-cells remain in a state 
of early apoptosis for longer than the control B-cells before entering late 
apoptosis.  
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Table 5.2 AnnexinV/PI staining of B cells from control and PI3KC2β mice 
B-cells were stimulated with LPS (2μg/ml) and IL-4 (20ng/ml) for 24 hr and 72 hr. Data 
are from two (24 hr) or three (72 hr) independent experiments. Statistical analysis was 
performed using unpaired multiple t-tests, corrected for multiple comparisons using 
the Sidak-Bonferroni method. Data represent mean values ± SEM. 
               24 hr              72 hr 
  Early apoptosis 
(AnV+/PI-) 
 
Late apoptosis 
(PI+/AnV+) Early apoptosis (AnV+/PI-) Late apoptosis (PI+/AnV+) 
Control 11.1 % ± 0.9 
n=6 
21.7 % ± 2.04 
n=6 
25.2 % ± 2.2 
n=9 
64.5 % ± 3.5 
n=9 
PI3K C2
 13 % ± 0.7     
n=6 
14.02 % ± 1  
n=6 
36.4 % ± 2.4  
n=9 
51.9 % ± 1.7  
n=9 
Difference 
± SEM 
+1.9 ± 1.2 -5.7 ± 1.2 +11.2 ± 3.2 -12.7 ± 3.9 
Significance 
  
p=0.14 p= 0.001 p= 0.003 p= 0.005 
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Figure 5.4 AnnexinV/PI staining of B cells from control and PI3KC2β mice 
stimulated with LPS (2μg/ml) and IL-4 (20ng/ml) for 24 hr. B-cells were stained 
with Annexin V (AnV) and propidium iodide (PI) and analysed using flow 
cytometry, 30,000 events were recorded per plot.  A; representative plots of 
FSC vs SSC at 24 hr for control (left) and PI3K C2β−/− (right) B-cells. B; 
AnnexinV/PI staining at 24 hr showing gating. C; Analysis the data showed 
comparable populations of AnV-/PI- (viable) B-cells (p=0.7). AnV+/PI- (early 
apoptotic) populations were also comparable (p=0.14). However the difference 
between control and PI3K C2 PI+/AnV+ (late apoptotic) populations (19.7 
% ± 1.2 and 14 % ± 1, respectively) was significant (p=0.001). Results are from 
two independent experiments using six control and six PI3K C2β−/− mice. 
Statistical analysis was performed using unpaired multiple t-tests, corrected for 
multiple comparisons using the Sidak-Bonferroni method. Data represent mean 
values ± SEM. 
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Figure 5.5 AnnexinV/PI staining of B cells from control and PI3KC2β mice 
stimulated with LPS (2μg/ml) and IL-4 (20ng/ml) for 72 hr. B-cells were stained 
with Annexin V (AnV) and propidium iodide (PI) and analysed using flow 
cytometry, 30,000 events were recorded per plot. A; representative plots of 
FSC vs SSC at 72 hr for control (left) and PI3K C2β−/− (right) B-cells. B; 
AnnexinV/PI staining at 72 hr showing gating. C; Analysis of data showed that 
populations of AnV-/PI- (viable) B-cells were comparable (p=0.9). AnV-/PI+ 
(early apoptotic) populations were higher in the PI3K C2 B-cells (36.4% ± 
2.4) compared to the control B-cells (25.2% ± 2.2) (p=0.003). PI+/AnV+ (late 
apoptotic) populations in PI3K C2 B-cells were smaller (51.9% ± 1.7) 
compared to the controls (64.5% ± 3.5) (p=0.005). Results are from three 
independent experiments using nine control and nine PI3K C2β−/− mice. 
Statistical analysis was performed using unpaired multiple t-tests, corrected for 
multiple comparisons using the Sidak-Bonferroni method. Data represent 
mean values ± SEM. 
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In culture, despite showing signs of being in early apoptosis by AnV/PI 
staining, B-cells from PI3K C2β−− mice appeared to maintain an increased 
level of activity compared to control B-cells. For example; when B-cells were 
stimulated with LPS (2μg/ml) and IL-4 (20ng/ml) and cultured at the same 
density, the media from PI3K C2β−− flasks became acidic more quickly 
indicating increased metabolic activity (Figure 5.6) and examination by light 
microscopy showed PI3K C2β−− B-cells generated foci more quickly than 
the controls. These observations coupled with the discovery that PI3K 
C2β−− B-cells survived for longer than the control B-cells and that the shift 
from early to late apoptosis appeared to be delayed, could provide an 
insight into the altered response that was previously demonstrated by the 
PI3K C2β−− mice. To examine whether a delay in the progression from early 
to late apoptosis correlated with increased metabolic activity, a 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was 
used. 
5.6 MTT assay 
The MTT reagent is converted to purple formazan crystals, by metabolically 
active cells. The formazan crystals are then dissolved before being read by 
spectrophotometer at 570nm. The rate at which formazan crystals are 
produced correlates to the metabolic activity of the cells and decreases as 
cells become less viable, which makes the MTT assay a useful tool for 
evaluating metabolic activity and cell viability.  
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Freshly isolated B-cells were examined following a brief rest period, or were 
stimulated with LPS (2μg/ml) and IL-4 (20ng/ml) to be examined at 72 hr. 
Results are from two independent experiments using six control and six PI3K 
C2β−− mice. Statistical significance was calculated using a Student’s t-test 
(Figure 5.6.) 
Following dissolution of the formazan crystals absorbance was read 
(570nm), the results for isolated B-cells at 0 hr was comparable for the 
control (0.06 ± 0.001) and PI3K C2β−− cells (0.06 ± 0.001). At 72 hr post 
stimulation PI3K C2β−/− wells had an increased absorbance reading of 0.8 ± 
0.04 compared to the controls which was 0.6 ± 0.02. The difference of 0.2 ± 
0.05, represented a 14.4 ± 0.7 fold increase in the PI3K C2β−− samples, 
compared to an 11.9 ± 0.5 fold increase in the control samples. Fold increase 
was calculated by dividing the absorbance at 72 hr for each sample (the 
mean of three replicates) by the absorbance of the corresponding sample 
at 0 hr (the mean of three replicates). 
The increase in absorbance in PI3K C2β B-cells was considered significant 
(p=0.006). This result correlated well with the previous AnV/PI data which 
had shown that PI3K C2β B-cells appeared to have a delayed shift from 
early to late apoptosis. This suggests that despite being in the early stages 
of apoptosis, as shown by the AnV/PI results, PI3K C2β B-cells remained 
metabolically active and displayed increased metabolic activity compared 
to the controls.  
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Figure 5.6 Assessment of B-cell metabolic activity using an MTT assay at 0 hr and 72 
hr post stimulation with LPS (2μg/ml) and IL-4 (20ng/ml). A; flasks showing control 
and PI3K C2β−/− B-cells seeded at 1X106 cells/ml and cultured under the same 
conditions. The change of colour seen in the PI3K C2β−/− flasks indicates that the pH 
indicator (phenol red), has become more acidic, suggesting increased metabolic 
activity. B; representative MTT assay following solubilisation of the formazan crystals 
at 72 hr. Samples were assessed in triplicate using B-cells from three control and 
three PI3K C2β−/− mice. C; analysis of the absorbance readings at 570 nm showed a 
20% increase in PI3K C2β samples compared the control samples (14.4 ± 0.7 and 
11.5 ± 0.5, respectively). The difference was statistically significant (p=0.006). The 
experiment was conducted in triplicate and repeated twice, using a total of six control 
and six PI3K C2β−/− mice. Statistical analysis was performed using an unpaired, two 
tailed t-test. Data represent mean values ± SEM. 
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5.7 Cell cycle analysis 
Data had shown that PI3K C2β B-cells appeared to have a delay in 
transitioning from early apoptosis to late apoptosis and showed higher 
metabolic activity than their control counterparts. However, cell 
proliferation had not been addressed; analysis of AnV/PI staining by flow 
cytometry involves the analysis of a pre-determined number of cells and 
results are assessed as a percentage. The MTT assay, is often referred to as 
a proliferation assay, as cells are seeded at equal predetermined densities 
and therefore increased metabolic activity could be as a result of increased 
cell numbers. Additionally, IHC of spleen sections from unimmunized mice 
and mice treated with sheep IgG and CFA had shown increased areas of 
PCNA staining, which is a marker of cell proliferation. To assess whether 
PI3K C2β B-cells showed any differences in proliferation, cell cycle 
analysis was performed on two separate occasions, using six control and six 
PI3K C2β mice.  
Analysis was conducted at 0, 24 and 72 hr following stimulation with LPS 
(2μg/ml) and IL-4 (20ng/ml). Cells were harvested and washed with PBS, cell 
pellets were then fixed in 70% ethanol and stored at 4oC until use (at least 
overnight). Following treatment with RNase and the addition of PI, cell cycle 
was assessed by flow cytometry (Figure 5.7). Following the exclusion of 
debris and doublets, gates were set to show the percentage of cells within 
the sub-G0/G1, G0-G1, synthesis (S) and G2/mitosis (M) phases of the cell 
cycle. Examination of the sub G0/G1 gate allowed further gating to the 
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highest viability population. Results from both the total population 
(excluding doublets and debris) and the highest viability population were 
assessed.   
At 0 there was minimal difference between control and PI3K C2β B-cells 
in any phases of the cell cycle, in either the total population or the highest 
viability population (Appendix 5). At 24 hr, there was a smaller percentage 
of PI3K C2 cells in sub-G0/G1 within the highest viability populations 
(p=0.003). By 72 hr, control and PI3K C2β B-cells had very similar 
percentages of the population within the S and G2/M phases, however 
differences could be seen in the sub G0/G1 and G0/G1 phases. Within the 
total B-cell populations, there was 9.2% more control B-cells within the sub 
G0/G1 gate compared to PI3K C2β B-cells. This difference rose to 12.2% 
within the highest viability population (p=<0.001). Differences were also 
observed within the G0/G1 gate, with 10.1% more PI3K C2β cells from 
the total population, although this was not considered statistically 
significant when analysed using multiple t-tests, with multiple comparisons 
corrected for using the Sidak-Bonferroni method. Within the highest 
viability population there was 14.9% PI3K C2βcell, compared to the 
controls (57.8% and 43.8%, respectively), which was statistically significant 
(p=<0.0001). Analysis of the phases of the cell cycle as a time series (Table 
5.3 and Figure 5.8), using a two-way ANOVA indicated that over the 72 hr 
period a lower percentage of the PI3K C2 cells fell within the sub-G0/G1 
gate in both the total population (excluding debris) and the highest viability 
158 
 
population (p=0.003 and p=0.007, respectively). This pattern was reversed 
when observing the G0/G1 populations, with the PI3K C2 B-cells having 
an increased percentage over time within the total population (excluding 
debris) and the highest viability populations (p=0.006 and p=0.005, 
respectively). Within the total population (excluding debris), there was also 
a very slight increase in the percentage of PI3K C2 cells within the G2/M 
gate over the time course (p=0.047).  
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Total population (excluding debris/ doublets) 
Sub G0/G1 Control  PI3K C2  Difference 
0 hr 8% ± 0.66  6.6% ± 0.56 1.4± 0.9 
24 hr 20.2% ± 2.7 14.4% ± 2.01 5.1 ± 3.4 
72 hr 67.8% ± 3.44 58.6% ± 1.4 9.2 ± 3.7 
p= 0.003 
G0/G1    
0 hr 88.3% ± 0.6 89.8% ± 0.6  1.5 ± 0.9 
24 hr 75.3% ± 2.8 79.6% ± 2.8 4.3 ± 4 
72 hr 23.5% ± 3.1 29.8% ± 1.2 6.2 ± 3.3 
p= 0.006 
Synthesis       
0 hr 1.1% ± 0.1 1.1% ± 0.2 0 ± 0.2 
24 hr 6.2% ± 0.9 7.8% ± 0.5 1.1 ± 1.1 
72 hr 4.8% ± 0.4 3.9% ± 0.3 0.9 ± 0.5 
p= 0.86 
G2/M    
0 hr 2.1% ± 0.2  2.2% ± 0.2  0.2 ± 0.3 
24 hr 1.2% ± 0.1 2.1% ± 0.4 0.9 ± 0.4 
72 hr 0.5% ± 0.1 0.5% ± 0.1 0  ± 0.1 
p= 0.047 
Highest viability population 
Sub G0/G1 Control PI3K C2  Difference 
0 hr 2.7% ± 0.5 2.7% ± 0.3  0 ± 0.6 
24 hr 15.9% ± 3.2 8.2% ± 1.8 7.7 ± 3.7 
72 hr 43.5% ± 5.3 31.4% ± 2 12.2 ± 5.6 
p= 0.007 
G0/G1    
0 hr 94.4% ± 0.5  94.3% ± 0.4  0.1 ± 0.6 
24 hr 84.4% ± 2.5 75.8% ± 4.2 8.6 ± 4.9 
72 hr 43% ± 4.6 57.8% ± 2.5 14.9 ± 5.3 
p= 0.005 
Synthesis    
0 hr 2.5% ± 0.7  1.6% ± 0.4  1.6% ± 0.4  
24 hr 2.5% ± 0.3 2.7% ± 0.5 0.2 ± 0.6 
72 hr 7.8% ± 1 6.1 ± 0.5  1.7 ± 1.1 
p= 0.12 
G2/M    
0 hr 2.4% ± 0.2  2.5% ± 0.2 0.4 ± 0.3 
24 hr 1.4% ± 0.1 2.5% ± 0.6 1.1 ± 0.6 
72 hr 0.8% ± 0.2 0.8% ± 0.1 0 ± 0.2 
p= 0.68 
Table 5.3 Summary of cell cycle analysis of B-cells from control and PI3K C2β mice after 
0, 24 and 72 h incubation with LPS (2 μg/ml) and IL-4 (20 ng/ml). 
B-cells were gated on the total population (excluding debris/doublets) and on the 
highest viability populations. Results are from two independent experiments using 
six control and six PI3K C2β mice. Statistical analysis was performed using a two-
way ANOVA. Data represent mean values ± SEM. 
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Figure 5.7 Cell cycle analysis of isolated B-cells from the spleens of control and 
PI3K C2β−/− mice Cells were fixed in ethanol, permeabilized and treated with 
RNAse before being stained with PI and assessed using flow cytometry, 10,000 
events were recorded per sample. A; an initial plot of FSC (area) vs FSC (height) 
was used to exclude doublets which could lead to false positive readings in the 
G2/M gate. B; FSC vs SSC gated to include single cells only. Gates were set to 
exclude debris (false negatives) and the highest viability and mixed viability 
gates were determined based on the percentage of the population that fell 
within the sub G0/G1 gate (mixed viability (i)) or the G0/G1, synthesis (S) or 
G2/M gates (highest viability). C; representative histograms at 0 hr, 24 hr and 72 
hr, gated on highest viability (top) or gated to exclude debris (bottom). 
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Figure 5.8 Phases of the cell cycle analysis presented as a time series. Analysis of the cell cycle 
data collected at 0, 24 and 72 hr (Figure 5.7) revealed that the differences between control 
and PI3K C2β−/− B-cells were not significant when assessed at each time point individually. 
However, when analysed by gate, there were consistent differences within the sub G0/G1 and 
G0/G1 gates over time. A; the PI3K C2β−/− sub G0/G1 population was reduced at each time 
point, within the ‘excl. debris and doublets’ gate (left) and the highest viability gate (right) 
(p=0.003 and p=0.007, respectively). B; within the G0/G1 gate the PI3K C2β−/− population was 
higher in both instances (p=0.006 and p=0.005). C; the results from PI3K C2 and control 
cells were comparable for S-phase. D; there was a small but statistically significant increase in 
the percentage of PI3K C2 B-cells in G2/M-phase of the cell cycle when analysed to exclude 
debris (p=0.047), however, no difference between the groups was observed when analysing 
the highest viability population.  The results are from two independent experiments, using six 
control and six PI3K C2β−/− mice. Statistical significance was calculated using a two-way 
ANOVA. 
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5.8 BCR isotype expression 
Surface IgM (sIgM) is the first immunoglobulin isotype to form the BCR on 
pro-B-cells (Loder et al., 1999) and it continues to be expressed on mature 
naïve B-cells until activation and subsequent isotype switching (Chaudhuri 
and Alt, 2004; Jung et al., 1994; Stavnezer et al., 2008). The expression of 
sIgM may remain following activation, but this is dependent on the method 
of activation. For example, T-cell dependent activation results in isotype 
class switching of sIgM to sIgG, sIgE or sIgA. However, following T-cell 
independent activation sIgM remains present (Charles A Janeway et al., 
2001b). Levels of sIgM expression also vary depending on the location or 
type of B-cell, follicular B-cells (Fo) typically express lower levels of IgM, 
while sIgM is highly expressed on marginal zone (MZ) B-cells (Loder et al., 
1999). As such, surface immunoglobulin expression can help identify the 
stage of B-cell differentiation.  
5.9 PI3K C2β−/− mice have fewer splenic IgM+ B-cells and reduced IgM 
expression. 
Analysis of surface IgM (sIgM) expression was assessed by labelling freshly 
isolated splenic B-cells with anti-IgM (PE) and analysing cells by flow 
cytometry. Results are shown from four independent experiments using a 
total of twelve control and twelve PI3K C2β mice. Statistical analysis was 
calculated using a Student’s t-test (total population) and two-way ANOVA 
(MFI). 
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The sIgM population was reduced in PI3K C2β B-cells (Figure 5.9). 
Control B-cells had a mean sIgM+ population of 89.6% ± 1, compared to 
81.1% ± 1.5 on PI3K C2β B-cells (p=0.0001). In addition to a reduced 
sIgM+ population, a consistent reduction in MFI suggested that the level of 
sIgM expression was also reduced on the PI3K C2β B-cells (p=<0.0001). 
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Figure 5.9 sIgM expression on isolated B-cells at 0 hr. Freshly isolated B-cells were allowed 
to rest for 1-2 hr before being labelled with a fluorophore conjugated antibody to sIgM, or 
an isotype control. Samples were analysed by flow cytometry with a minimum of 10,000 
events recorded per plot.  A; shows the B-cell population being analysed. B; representative 
dot plot for the isotype control. C and D; typical sIgM+ plots for control and PI3K C2β, 
respectively. E; analysis of the results revealed that PI3K C2β B-cells contained a lower 
percentage of sIgM+ cells compared to the control B-cells (81% ± 1.5 and 89.6% ± 1, 
respectively) this was statistically significant at p= 0.0001. F; sIgM+ B-cells from PI3K C2β 
mice also had a consistent reduction in median fluorescent intensity (p=<0.0001). The 
results are from four independent experiments, using twelve control and twelve PI3K 
C2β mice. An unpaired, two tailed Student t-test was used to calculate statistical 
significance for the sIgM+ populations (E) and a two-way ANOVA was used to assess MFI 
(F). Data represent mean values ± SEM. 
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5.10 Differential surface IgM+ expression between control and PI3K 
C2βB-cells 
Basic analysis of surface IgM (sIgM) on freshly isolated B-cells at 0hr showed 
that PI3K C2β B-cells had a reduced sIgM+ population and that the level 
of expression within the population was reduced (Figure 5.9). Further 
assessment of the sIgM+ populations against forward scatter revealed a 
distinct expression pattern when compared to the control IgM+ B-cells 
(Figure 5.10). B-cells were gated according to the level of sIgM expression 
(high, mid or low). From the total population of sIgM+ B-cells, 18.2% of 
control B-cells were IgMhi, compared to 9.5% of the PI3K C2β sIgM+ B-
cells. This represents a 48% reduction (p=<0.0001). There were also fewer 
PI3K C2βIgM+ B-cells within the IgMmid gate compared to the controls 
(35.6% and 40.7% respectively) (p=0.008). The trend was reversed for IgMlow 
B-cells, with 36.7% of PI3K C2β B-cells being IgMlow, compared to 29.2% 
of the controls, which represents a 20.5% increase (p=0.0006). These data 
suggest that in addition to PI3K C2β splenic B-cells containing fewer 
sIgM+ B-cells under basal conditions, there is also a difference in the 
expression profile. The reduction in the total population appears to be as a 
result of fewer IgMhi and IgMmid expressing B-cells. The increased IgMlow 
population in the PI3K C2β B-cells suggests that the difference was not 
simply due to an overall reduction in the sIgM+ population. 
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Table 5.4 Summary of sIgM expression at 0hr 
 
  
 
IgM+ 
population IgMhi IgMmid IgMlo 
Control 
B-cells 
89.6 % ± 1  18.2 % ± 1.2 40.7 % ± 0.6  29.2 % ± 1.2  
PI3K C2 
B-cells 
81.01 % ± 1.5  9.5 % ± 1.1   35.6 % ± 1.6  36.7 % ± 1.5  
 
Difference 8.6 % ± 1.8 8.7 % ± 1.6 5.02 % ± 1.7  7.5 % ± 1.9 
IgMhi,mid and low refers to the gating strategy (Figure 5.10). Results are from four 
independent experiments using twelve control and twelve PI3K C2β−/− mice. Data 
represent the mean ± SEM. 
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Figure 5.10 Differences in sIgM expression in unstimulated, freshly isolated B-cells. Results had 
shown that the sIgM+ population was consistently smaller in B-cells from PI3K C2 mice, 
compared to the controls (Figure 5.9). The difference in MFI suggested that this was not simply 
due to PI3K C2 mice having fewer sIgM+ B-cells. To examine the expression profile, cells were 
gated as high, medium or low expression based on the expression levels in the control B-cells. A 
minimum of 10,000 events were recorded per experiment. A and B; show representative plots 
with gating for IgM
hi
, IgM
mid
 and IgM
lo
 populations, for control and PI3K C2
 
B-cells, 
respectively. C; the mean IgM
hi 
populations were consistently reduced in the PI3K C2
 
B-cells 
(9.5 % ± 1.1) compared to the controls (18.2 % ± 1.2). This difference was considered very 
significant (p<=0.0001). D; within the IgMmid gate, the PI3K C2 population (35.6 % ± 1.6) were 
also significantly reduced compared to the controls (40.7 % ± 0.6) (p=0.008). E; the trend was 
reversed for the IgMlow population, which had a consistently higher mean population of PI3K 
C2
 
B-cells (36.7 % ± 1.5) compared to the controls (29.2 % ± 1.2) (p=0.001). The results are 
from four separate experiments using a total of twelve control and twelve PI3K C2 mice, a 
student t-test was used for statistical analysis. Data represent mean values ± SEM. 
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5.11 sIgG1 and sIgE expression at 0hr 
Freshly isolated, unstimulated PI3K C2β B-cells had reduced sIgM+ 
populations and reduced MFI compared to B cells from control animals 
indicating that the level of expression was also reduced (Figure 5.9). 
Following isotype switching, which occurs within the germinal centre in 
response to activation, B-cells exchange surface IgM for IgG, IgE or IgA.  
The increased size of germinal centre cross sectional areas previously 
observed in PI3K C2β spleens (Figure 3.5 and Figure 3.6), in addition to 
a reduction in the sIgM+ populations on freshly isolated B-cells, may 
indicate that spleens in these knockout mice contain a higher background 
level of isotype switched B-cells. To explore this hypothesis, anti-IgG (PE), 
anti-IgE (PE) or an isotype control were used to label freshly isolated B-cells, 
following a two hour rest period. Flow cytometric analysis revealed that B-
cells from PI3K C2β mice had small but statistically significant increases 
in both sIgG1 and sIgE populations at 0 hr (Figure 5.11 and Figure 5.12). 
sIgG1 was detected on 6% ± 0.5 of PI3K C2β B-cells, compared to 3.8% ± 
0.2 of control cells (p=0.002), while sIgE was detected on 2.9% ± 0.1 of PI3K 
C2β B-cells and 2.04% ± 0.1 of control B-cells (p=0.0005). Although small, 
these increases could suggest that PI3K C2β mice kept under basal 
conditions have a slightly higher background of class switched splenic B-
cells. Analysis of MFI revealed no difference in the expression of sIgE on B 
cells from control and PI3KC2β mice (data not shown). Examination of 
the sIgG1 positive samples, demonstrated an increased population of PI3K 
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C2β B-cells, falling within the sIgG1 ‘switching gate’ (Figure 5.11). This 
population lay between the IgG1- and IgG1+ populations, and had an 
increased MFI compared to the controls, which might indicate that they 
were in the process of up-regulating sIgG1 as a result of class switching 
(p=0.02). 
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Figure 5.11 Analysis of IgG1 expression on freshly isolated B-cells (0 hr). Following 
isolation, B-cells were allowed to rest for 1-2 hr before being labelled with fluorophore 
conjugated antibodies to IgG or an isotype control. 10,000 events were recorded per plot. 
A; all cells were gated to include the highest viability population. B; a typical plot showing 
the isotype control used for gating. C; representative plots of IgG1+ B-cells from control 
(left) and PI3K C2 (right) mice D; results showed a small but significant increase in 
IgG1+ B-cells from the PI3K C2 mouse spleens, compared to the control mice. E; cells 
were gated to examine IgG1 MFI, of B-cells that were on the borderline between negative 
and positive (B and C), PI3K C2 B-cells consistently had a slight increase in MFI (p=0.02). 
The increase in MFI might suggest that the PI3K C2 B-cells have small population that 
are in the process of class switching. Results are from three independent experiments, 
using nine control and nine PI3K C2 mice. Statistical analysis was performed by 
Student’s t-test (D) and two-way ANOVA (E). Data represent mean values ± SEM. 
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Figure 5.12 Analysis of IgE expression on freshly isolated B-cells (0 hr).  
Following isolation, B-cells were allowed to rest for 1-2 hr before being 
labelled with fluorophore conjugated antibodies to IgE or an isotype control 
and analysed by flow cytometry. 10,000 events were recorded per plot. A; 
cells were gated to include the highest viability population. B; a typical plot 
showing the isotype control used to exclude non-specific binding. C; 
representative plots of IgE+ B-cells from control (left) and PI3K C2 
(right) samples.  D; results showed a small but significant increase in IgE+ B-
cells from the PI3K C2 samples (2.9% ± 0.1), compared to the controls 
(2% ± 0.1) (p=0.0005). Results are from two independent experiments, 
using six control and six PI3K C2 mice. Statistical analysis was 
performed using an unpaired, two tailed Student’s t-test. Data represent 
mean values ± SEM. 
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5.12 Differential surface CD23 expression between control PI3K 
C2B-cells 
In the splenic B-cell population, the low affinity IgE receptor, FcεRII (CD23) 
is expressed on the surface of mature follicular (Fo) B-cells, but is absent 
from immature transitional stage 1 (T1), and MZ B-cells (Best et al., 1995). 
Newly activated B-cells initially upregulate surface CD23 (sCD23), however 
expression is reduced post activation (Rabin et al., 1992) and is lost 
following class switch recombination (CSR) (Kehry and Hudak, 1989). These 
differential expression patterns make sCD23 useful for identifying the stage 
of B-cell maturation, activation state and specific populations when used in 
conjunction with other markers. Freshly isolated B-cells were stained with 
anti-CD23 (FITC) and analysed by flow cytometry. To determine the CD23+ 
populations, cells were gated on the highest viability cells and a negative 
isotype control was used to exclude any non-specific antibody binding 
(Figure 5.13). Analysis was performed over three individual experiments 
using a total of nine control and nine PI3K C2βmice. PI3K C2β mice 
had a reduction of 30.2% ± 1.5 of their overall sCD23+ B-cell population 
compared to control B-cells which were consistently >80% sCD23 positive 
(mean = 87.8% ± 0.7), as opposed to the PI3K C2βB-cells, for which the 
mean sCD23+ population was 57.6% ± 1.4 of total B-cells (p= < 0.0001). 
Breakdown of the sCD23+ populations showed that PI3K C2β B-cells had 
an increased population of CD23low B-cells compared to the controls (Figure 
5.14). The association between sCD23 expression and the stage of B-cell 
maturation and activation state made this population of potential interest. 
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B-cell populations were gated to show the sCD23low populations, revealing 
a significant increase in the PI3K C2βsamples (p=<0.0001). 
25.2% ± 1.4 of all control B-cells within the highest viability gate were 
CD23low, compared to 48.1% ± 1.2 of the PI3K C2βB-cells (Figure 5.14), 
which represents 28.0% ± 1.5 of the sCD23+ population (control) compared 
to 82.2% ± 0.8 (PI3K C2β). Examination of FSC revealed a small but 
consistent increase in the PI3K C2β sCD23low B-cells of 9% (mean of three 
experiments), indicating that cell size was increased, relative to the control 
B-cells. Measurement of MFI was also reduced in the PI3K C2β samples, 
in each of the three experiments (by 61%, 62% and 55%). This indicated that 
in addition to having fewer sCD23+ B-cells, the sCD23 expression was lower 
in the PI3K C2β B-cells compared to the control B-cells. 
 
 
 
 
  
 
CD23low population  
(of all viable B-cells) 
CD23low population  
(within CD23+ B-cells) 
 
Control 25.2 % ± 1.4 28 % ± 1.5 
 
PI3K C2 48.1 % ± 1.2  82.2  ± 0.8   
 
Difference  
between means 
22.9 % ± 1.8 54.2 % ± 1.7 
 
Significance p=< 0.0001 p=< 0.0001 
 
CD23low expressing B-cell populations at 0hr. Results are from three independent 
experiments, using nine control and nine PI3K C2mice. Statistical analysis was 
performed using an unpaired, two-tailed Student t-test. Data represent mean values ± 
SEM. 
 
Table 5.5 sCD23+ breakdown 
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CD23low mean forward 
scatter 
CD23+ median fluorescent 
intensity  
 Expt1 Expt2 Expt3 Expt1 Expt2 Expt3 
Control 1.3 1.5 1.2 6.8 7 6 
PI3K C2 1.4 1.6 1.3 2.7 2.7 2.7 
Difference  
between means 
0.1 0.1 0.1 4.1 4.3 3.3 
Significance p= < 0.0001 p= < 0.0001 
 
Median fluorescent intensity and mean forward scatter over the course of three 
individual experiments, units used are arbitrary and are displayed to allow 
comparison. Statistical analysis was performed using a two-way ANOVA. 
 
Table 5.6 sCD23lowmean forward scatter and median fluorescent intensity for CD23+ 
B-cells 
 
175 
 
  
Figure 5.13 sCD23 expression at 0 hr. Following isolation, B-cells were allowed 
to rest for 1-2 hr before being labelled with fluorophore conjugated antibodies 
to CD23 or an isotype control and analysed by flow cytometry. 10,000 events 
were recorded per plot. A; representative plots showing the highest viability 
population that was analysed. B; shows the negative isotope control used for 
gating. C; characteristic positive staining for anti-CD23 (FITC). D; PI3K C2β−/− 
mice had consistently fewer CD23+ B-cells (57.6% ± 1.3) compared to the controls 
(87.8% ± 0.7) (p= < 0.0001). Results are from three independent experiments 
using nine control and nine PI3K C2β−/− mice. Statistical analysis was performed 
using an unpaired, two-tailed Student t-test. Data represent mean values ± SEM. 
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Figure 5.14 sCD23low populations at 0hr. Freshly isolated B-cells were labelled with 
fluorophore conjugated anti-CD23 or an isotype control and examined by flow cytometry. 
10,000 events were recorded per plot (Figure 5.13).  Median fluorescent intensity and forward 
scatter were analysed A; representative dot plots showing sCD23low populations. B; 
representative histogram showing the difference in median fluorescence between control and 
PI3K C2β−/− sCD23+ B-cells. C; analysis of results revealed PI3K C2β−/− B-cell populations had 
an increased population of sCD23low cells (82.2% ± 0.8) compared to the controls (28% ± 1.4). 
(P=<0.0001). D; The MFI of the sCD23+ PI3K C2β−/− B-cells was also consistently lower than the 
controls (mean reduction of 59%) (p=<0.0001), indicating that sCD23 expression was reduced. 
E; mean FSC was slightly increased in the PI3K C2β−/− samples, in each experiment (mean 
increase of 9%) (p=<0.0001). Results are from three independent experiments, using nine 
control and nine PI3K C2β−/− mice. Statistical analysis was performed using an unpaired, two-
tailed Student t-test (C) and two-way ANOVA (D and E). Data represent mean values ± SEM. 
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5.13 PI3K C2βB-cells show altered CD23/CD19 expression 
compared to controls  
Co-staining in conjunction with flow cytometry provides a useful tool to 
assess cell populations. B-cell populations and subsets are often identified 
by way of multiple surface markers and their relative expression levels. 
Multiple staining involves labelling samples with each antibody and isotype 
control individually, as well as multi-labelling. This ensures that colour 
compensation can be set to avoid erroneous results due to overspill 
resulting in fluorophore signals being ‘read’ by the incorrect detector. 
Analysis had shown that PI3K C2βmice have approximately a 30% 
reduction in sCD23+ splenic B-cells (Figure 5.13). Reduced sCD23 expression 
has been linked to B-cell maturation and class switch recombination (CSR) 
(Rabin et al., 1992), and increased CD19 expression is associated with a 
reduction in B-cell “interaction thresholds” and can lead to increased 
survival (Nicholas et al., 2008), which has been observed in PI3K C2βB-
cells (Section 5.3). To investigate further, dual staining with anti-CD19 and 
anti-CD23 was performed to identify any differences between B-cell 
populations. Freshly isolated B-cells were used from six control mice and six 
PI3K C2βmice, in two independent experiments and an unpaired, two-
tailed Student t-test was used for statistical analysis unless otherwise 
stated.  
Previous results had shown a reduction in the PI3K C2β sCD23+ 
population and an upregulation in the expression of CD19 (Figure 5.13 and 
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Figure 5.3). However, examining the expression profile may provide insight 
into the subsets present and their stage of differentiation.   
5.14 CD19hi/sCD23hi B-cells are almost absent in PI3K C2 spleens 
Analysis of the co-staining results revealed a small population of 
CD19hi/sCD23hi B-cells in the controls that was almost absent in the PI3K 
C2βB-cells (Figure 5.15). In control B-cells the mean CD19hi/sCD23hi 
population was 6.2% ± 0.5 of all viable B-cells analysed (7.3% of the total 
sCD23+/CD19+ population), whereas 1.1% ± 0.1 of the PI3K C2βB-cells 
were CD19hi/sCD23hi (representing 2.3% of the total sCD23+/CD19+ 
population). This represents a reduction of 82.3%. Statistical significance 
was calculated using an unpaired two-tailed student t-test, using Welch’s 
correction for unequal variance (p=0.0001). 
5.15 CD19hi/sCD23lo 
Enlarging the CD19/sCD23 plots revealed the presence of a CD19hi/sCD23low 
population (Figure 5.16) that made up 19.1% of the total PI3K C2βB-cells 
but was significantly reduced in the control samples at 6% (p=0.0005). As 
sCD23 expression is downregulated following activation, the 
CD19hi/sCD23low populations were separated into low forward scatter (FSC) 
and high FSC gates, which showed that there was an increased percentage 
of PI3K C2βB-cells within the high FSC gate (77.7% ± 3.5) compared to 
the controls (65.4% ± 2.4), the difference of 12.3% ± 4.3 was considered 
significant (p=0.02). In addition to having an increase in the percentage of 
high FSC cells, the FSC reading for CD19hi/sCD23low B-cells was higher in the 
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PI3K C2βsamples, compared to the controls (2.4 ± 0.05 and 2.1 ± 0.04, 
respectively). The unit for FSC is arbitrary and is provided to allow 
comparison, but the difference represents an increase of 11.8%, which was 
significant (p=0.002). 
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Figure 5.15 Dual staining with anti-CD23 (FITC) and anti-CD19 (Alexa Flour 647). 
Freshly isolated splenic B-cells were allowed to rest for 1-2 hr before being labelled 
with fluorophore conjugated antibodies to CD23 only, CD19 only or both CD23 and 
CD19, or the appropriate isotype control. Cells were then examined using flow 
cytometry, with 10,000 events recorded per plot. A and B; representative staining 
pattern showing a distinct population of control B-cells that were CD19hi/sCD23hi 
(6.2% ± 0.5), which were significantly reduced in the PI3K C2populations (1.1% 
± 0.1). C; analysis of the flow cytometry data confirmed the reduction of the 
CD19hi/sCD23hi population within the PI3K C2 B-cells (p=<0.0001). Results are 
from two independent experiments, using six control and six PI3K C2 mice. 
Statistical analysis was performed using an unpaired, Student t-test with Welch’s 
correction. Data represent mean values ± SEM. 
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Figure 5.16 Dual staining with anti-CD19 (Alexa-fluor 647) and anti-CD23 (FITC). A; 
representative plots for control (top) and PI3K C2B-cells, respectively.  Plots are 
duplicates from Figure 5.15 that have been enlarged to show a distinct CD19hi/sCD23low 
population that is increased in the PI3K C2samples. B; typical plots showing the FSC/SSC 
of B-cells within the CD19hi/sCD23low gate for control (top) and PI3K C2(bottom), plots 
have been separated to show low FSC and high FSC populations. C; analysis of the results 
confirmed that the CD19hi/sCD23low population was significantly higher in the PI3K C2B-
cells (19.1% ± 2.4), compared to the controls (6% ± 1) (P=0.0005). D; there was also an 
increased percentage of CD19hi/sCD23low PI3K C2B-cells within the high FSC gate 77.7% 
± 3.5), compared to the controls (65.4% ± 2.4) (p=0.02). E; in addition to having a higher 
percentage of cells within the high FSC gate, PI3K C2B-cells that were within the 
CD19hi/sCD23low gate had a 11.8% increase in the mean FSC reading (p=0.002). Results are 
from two independent experiments, using six control and six PI3K C2mice. Statistical 
analysis was performed using an unpaired, two-tailed Student t-test. Data represent mean 
values ± SEM. 
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5.16 sCD23/sIgM 
Previous assessment of sCD23+ B-cells had shown that PI3K C2βsamples 
had an increased population of sCD23low B-cells, and that they had a higher 
FSC profile compared to the controls. Furthermore, an increased population 
of sIgMlow B-cells had also been observed in the PI3K C2βsamples 
(Figure 5.10). Activated, differentiating B-cells are typically sIgMlow/CD23low 
(Loder et al., 1999), and an increased FSC suggests increased cell size, which 
is also observed in activated B-cells (Allen et al., 2012). To investigate 
further, a preliminary experiment was carried out. Freshly isolated B-cells 
were co-stained with anti-IgM (PE) and anti-CD23 (FITC) and analysed by 
flow cytometry. Results are from a single experiment using three control 
and three PI3K C2βmice. Statistical analysis was performed using an 
unpaired, two-tailed Student’s t-test and data represent mean values ± 
SEM. Although this form of statistical analysis is used in the literature on 
small sample sizes (Allen et al., 2012; Carmichael et al., 2009; Dengler et al., 
2008), it may not be appropriate as the normality of the data cannot be 
determined. However, the power of this analysis, based on the standard 
deviation and difference between the means indicates that this experiment 
was powered at 0.9 and 0.99 respectively.  
An sIgMlow/sCD23low population was identified (Figure 5.17), using the 
gating strategy presented in Appendix 6, this revealed an increase within 
the PI3K C2βsamples compared to the controls (24% ± 0.7 and 15% ± 
1.5, respectively). Cells with the highest FSC were also identified which 
showed that 17% ± 1.4 of the control sIgM+/sCD23+ population had an 
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increased FSC, while 32% ± 0.9 of the PI3K C2βB-cells had an increased 
FSC. 
 
Table 5.7 Summary of sIgM+/sCD23+ data. 
 
  sIgMlow/sCD23low 
(percentage of 
viable B-cells) 
Percentage of sIgM+ 
sCD23+ cells  
with increased FSC 
Control 15 ± 1.5  17 ± 1.4  
PI3K C2
 24 ± 0.7   32 ± 0.9 
Difference between 
the means 
8.8 ± 1.7  15 ± 1.7 
  
Results are from a preliminary experiment using three control and three PI3K C2 
mice. Data represent mean values ± SEM 
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Figure 5.17 sIgMlow/sCD23low population is increased in PI3K C2 B-cells.  Freshly 
isolated B-cells were labelled with anti-IgM (PE) and anti-CD23 (FITC) and analysed using 
flow cytometry, 10,000 events were recorded per plot. A; cells within the highest viability 
gate were used for analysis. B; representative plots showing the sIgMlow/sCD23low 
populations for control (top) and PI3K C2 (bottom) B-cells (see Appendix 6 for gating 
strategy). C; plots show FSC versus SSC of the total sIgM+/sCD23+ populations (see also 
Appendix 7). D; the results showed an increased population of sIgMlow/sCD23low B-cells in 
the PI3K C2samples (24% ± 0.7) compared to the controls (15% ± 1.5). E; the 
percentage of B-cells with an increased forward scatter, within the sIgM+/sCD23+ 
population, was also higher in the PI3K C2samples (32% ± 0.9), compared to the 
controls (17% ± 1.4). Results are from a single experiment. This experiment is powered at 
0.9 (d) and 0.99 (e).  Data represent mean values ± SEM 
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5.17 IgMhi/sCD23- populations 
Surface CD23 expression is absent from marginal zone (MZ) B-cells (Best et 
al., 1995), which in mice, are a population of mature non-circulating B-cells 
found within the MZ of the spleen (Loder et al., 1999). Their location places 
them between the red pulp and follicles, where they can react to blood 
borne antigens directly, in a T-cell independent (TI) manner (Tsolaki, 2011). 
MZ B-cells have also been shown to provide T-cell stimulation (Oliver et al., 
1999). However there is also a subset of immature B-cells termed T1 
(transitional stage 1), that are also sCD23-/sIgMhi, these are typically small 
B-cells, newly arrived in the spleen from the bone marrow (Sims et al., 
2005). 
By gating to reveal the sIgM+/sCD23+ populations (Appendix 6), it was 
possible to also identify a distinct population of sIgMhi/sCD23- B-cells within 
the control B-cells (Figure 5.18), accounting for 5.3% ± 0.4 of the total 
population. Within the PI3K C2β samples there were 19% ± 0.5 
sIgMhi/sCD23- B-cells, a difference of 14% ± 0.6, compared to the controls. 
Results were powered to detect a difference, with the exception of Figure 
5.2 (E), which was underpowered at 0.6. 
CD19 expression was also assessed as it has been described as being 
upregulated in MZ B-cells (Genestier et al., 2007). Upregulation of CD19 has 
also been observed in MZ B-cells following activation (Palm et al., 2016a). 
As MZ B-cells have been shown to have an increased forward scatter (Arnon 
et al., 2013), this was also examined in the sIgMhi / sCD23- B-cells. The gating 
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strategy was the same as used for the sIgMlow/sCD23low population (Figure 
5.17), further details are provided in Appendix 8 and Appendix 9. 
Analysis of the results showed that in each of the PI3K C2β plots there 
was a population of high FSC cells that was greatly reduced in the control 
plots (8.3% ± 0.8 compared to 2.8% ± 0.5, respectively).  Measurement of 
CD19 MFI revealed that there was a consistent increase in each 
sIgMhi/sCD23- sample (mean increase: 23.3%) in the PI3K C2βB-cells.  
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Figure 5.18 sIgMhi/sCD23- B-cell populations at 0 hr. Freshly isolated B-cells were either 
labelled individually with anti-CD23 (FITC), IgM (PE) and CD19 (Alexa-fluor 647), the relevant 
isotype control, or all three antibodies and assessed by flow cytometry. A minimum of 10,000 
event were recorded per plot. Cells analysed were within the highest viability gate (Figure 
5.17) and the gating strategy used is presented in Appendix 8 and Appendix 9 . A; 
representative plots showing the sIgMhi/sCD23- populations for control (left) and PI3K 
C2B-cells (right). B; plots showing CD19 staining of the sIgMhi/sCD23- B-cells. There was 
a small population of B-cells with an increased FSC in PI3K C2 samples (right) that was 
almost absent in the control samples (left). C; the sIgMhi/sCD23- population within the PI3K 
C2 samples was increased (19% ± 0.5) compared to the controls (5.3 ± 0.4).  D; the 
percentage of CD19+, sIgMhi/sCD23- within the ‘increased FSC’ gate (B) was increased in PI3K 
C2 B-cells (8.3% ± 0.8) compared to the controls (2.8 ± 0.5). E; CD19 MFI was found to 
be higher in the PI3K C2 B-cells (3 ± 0.1), compared to controls (2 ± 0.1). F; 
representative histogram showing the difference in fluorescent intensity. Results are from a 
single experiment using three control and three PI3K C2mice. These data are powered 
at 1 (c), 0.95 (d) and 0.57 (e).Data represent mean values ± SEM. 
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5.18 B-cell activation  
Under normal physiological conditions, to avoid apoptosis both in vivo and 
in vitro, B-cells must receive ‘survival’ signals that are typically generated 
via surface receptors. For the purpose of this project lipopolysaccharide 
(LPS) and IL-4 were used, which are associated with isotype switching to 
IgG1 and IgE (Györy et al., 2012).  
5.19 Class switching  
Class switching, also referred to as isotype switching occurs in mature B-
cells in response to interaction with antigen. Gene rearrangement leads to 
the constant region of the heavy chain (CH) being ‘switched’, typically from 
IgM or IgD to IgG, IgE or IgA. Class switching is an important step in the 
differentiation of mature B-cells into either memory B-cells or antibody 
secreting plasma cells. Identification of surface antibody expression can 
provide insight into effector immune pathways. B-cell activation can be 
achieved using various stimuli, in different combinations and 
concentrations. The combination of LPS and IL-4 are frequently used and 
optimal levels are generally considered to be 20μg/ml and 50ng/ml, 
respectively (Heise et al., 2014; Lin and Calame, 2004; Omori et al., 2006). 
Having observed CD19 upregulation and a slight increase in surface IgG1 and 
IgE expression on PI3K C2βB-cells at 0hr in unimmunized mice, class 
switching under optimal conditions and also sub-optimal conditions, was 
examined.  
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5.20 Optimal conditions: LPS (20μg/ml) and IL-4 (50ng/ml)  
Following activation with LPS (20μg/ml) and IL-4 (50ng/ml), B-cells were 
labelled with anti-IgG1 (PE) and anti-IgE (PE) and assessed by flow cytometry 
(Figure 5.19). Results are from two independent experiments using seven 
control and seven PI3K C2βmice (IgG1) or six control and six PI3K 
C2βmice (IgE).  
The mean expression of sIgG1 at 86hr post stimulation was 19.1% ± 2.1 on 
control B-cells and 24% ± 2.31 on PI3K C2β B-cells (p=0.2). sIgE 
expression was also higher on the PI3K C2β B-cells (7.8% ± 1.2 and 3.7% 
± 0. 6, respectively), but the difference was not significant (p=0.1). MFI was 
also measured (data not shown), with no difference observed in either; IgG1 
(p=0.3) or IgE (p=0.7).   
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Figure 5.19 IgG1 and IgE expression 86 hr post stimulation with LPS (20g/ml) and IL-4 
(50ng/ml). B-cells were labelled with anti-IgG1 (PE) or anti IgE (PE) and assessed using 
flow cytometry, with 30,000 events recorded per plot. A; a typical plot showing FSC vs SSC 
at 86hr. Cells analysed fell within the highest viability gate. B; plots showing IgG1 labelled 
B-cells, isotype control (left) and representative plots from control (centre) and PI3K 
C2 (right) B-cells. C; plots showing IgE labelled B-cells, isotype control (left) and 
representative plots from control (centre) and PI3K C2 (right) B-cells. D and E; 
analysis of the results revealed that  although PI3K C2samples had a slightly higher 
means,  for both sIgG1+ and sIgE+ B-cells (24% ± 2.3 and 7.8% ± 2, respectively), compared 
to the controls (19.1% ± 2.1 and 3.7% ± 0.6) the difference was not statistically significant. 
Results are from two independent experiments, using seven control and seven PI3K 
C2mice (D) or six control and six PI3K C2mice (E).  Statistical significance was 
calculated using an unpaired, two-tailed Student t-test (D), with Welch’s correction 
applied (E). Data represent mean values ± SEM. 
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5.21 Sub-optimal conditions: LPS (2g/ml) and IL-4 (20ng/ml) 
Following activation with LPS (2g/ml) and IL-4 (20ng/ml), B-cells were 
labelled with anti-IgG1 (PE) and anti-IgE (PE) and assessed by flow cytometry 
(Figure 5.20 and Figure 5.21). Results are from three independent 
experiments using nine control and nine PI3K C2mice (IgG1) or four 
independent experiments using twelve control and twelve PI3K 
C2mice (IgE).  
Using sub-optimal doses of LPS and IL-4 (Appendix 2 and Appendix 3), sIgG1 
expression was 12.4% ± 2.3 higher on PI3K C2B-cells than on the 
controls (25.8% ± 1.4 compared to 13.5% ± 1.8), this difference was 
considered significant (p=<0.0001). Additionally, the MFI for PI3K C2 
sIgG1 was significantly higher (p=0.001), at 3.5 (arbitrary units) compared to 
2.9 (mean of three experiments), which represents a mean increase of 
17.1%. sIgE expression was also significantly increased on PI3K C2B-
cells (p=0.0002), with 15.5% ± 1.6 being  sIgE+, compared to 7.1% ± 0.7. The 
difference between control and PI3K C2 C2IgE MFI was not statistically 
significant (p=0.07) when measured (data not shown). Data represent mean 
values ± SEM. 
The results show that the level of class switching to IgG1 in control B-cells 
was higher when cultured under optimal conditions. However, this was not 
the case for PI3K C2B-cells, which had a slightly higher percentage of 
sIgG1+ cells following culture in sub-optimal conditions. The percentage of 
sIgE+ B-cells was significantly higher for both control and PI3K C2under 
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sub-optimal conditions, compared to being cultured under optimal 
conditions.  
Surface IgM was also assessed following sub-optimal stimulation (Figure 
5.22), showing a reduction in the PI3K C2sIgM+ population compared 
to the controls (69.8% ± 2.2 compared to 78.9% ± 2.5). This supports the 
previous data showing increased class switching to sIgE or sIgG1 in the 
PI3K C2populations.  
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Figure 5.20 sIgG1 expression 86 hr post stimulation with LPS (2g/ml) and IL-4 (2-
ng/ml). B-cells were labelled with anti-IgG1 (PE) and assessed using flow cytometry, 
with 30,000 events recorded per plot. A; a typical plot showing FSC vs SSC at 86 hr. 
Cells analysed fell within the highest viability gate. B; typical staining pattern for the 
isotype control. C; representative plots showing sIgG1+ B-cells from control (left) and 
PI3K C2spleens (right). D; analysis of the results revealed that the percentage of 
sIgG1+ B-cells was significantly higher (p=<.0001) in the PI3K C samples (25.8% ± 
1.4) compared to the controls (13. 5% ± 1.8). E; sIgG1+ B-cells from PI3K C2 spleens 
also had an increased MFI in each experiment, indicating that the level of expression 
was higher than on the control B-cells (p=0.001). Results are from three independent 
experiments and statistical significance was calculated using an unpaired, two-tailed 
student t-test Student t-test (D) and a two-way ANOVA (E). Data represent mean 
values ± SEM. 
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Figure 5.21 sIgE expression 86 hr post stimulation with LPS (2g/ml) and IL-4 
(20ng/ml). B-cells were labelled with anti-IgE (PE) or an isotype control, and 
assessed using flow cytometry. 30,000 events were recorded per plot. A; a typical 
plot showing FSC vs SSC at 86 hr. Cells analysed fell within the highest viability 
gate. B; typical staining pattern for the isotype control. C; representative plots 
showing sIgE+ B-cells from control (left) and PI3K C2 spleens (right). D; 
analysis of the results revealed that the percentage of sIgE+ B-cells was 
significantly higher (p=0.0002) in the PI3K C2 samples (15.5% ± 1.6) 
compared to the controls (7.1% ± 0.7). Results are from four independent 
experiments and statistical significance was calculated using an unpaired, two-
tailed Student t-test, with Welch’s correction for unequal variance. Data 
represent mean values ± SEM. 
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Figure 5.22 sIgM expression 86 hr post stimulation with LPS (2g/ml) and IL-4 (2-
ng/ml). B-cells were labelled with anti-IgM (PE) and assessed using flow cytometry. 
30,000 events were recorded per plot. A; a typical plot showing FSC vs SSC at 86 
hr. Cells analysed fell within the highest viability gate. B; shows the typical staining 
pattern for the isotype control. C; representative plots showing sIgM+ B-cells from 
control (left) and PI3K C2 spleens (right). D; analysis of the results revealed 
that the percentage of sIgM+ B-cells was significantly lower (p=0.01) in the PI3K 
C2 samples (69.8% ± 2.2) compared to the controls (78.9% ± 2.5). Results are 
from three independent experiments, using nice control and nine PI3K C2 
mice. Statistical significance was calculated using an unpaired, two-tailed Student 
t-test. Data represent mean values ± SEM. 
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5.22 Further downregulation of PI3K C2 sCD23+ at 86hr  
Having observed a difference in CD23+ populations at 0 hr, cultures were 
examined following sub-optimal stimulation with LPS (2μg/ml) and IL-4 
(20ng/ml) for 86 hr. The reduced surface CD23+ on freshly isolated PI3K 
C2β B-cells could indicate altered ratios of several B-cell populations, 
such as immature T1 and/or MZ B-cells, or activated B-cells that have 
undergone CSR, none of which express surface CD23 (Allman et al., 2001; 
Best et al., 1995; Lindsley et al., 2009; Loder et al., 1999). Stimulation with 
IL-4 and LPS has been shown to initially upregulate sCD23 expression on 
murine B-cells (Paul, 1991), before down regulation. As such, differences in 
the sCD23 populations following in vitro activation may shed some light on 
this anomaly. Control and PI3K C2β B-cells were labelled with anti-CD23 
and analysed as before. Results were obtained over the course of three 
experiments using nine control and nine PI3K C2βmice. Following 
stimulation with sub-optimal concentrations of LPS and IL-4 for 86 hr PI3K 
C2βB-cells had a reduced sCD23+ population of 33.3% ± 2.6 compared 
to the control B-cells which had a sCD23+ population of 47.6% ± 2.85, a 
difference of 14.25% ± 3.89 (p= 0.0014).   
 0hrs 72-86hrs 
Control B-cells 87.8 % ± 0.7  47.6% ± 2.9  
PI3K C2B-cells 57.6 % ± 1.4 33.3% ± 2.6 
Difference between means 30.2 ± 1.5 14.3 ± 3.9 
Significance p=< 0.0001 p=0.001 
 
Table 5.8 Summary of results for sCD23+ B-cells at 0 hr and 86 hr (percentage of the B-cell 
population) 
 
CD23+ B-cells following stimulation with 2g/ml LPS and 20ng/ml IL-4.Results are from three 
independent experiments using nine control and nine PI3K C2 mice. Statistical 
significance was calculated using an unpaired, two-tailed Student t-test. Data represent mean 
values ± SEM. 
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Median fluorescent intensity was also measured over the three 
experiments, for the sCD23+ populations. In each experiment the control B-
cells had an increase in sCD23 MFI compared to the PI3K C2βpopulation 
(Figure 5.23). The difference in MFI for sCD23+ control B-cells and sCD23+ 
PI3K C2β−/−B-cells was considered significant (p=0.01).  
While initial activation causes an up regulation in CD23 surface expression, 
it is reduced during CSR and lost on plasma cells (Kehry and Yamashita, 
1989; Rabin et al., 1992). It is therefore likely that any immediate increase 
in CD23 expression, following activation, would have been lost by 86hr.  
 
 
 
5.23 PI3K C2β  B-cells have increased MEK1/2 phosphorylation  
Preliminary analysis of B-cells at 72hr following sub-optimal stimulation with 
LPS (2μg/ml) and IL-4 (20ng/ml) showed than PI3K C2β B-cells had increased 
phosphorylation of MEK1/2. Increased MEK activation is associated with both 
CD19 and activation through toll-like receptors (Li and Carter, 1998; Rui et al., 
2006).  
 Experiment 1 Experiment 2 Experiment 3 
MFI (arbitrary  unit) 
Control 
5.8 10.4 12.3 
MFI (arbitrary  unit) 
PI3 K C2 
 
4.7 5.1 7.4 
Difference 1.2 5.3 7.4 
Significance p=0.01   
Table 5.9 Summary of median fluorescent intensity for CD23+ B-cells at 86hr 
 
B-cell were stimulated with 2g/ml LPS and 20ng/ml IL-4. Each experiment used three 
control and three PI3K C2 mice. Statistical analysis was performed using a two-
way ANOVA. 
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Figure 5.23 sCD23 expression at 86 hr following stimulation with LPS (2g/ml) and IL-4 
(20ng/ml). B-cells were labelled with fluorophore conjugated anti-CD23 and assessed using 
flow cytometry. 30,000 events were recorded per plot. A; representative plots showing the 
highest viability population that was analysed. B; shows the negative isotope control used for 
gating. C; plots showing characteristic positive staining for sCD23. D; PI3K C2mice had 
fewer sCD23+ B-cells (34.8% ± 2.8) compared to the controls (49.3% ± 3.5) (p=0.001) E; a 
representative histogram showing the difference in fluorescent intensity at 86hrs. F; Analysis 
of MFI showed that there was an increase in the control MFI in each of the three experiments, 
compared to the PI3K C2 population (p=0.01). G; PI3K C2 sCD23+ B cells were also 
found to have an increased forward scatter compared to the controls (p=0.02). A total of nine 
control and nine PI3K C2mice were used over three independent experiments. Statistical 
analysis was performed using an unpaired, two-tailed Student t-test (D), and two-way ANOVA 
(F and G). Data represent mean values ± SEM. 
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Figure 5.24 MEK1/2 is upregulated in PI3K C2 B-cells. Isolated B-cells 
were stimulated with LPS 2g/ml and IL-4 at 20ng/ml. At 72 hr post 
stimulation B-cells were lysed and following the fractionation of B-cell 
lysates by SDS PAGE, proteins were immunoblotted and membranes were 
probed with anti-pMEK1/2 followed by anti-MEK1/2 to assess loading. 
HRP-conjugated secondary anti-body allowed visualisation of the protein 
using ECL. A; PI3K C2 B-cells had increased phosphorylated MEK1/2 
compared to control B-cells at 72 hr post stimulation. B; anti-MEK1/2 was 
used to compare loading. Results are from two control mice and two PI3K 
C2 mice. 
 
pMEK1/2 
MEK1/2 
A 
B 
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5.24 Discussion 
As described in the previous chapter, CD19 expression was increased in 
freshly isolated PI3K C2βsplenocyte cultures compared to cultures from 
control mice (0 hr). Following stimulation with LPS and IL-4, the CD19+ 
population was increased as was CD19 MFI, demonstrating its increased cell 
surface expression. 
To investigate this further, splenic B-cells were isolated and examined.  
Upregulation of CD19 is associated with a reduction in B-cell activation 
thresholds (Carter and Fearon, 1992; Inaoki et al., 1997), isolated B-cells 
were stimulated with ‘sub-optimal’ doses of LPS and IL-4. Data showed that 
PI3K C2β B-cells had increased viability in comparison to controls. CD19 
has been shown to enhance B-cell survival via co-ligation with the BCR 
ensuring maximum Akt phosphorylation, which leads to the inhibition of 
pro-apoptotic factors (Otero et al., 2001). This has been shown to be 
important in propagating the tonic survival signals required for mature B-
cells  (Otero et al., 2003). 
B-cells that lack CD19 expression show diminished activation by LPS, while 
over expression of CD19 leads to increased activation, even with reduced 
concentrations of LPS  (Engel et al., 1995; Yazawa et al., 2003). LPS has been 
shown to stimulate B-cells through toll-like receptor 4 (TLR4) in a CD19 
dependent manner (Iwata et al., 2009). This would correlate with the 
increased survival and metabolic activity in the PI3K C2β−/−B-cells. 
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Following stimulation with a sub optimal dose of LPS and IL-4, isolated PI3K 
C2β B-cells showed a consistent reduction in propidium iodide (PI) 
staining compared to the controls. However, Annexin V (AnV) staining was 
increased suggesting increased apoptosis, but despite being in the early 
stages of apoptosis PI3K C2β B-cells appeared healthier and had 
increased metabolic activity. Because AnV externalization in lymphocytes 
occurs at the very earliest stage of apoptosis, before DNA degradation or 
induction of cell lysis (Verhoven, 1995), this finding was initially interpreted 
as being due to a delay in which PI3K C2  B-cells shift from early to late 
apoptosis. However, it has been shown that phosphatidylserine (PS) is 
externalized on viable B-cells following BCR activation, and is involved in 
membrane remodelling by co-capping with IgM and CD19 to ensure 
signalling molecules are correctly positioned (Dillon et al., 2000). A further 
study confirmed that PS externalization on viable splenic B-cells was 
dependent on their activation state, and was also associated with 
continuous tolerogenic signals received via the BCR (Dillon et al., 2001). 
These findings might indicate that PI3K C2 B-cells were not in the early 
stages of apoptosis as initially thought, but were in a heightened activation 
state. 
The increased CD19 expression on PI3K C2β B-cells may lower the 
activation threshold. As such, the sub-optimal treatment with LPS/IL-4 could 
provide adequate stimulation, which resulted in the increased survival and 
metabolic activity observed. Analysis of the cell cycle correlates with these 
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findings, showing an increase in the G1 and a reduction in the sub-G1 
populations within the PI3K C2β samples over time, compared to the 
controls. Cells within the G1 (growth) phase of the cell cycle have been 
shown to have increased metabolic activity (Doughty et al., 2006), as they 
either prepare for the transition into S-phase thereby committing to cell 
division, or, carry on their effector functions as non-dividing cells. The 
reduced PI3K C2β population within the sub G0/G1 gate suggests that 
there was a lower percentage of PI3K C2β B-cells that were either in late 
apoptosis or dead, as the reduced PI signal in the sub-G0/G1 gate is likely to 
be as a result of fragmenting DNA. Despite the increased amount of 
germinal centre associated proliferation in unimmunized mice, there was 
no difference between the percentage of control and PI3K C2β B-cells 
undergoing DNA synthesis or mitosis. This could be due to any increase in 
the G2/M phase being diluted within the total B-cell population. Mouse 
germinal centre B-cells have poor viability during and following isolation, 
with cell death often occurring within 4 hr of isolation (Cato et al., 2011), it 
is therefore possible that if there were any differences in G2/M they may 
not be observed. However, finding comparable populations of B-cells within 
G2/M is compatible with the lack of obvious health issues displayed by the 
PI3K C2β mice. Disruption in the cell cycle, such as an increase in 
proliferation would be expected to result in a pathological phenotype (Klein 
and Dalla-favera, 2008; Vinuesa et al., 2009), which has not been observed 
in unchallenged PI3K C2 mice.  
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In addition to identifying the stage of B-cell differentiation, the BCR isotype 
can help to identify potential immune dysregulation. For example, the 
failure of sIgM+ B-cells to switch to IgG1 following an immune challenge and 
elevated serum sIgM is indicative of hyper IgM syndrome, which are a group 
of immune deficiency disorders (Etzioni and Ochs, 2004), while elevated IgE 
is associated with allergy and inflammation (Galli and Tsai, 2012). There 
were modest differences in surface BCR isotype between PI3K C2β and 
control B-cells at 0hr. Although the difference was significant, the 
differences are likely to represent a variation in the stage of B-cell 
differentiation following CSR. The most notable difference was the decrease 
in the sIgM+ population and reduced expression in the PI3K C2β B-cells 
compared to the controls. There was also an increased sIgG1 MFI associated 
with the PI3K C2 B-cells which might indicate that as sIgM was being 
downregulated, sIgG1 was being upregulated as a result of increased class 
switching activity. Alternatively, a sIgMlow phenotype is a characteristic of B-
cell anergy (Browne et al., 2009). Interestingly, in a study using a transgenic 
mouse model with functionally anergic B-cells, anergy was overcome by 
increased expression of CD19. Furthermore, without an additional immune 
challenge these B-cells did not produce autoantibodies, however treatment 
with complete Freund’s adjuvant (CFA) led to hyper-responsiveness and 
eventual autoantibody production (Inaoki et al. 1997). This might suggest 
that upregulation of CD19 creates a predisposition for autoantibody 
production but is not the direct cause. 
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Further analysis of the sIgM+ populations revealed a distinct sIgM 
expression pattern in the PI3K C2β population. In addition to B-cell 
anergy, an sIgMlow phenotype is observed in a subset of immature B-cells 
that have been developmentally arrested, they are known as transitional 
type 3 (T3) and represent a potentially autoreactive population (Cambier et 
al., 2007; Merrell et al., 2006). The T3 population is sIgMlow and express 
surface CD23 (sCD23) (Allman et al., 2001; Yarkoni et al., 2010). Anergic B-
cells are typically CD19low (Liubchenko et al., 2012), which does not 
correspond to the PI3K C2β B-cells which are CD19hi. This was confirmed 
by double staining with CD19/CD23, which showed the sCD23- population 
within the PI3K C2β B-cells had increased CD19 expression compared to 
controls. An alternative explanation is that the PI3K C2β−/− sIgMlow B-cells 
could represent a population that were undergoing class switch 
recombination (CSR). Interestingly, a small population of CD19hi/sCD23low B-
cells has been described that spontaneously produce IgG and IgA antibodies 
in unimmunized mice, which are thought to be activated by interaction with 
microbes that are part of the normal flora, such as intestinal bacteria. These 
cells also produced higher forward scatter readings than follicular B-cells, 
which has been attributed to an activated state (de Andres et al., 2007). 
Examination of BCR isotype at 0hr had shown that PI3K C2β B-cells had 
a modest increase of sIgG1+, compared to the controls, and had shown an 
increased population that appeared to be in the process of upregulating 
sIgG1.  
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In order to assess CSR further, B-cells from the spleens of PI3K C2β and 
control mice were cultured under ‘optimal’ conditions or ‘sub-optimal’ 
conditions. The use of a sub-optimal concentrations of LPS and IL-4 was to 
examine whether PI3K C2β B-cells exhibited a reduction in activation 
threshold, that is associated with increased CD19 expression (Inaoki et al. 
1997; Carter & Fearon 1992). Under optimal conditions there was a slight 
increase in the mean percentage of sIgG1+ B-cells in the PI3K C2β 
populations, compared to the controls, but it was not statistically 
significant. A similar outcome was observed in the sIgE+ populations. 
However, following sub-optimal stimulation the PI3K C2β cultures had a 
significantly higher proportion of both sIgG1+ and sIgE+ isotype switched B-
cells compared to the controls after 86 hr in culture. PI3K C2β B-cells 
appeared unaffected by the reduced LPS and IL-4 concentrations, whereas 
the percentage of control B-cells that had switched to sIgG1+ was reduced. 
Data produced at 86 hr also showed a reduction in sIgM and sCD23 
populations within the PI3K C2β B-cells compared to controls, which is 
supportive of the CSR results (Rabin et al., 1992). The finding that PI3K 
C2β B-cells had undergone increased CSR, compared to the control B-
cells when subjected to sub-optimal stimulation is in keeping with a 
reduction in activation threshold that is associated with CD19 upregulation. 
PI3K C2β B-cells also had a consistent reduction in their total sCD23+ 
population. The two main B-cell subsets in the spleen that are sCD23 
negative (sCD23-) are, marginal zone (MZ) B-cells and immature transitional 
stage 1 (T1) B-cells, both of which are also sIgMhi (Best et al., 1995; Loder et 
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al., 1999). Dual staining with fluorophore conjugated antibodies to 
CD23/IgM revealed more than a two-fold increase in the PI3K C2β 
population of sIgMhi/sCD23- B-cells. Immature T1 B-cells are new arrivals 
from the bone marrow and as such are associated with low forward scatter 
(FSC) (Sims et al., 2005), whereas MZ B-cells have a high FSC (Arnon et al., 
2013). An increased FSC was seen in the PI3K C2β sIgMhi/CD23-B-cells 
which were also CD19hi. As CD19 expression is higher on mature B-cells 
compared to immature cells, this would suggest that the increased 
sIgMhi/sCD23- population was more likely to be MZ B-cells rather than 
immature T1 B-cells. However, it is not possible to confirm definitively that 
this population were MZ B-cells, without the use of further markers, the 
control population fits well with the literature which suggests MZ B-cells are 
approximately five to ten percent of the murine splenic B-cell population 
(Carsetti, 2004; Loder et al., 1999).  
As a subtype, MZ B-cells have been described as potent activators of CD4 T-
cells, and have been shown to shuttle back and forth between the marginal 
zone and the follicles to present antigen to CD4 T-cells (Arnon et al., 2013; 
Attanavanich and Kearney, 2004a; Cinamon et al., 2007). This would also fit 
well with the PI3K C2mice who had an increased CD4+ population that 
was observed at 0 hr and also within total splenocyte cultures, which was 
not observed in the isolated T-cell cultures, seen in the previous chapter. 
Although typically thought of as a source of ‘natural’ IgM, MZ B-cells have 
been shown to undergo CSR in response to T-cell independent (TI) 
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interaction with antigen (Puga et al., 2011), which occurs independently of 
CD40/CD40L (Cerutti, 2008; Kim et al., 2011). It has been demonstrated that 
autoreactive immature B-cells have reduced activated ERK compared to 
non-autoreactive B-cells, and that the level of basal ERK activation is 
proportional to the sIgM expression. Additionally, inhibition of MEK leads to 
a reduction in cell differentiation (Teodorovic et al., 2014). 
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6 Conclusion 
6.1 Summary of results 
Data generated during this project support previous reports that PI3K 
C2mice do not display an overt phenotype (Alliouachene et al., 2015; 
Harada et al., 2005). However, my results suggest that PI3K C2 mice 
appear to have increased fecundity and produce offspring with a skewed 
sex ratio, which has not been previously reported.   
The increased splenic germinal centre reactions observed under basal 
conditions, which were exacerbated following IgG/CFA treatment, suggest 
that PI3K C2 mice display a more pronounced immune response 
compared to the control mice. Examination of lymphocyte populations in 
the spleen revealed that PI3K C2 mice had an increased CD4+ T-cell 
population, which was maintained over time in splenocyte cultures. 
However when cultured in isolation, there was no difference in the 
CD4+/CD8+ ratio, compared to the controls. This finding could indicate that 
an alternative cell type might be maintaining the CD4+ population observed 
in the total splenocyte cultures.  
Analysis of splenic B-cell populations revealed that, versus control B-cells, 
the B-cell co-receptor CD19 was consistently upregulated on PI3K C2 B-
cells. Cell cycle analysis indicated that while the percentage of B-cells 
undergoing mitosis was comparable, the PI3K C2 B-cells had an 
increased population of live cells which were more metabolically active after 
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72 hr in culture. To address whether the PI3K C2B-cells had a reduced 
activation threshold, consistent with increased CD19 expression (Carter and 
Fearon, 1992; Inaoki et al., 1997), class switched populations were 
examined. These results showed that freshly isolated B-cells from PI3K 
C2 mice had a slightly increased population of IgG+ and IgE+ B-cells 
compared to the controls. Additionally, CSR was increased in PI3K C2 
B-cells that were cultured with sub-optimal doses of IL-4 and LPS.  
Following analysis of B-cell expression profiles, PI3K C2 mice appeared 
to have an increased MZ population, with increased CD19 expression. This 
could provide a potential explanation for the increased CD4+ T-cell 
populations in PI3K C2 spleens, as MZ B-cells are known to be efficient 
activators of CD4+ T-cells (Attanavanich and Kearney, 2004b). In addition, 
preliminary investigation of MEK1/2 activation indicated that it was 
increased in PI3K C2splenocytes, which is in keeping with upregulated 
CD19 (Li and Carter, 1998; Li and Carter, 2000).  
6.2 Breeding data 
The overview of PI3K C2mice showed that in matched breeding cages 
over the same period of time, mice lacking PI3K C2 successfully weaned 
36% more offspring than the control mice. In addition, a bias towards 
female offspring was recorded. It should be noted that the PI3K 
C2mice used in this project were originally generated elsewhere and 
were rederived in our lab, in the original study it was reported that PI3K 
C2 mice were born at a normal Mendelian ratio (Harada et al., 2005). 
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More recently a kinase dead, knockin mouse was generated, in which a 
point mutation resulted in a structurally intact protein that lacked kinase 
activity. This strategy allowed for kinase activity to be studied 
independently of structural interactions. This study also reported no 
differences in fertility and that offspring were produced at a normal 
Mendelian ratio (Alliouachene et al., 2015).  
Housing conditions are known to affect fecundity in lab mice and the use of 
mating trios and carefully timed matings are strategies used to increase the 
number of pups born as well as producing mice that are precisely age 
matched (Stiles et al., 2013). As such, the breeding data reported for this 
project was taken from matched cages and analysed retrospectively. It is 
thought to be unlikely that differences in environmental factors such as the 
housing conditions or diet would cause differences in the number of 
offspring weaned or a skewed sex ratio.  
It has been proposed that sex bias occurs as a form of natural selection, 
whereby paternal and maternal condition influence whether male or female 
offspring are produced. This hypothesis is based on the assumption that a 
male in good condition will produce more offspring than a female in good 
condition. However, a male in poor condition will produce fewer offspring 
than a female in the same condition (Trivers and Willard, 1973). It is 
suggested that this is because dominant males, which are typically strong 
and in good condition will have more opportunity to sire offspring. The 
condition of the female is less influential because of the competition 
211 
 
between dominant males to inseminate females. As such, if a healthy, 
strong female mates with a healthy, strong male their offspring are more 
likely to be in good condition. If they produce a male, he is likely to have the 
opportunity to produce more offspring than a female. If, on the other hand, 
the offspring is likely to be in poor condition, a male may not have any 
opportunity to produce offspring, while a female would. Therefore 
producing female offspring would be advantageous.  
While the Trivers-Willard hypothesis is still relevant, it is often used to 
describe animals with small brood sizes and for those breeding in their 
natural habitat. It is therefore difficult to determine whether it is applicable 
for inbred laboratory animals which are being kept in a carefully managed 
environment. A study in 2003 using outbred mice found that mothers on a 
very high fat diet were more likely to have male offspring. This was reversed 
for mothers on a very low fat diet, who produced more females, suggesting 
that diet is a contributing factor rather than just maternal condition. While 
changes in diet appear to result in a sex bias, no difference in litter size or 
fecundity was reported (Rosenfeld et al., 2003). More recently, a study 
showed that anogenital distance, in addition, to maternal condition 
influenced gender bias in the house mouse (Mus musculus). The study 
found that females with a greater anogenital distance produced more male 
offspring. They also showed a correlation between female weight and 
anogenital distance in pre-pubertal mice, with a lower bodyweight being 
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associated with a smaller anogenital distance, although this was not 
observed in adult mice (Szenczi et al., 2013). 
The data collected from control mice and PI3K C2 mice during this 
project did not include anogenital distance, but female PI3K C2 mice 
weighed slightly less than their control counterparts over time, despite 
being fed the same diet.  
In 2008, Cameron and colleagues reported that changes in blood glucose 
levels resulted in skewing of the sex ratio in NMRI mice. They found that 
females drinking dexamethasone treated water, which reduces plasma 
glucose concentrations, produced more female pups in comparison to the 
controls (Cameron et al., 2008). This finding is of particular interest because 
the loss of PI3K C2 kinase activity in mice has been recently shown to 
increase insulin sensitivity and glucose metabolism, resulting in reduced 
blood glucose in comparison to controls (Alliouachene et al., 2015). 
Although this might be a potential mechanism to explain the skewed sex 
ratio, the study reported that offspring were born at the expected 
Mendelian ratio. However, neither of the publications provide any further 
information regarding the breeding data, so it is not known how many mice 
were assessed, how soon after birth they were sexed or how many survived 
weaning. My own data is unlikely to provide a complete picture either 
because of the way that breeding cages are typically managed. For example, 
it would be unusual for the cessation of breeding to occur naturally, as 
breeding cages are usually disbanded when mice each reach a certain age 
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or are deemed to be no longer optimally fertile. Therefore, although this 
might be of interest, particularly with regard to loss of PI3K C2 and the 
effect on blood glucose levels, without performing a more dedicated study 
it is difficult to draw any conclusions from the breeding data. 
6.3 Alternative explanations and potential limitations 
In keeping with previous results from our lab, PI3K C2 spleens during 
this project consistently had an increased population of CD4+ T-cells 
compared to the control mice, which were maintained when cultured within 
a total splenocyte population. However, no difference in the size of the 
CD4+ population was observed in isolated T-cells, suggesting that they may 
not be driving the immune response. When analysed, isolated B-cells 
appeared to have a lower activation threshold, survived for longer and 
displayed a more activated phenotype compared to the control B-cells. This 
could provide a mechanism to explain the previously described T-cell 
infiltration and the increased CD4+ population (Balakrishnan, 2012). This is 
supported by the increased marginal zone B-cell population, which are 
known to effectively activate CD4+ T-cells (Attanavanich and Kearney, 
2004b). However, in addition to mediating a range of effector functions, B-
cells are also regulated by a range of chemokines, cytokines and cell to cell 
interactions within the microenvironment (Vazquez et al., 2015). A further 
complication is that the role of PI3K C2 appears to either be cell specific 
or dependent on its method of activation (Table 1.1).   
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6.4 Calcium signalling 
Murine lymphocytes express two K+ channels, the voltage gated Kv1.3 
channel and the Ca2+ activated KCa3.1 channel. Their role is to regulate 
membrane potential, which controls the influx of Ca2+ required to activate 
signalling pathways. Expression levels are subset specific and vary 
depending on the activation state and stage of differentiation (Wulff et al., 
2004). One of the confounding aspects of this project is the role that had 
been previously identified for PI3K C2 in KCa3.1 dependent calcium influx, 
and it was anticipated that loss of PI3K C2 may lead to lymphocyte 
suppression. However, PI3K C2 B-cells appeared to have a more 
activated phenotype, which was not in keeping with the loss of PI3K C2 
recorded in T-cells (Srivastava et al., 2009) . 
Previous examination of K+ channel expression during B-cell differentiation 
indicates that class switched memory B-cells upregulate Kv1.3 expression 
following activation, while KCa3.1 expression remain unchanged. 
Additionally increased expression of Kv1.3 was observed on marginal zone 
B-cells (Wulff et al., 2004), suggesting that these B-cell subsets are less 
reliant on KCa3.1. Interestingly, KCa3.1 dysregulation has been observed in 
chronic lymphocytic leukaemia (CLL), which affects B-cells, and as such 
KCa3.1 has been identified as a potential therapeutic target (Grössinger et 
al., 2014). However, gene analysis has indicated that CLL cells do not express 
PI3K C2 (McCarthy et al., 2015), which might indicate that under certain 
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conditions KCa3.1 activation may not be solely dependent on PI3K C2 in B-
cells.                                    
Work performed using human CD4+ T-cells and KCa3.1 transfected Jurkat 
cells showed that silencing of PI3K C2 led to a reduction in KCa3.1 
mediated Ca2+ influx following T-cell receptor activation (Srivastava et al., 
2009). T-cells from KCa3.1 mice show reduced T-cell receptor mediated 
activation and cytokine production due to reduced Ca2+ influx. However, 
while Th1 and Th2 T-cells were effected, the Th17 and Treg subsets were 
not (Di et al., 2010). The role of KCa3.1 signalling appears to be more 
complex in vivo, as global knockout mice have been shown not to display an 
obvious phenotype. Although they are reported as having slight 
abnormalities in cell volume, which includes T-cells, and develop 
progressive splenomegaly as they age (Heike Wulff and Neil A. Castle, 2010). 
6.5 Global knockout of PI3K C2 
The use of global knockout mice in this project allowed a potentially altered 
immune response in PI3K C2 mice to be identified, which may not have 
been possible using a more refined targeted knockout strategy. This is due 
to differences between the strains being very subtle and, to date, no clear 
phenotypic changes have been described (Alliouachene et al., 2015; Harada 
et al., 2005). Therefore without a preconceived model to work from, 
targeting individual genes could be extremely time consuming, financially 
prohibitive and may not be in keeping with NC3Rs. Even considering the 
previous work that this project was based on, in which renal damage with 
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T-cell infiltration was reported (Balakrishnan, 2012), if CD4+ T-cells had 
been targeted for PI3K C2 knockdown, the observed renal  pathology may 
not have developed. Such damage may have been prevented  by reduced T-
cell receptor associated differentiation and impaired Ca2+ signalling in 
specific T-cell subsets following the loss of PI3K C2 (Cai et al., 2011; 
Srivastava et al., 2009). The drawback of a global knockout is that to 
delineate the results may not be possible, especially when studying the 
complex interactions within the immune system. Therefore, although this 
project focuses on a heightened activation state of PI3K C2 splenic B-
cells, it is not possible to identify if this difference originates in PI3K C2 
B-cells or is potentially driven by another cell type. For example, mast cells 
have recently be described as potent activators of B-cells, not only 
promoting their differentiation into CD19high blasts, but also into antigen 
presenting cells with upregulated MHCII and CD86 expression (Palm et al., 
2016a). An additional drawback of a global knockout is that it is not possible 
to differentiate between the kinase activity mediated by PI3K C2 or a 
potential structural role it may have. This could be addressed by using a 
similar knock-in strategy as described by Alliouachene and colleagues 
(2015), who have generated a mouse model in which PI3K C2 is structurally 
intact but lacks kinase activity. 
6.6 Potential role of PI3K C2 in B-cells 
Data generated during this project suggest that loss of PI3K C2β results in 
splenic B-cells having a heightened activation state. However, a pathological 
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outcome only becomes apparent following an immune insult (Balakrishnan, 
2012). The potential for these B-cells to mediate an inappropriate response 
may be due to the increased expression of the B-cell co-receptor CD19, and 
the observed increase in phosphorylated MEK1/2 at 72 hr is supportive of 
an increased activation state. Taken together this might suggest that in B-
cells PI3K C2β plays a role in a negative regulatory pathway.  
It has been shown that PI3K C2β binds with nucleotide free Ras, potentially 
mediating negative regulation of the Ras, Raf, MEK, ERK pathway (Wong et 
al., 2012b). Recently, targeting MEK1/2 in CLL B-cells has been shown to 
cause apoptosis by inhibiting ERK1/2 and AKT activity, and has been 
proposed as a potential therapeutic strategy for CLL (Crassini et al., 2015). 
As gene analysis has revealed that while PI3K C2β is moderately expressed 
in normal B-cells, expression is lost from B-cells of patients with chronic 
lymphocytic leukaemia (CLL) (McCarthy et al., 2015), this might add support 
to the notion PI3K C2β is involved in negatively regulating B-cell responses.  
The role of PI3K C2 has typically been found to be one of positive 
regulation (Balzarotti et al., 2015; Cai et al., 2011; Chikh et al., 2016; Domin 
et al., 2005; He et al., 2015; Srivastava et al., 2009). However, it has been 
reported that the C2 domain within the C-terminus of PI3K C2 can 
negatively regulate catalytic activity by competitively binding substrate 
(Arcaro et al., 1998).  Of particular interest, with regards to this project is 
the previously mentioned discovery that PI3K C2 may be involved in 
negatively regulating Ras (Wong et al., 2012b).  
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Additionally, the increased expression of CD19 is likely to play a role in the 
reduced activation threshold that was observed in vitro (Inaoki et al., 1997; 
Tedder et al., 1997). The increased CD19 expression on PI3K C2 B-cells 
may be a result of defective receptor internalization. Following activation, 
internalization of CD19 has been shown to be clathrin dependent (Ingle et 
al., 2008) which could potentially be impaired by the loss of PI3K C2. PI3K 
C2 has been shown to bind to clathrin and is potentially involved in clathrin 
coated vesicle transport (Wheeler and Domin, 2006) and loss of PI3K C2 
has also been shown to result in defective receptor trafficking (Alliouachene 
et al., 2015). As receptor internalization in B-cells may result in the 
inactivation of receptor signalling (Stoddart et al., 2005), this could present 
a potential explanation for the increased CD19 expression and MEK1/2 
phosphorylation. However, this is complicated by the recruitment of CD19 
to the BCR following activation, as the BCR is not dependent on clathrin 
mediated endocytosis (Song et al., 2013).  
PI3K C2 has been shown to associate with GRB2 (Błajecka et al., 2012; 
Wheeler and Domin, 2001), which is known to bind to the inhibitory 
signalling molecule CD22 (Jang et al., 2011) (Section 1.6.4). The exact 
function of the CD22/GRB2 interaction is not clear at present, although 
GRB2 B-cells have been shown to be hyper-responsive and CD22 
phosphorylation in GRB2  B-cells is  reduced (Ackermann et al., 2011; Jang 
et al., 2011). Using PathwayNet, which is an integrated strategy designed to 
predict functional associations, co-complexes, transcriptional regulation 
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and post translational regulation between human genes and protein 
products, PI3K C2 is predicted to form a functional association with CD22 
with 0.84 confidence, and the functional association with GRB2 is predicted 
at 0.94 confidence (Appendix 10). As such, this could potentially provide a 
mechanism by which PI3K C2 functions in negatively regulating B-cell 
activation (Figure 6.1). This model suggests two potential roles for PI3K C2, 
the first being that it negatively regulates Ras by competitively binding to it 
in its nucleotide free form, which prevents GTP binding and activation 
(Wong et al., 2012b). In this case loss of PI3K C2 could lead to increased 
Ras activation, which in turn would increase MEK1/2 phosphorylation. The 
second mechanism involves the inferred functional association between 
CD22, GRB2 and PI3K C2. Loss of GRB2 has been shown to reduce CD22 
phosphorylation. CD22 negatively regulates SYK which is required for 
activation of the effector BLNK (B-cell linker), also known as SLP65. BLNK has 
been shown to act as a platform for several signalling molecules that act 
downstream of the B-cell receptor (Baba et al., 2001). While GRB2 is 
associated with positive regulation in T-cells, including reduced calcium 
mobilization (Jang et al., 2010), it appears to play a role in negative 
regulation in B-cells (Ackermann et al., 2011; Jang et al., 2011). In addition 
the CD22 / GRB2 complex has been identified as being a negative regulator 
of calcium signalling in B-cells (Chen et al., 2016).  
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Figure 6.1. Schematic showing two mechanisms whereby PI3K C2 could play a role in 
inhibitory signalling in B-cells. The first mechanism involves the binding of PI3K C2 to Ras in 
its nucleotide free (nf) state. This prevents GTP binding, keeping Ras inactivated. The 
association of ITSN1 to PI3K C2 causes nucleotide free Ras to disassociate, allowing GTP to 
bind which causes Ras activation (Wong et al., 2012b). The second mechanism is based on 
software designed to predict functional associations, co-complexes, transcriptional regulation 
and post translational regulation between genes and protein products. PI3K C2is predicted 
to form a functional association with the negative regulatory molecule CD22, and a functional 
association with GRB2 has already been established (Błajecka et al., 2012; Wheeler and Domin, 
2001). GRB2 is known to bind to CD22 (Jang et al., 2011) and although exact function of the 
CD22/GRB2 interaction is not clear at present, GRB2 B-cells have been shown to be hyper-
responsive and CD22 phosphorylation in GRB2 B-cells is  reduced (Ackermann et al., 2011; 
Jang et al., 2011). If PI3K C2 were involved in optimizing the GRB2/CD22 interaction, the loss 
of PI3K C2 may lead to a reduction in negative regulation and increased MEK1/2 
phosphorylation.  
221 
 
6.7 Future directions 
There are several key experiments that are missing from this project that 
would pull together the results and provide a clearer picture regarding the 
role of PI3K C2 within the splenic environment. Firstly, analysis of the 
cytokines produced by PI3K C2 splenocytes would provide more 
detailed information regarding the role of the different cell types within the 
environment. For example, stromal cells within the spleen play a role in the 
cytokine and chemokine production that influence immune cell behaviour 
(den Haan et al., 2012). Additionally, innate lymphoid cells within the spleen 
are important mediators of T-cell independent marginal zone B-cell 
activation (Magri et al., 2014) and mast cells have been shown to promote 
B-cell differentiation (Palm et al., 2016b). Cytokine arrays are available as a 
membrane based sandwich assay or a 96 well multiplex ELISA and are 
designed to detect and quantify a range of cytokines and chemokines. 
Further activation assays would confirm the preliminary finding that 
phosphorylated MEK1/2 may be upregulated in PI3K C2 B-cells. 
Downstream expression of phosphorylated AKT should also be examined, 
as if PI3K C2 plays an inhibitory role in MEK1/2 signalling, pAKT may be 
affected (Crassini et al., 2015; Otipoby et al., 2008).  
Immunoprecipitation assays may provide missing information regarding the 
possible functional interactions or co-complexes formed by PI3K C2 in 
control B-cells. In particular GRB2 and CD22 may be of particular interest 
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due to the inferred functional association (Figure 6.1) and the potential role 
in negative regulation. 
It may also be beneficial to perform a more comprehensive multi-parameter 
flow cytometric analysis, which may identify whether specific B-cell subsets 
are affected by the loss of PI3K C2. This might have an ongoing relevance 
with regard to the loss of PI3K C2 in CLL cells (McCarthy et al., 2015). This 
could be undertaken using combinations of the markers listed in Tables 6.1 
and 6.2 below. 
B1a B1b MZ Fo  Breg 
CD5+ CD5- CD5- CD5- CD5+ 
CD19hi CD19hi CD19mid CD19mid CD19hi 
CD1d CD1dmid CD1dhi CD1dmid CD1dhi 
CD23- CD23- CD23- CD23+ CD23+/- 
CD43+ CD43+ CD43- CD43- CD43- 
IgMhi IgMhi IgMhi IgMlow IgMhi 
IgDlow IgDlow IgDlow IgDhi IgDmid 
 
 
Mature 
Activated Plasma blast Plasma cell Memory CS Memory 
CD21+ CD27hi CD27hi CD27+ CD27+ 
CD19+ CD19+ CD19- CD19+ CD19+ 
IgM+ IgM- Ig+ IgM+ IgM- 
IgD+ CD20- CD20+ IgDlow IgD- 
CD38+ CD38hi CD38hi CD38- CD38- 
 
 
CD28hi    
 
Table 6.1 B-cell subset markers  
MZ; marginal zone, Fo; follicular (Baumgarth, 2011) 
Table 6.2 B-cell differentiation markers 
CS; class switched. (Edwards and Cambridge, 2006; Park et al., 2008) 
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6.8 Concluding comments 
Despite ongoing investigation, the biological role of the PI3K C2 isoform 
remains poorly understood. The data presented in this thesis indicate that 
PI3K C2 may play an inhibitory role in the murine immune system, and this 
may be mediated by B-cells. Given the complexity of immune system 
regulation, which involves a variety of cell types and a spectrum of cytokines 
and chemokines, a robust interpretation of my data is difficult. Therefore, 
although the context in which these experiments were conducted offer the 
potential for future therapeutic intervention using PI3K C2 as a drug target, 
many questions remain unanswered. 
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Appendix 1. Breakdown of breeding data (see also Figure 3.2). Data were collected over 
the same time period from cages set up at the same time, using mice that were aged 
matched as closely as possible. A; shows the date of birth (DOB) of the female (F) and male 
(M) mice, the number of litters produced, the average litter size and the period of time that 
the mice were actively breeding. B; provides details about the litters including those that 
were found dead (FD) or eaten. 101 control mice were successfully weaned (48M and 51F) 
compared to 158 PI3K C2mice (66M and 92F). Data were obtained from stockfiles 
provided by the animal technicians at CSB, Imperial College London, Hammersmith Campus. 
PI3K C2 
Controls 
Controls PI3K C2 
Number of offspring per litter Number of offspring per litter 
Total 
Av. Litter 
Total 
Av. Litter 
A 
B 
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B-cells 10g/ml LPS 20ng/ml IL-4 
Control Control 
PI3K C2 PI3K C2 
B-cells 5g/ml LPS + 20ng IL-4 
PI3K C2 PI3K C2 PI3K C2 
Control Control Control 
A 
B 
Appendix 2. Reducing the concentration of LPS and IL-4. Initially B-cells were 
stimulated with 20g/ml LPS and 50ng/ml IL-4, which are concentrations that have 
previously been used in our lab. Examination of CD19 expression had shown that levels 
were increased on PI3K C2 B-cells. This was of interest because increased CD19 has 
been shown to lower the activation threshold in B-cells. To examine the theory that 
PI3K C2 B-cells may have a reduced activation threshold compared to control B-
cells the concentration of LPS and IL-4 were reduced. A; At 10g/ml LPS and 20ng/ml 
IL-4 both the control and PI3K C2 cultures had formed foci at 48 hr, which is 
associated with proliferation. B-cells were plated at 1 x 106 per ml and kept at 37oC in a 
humidified 5% CO2 incubator. B; Dot plots showing that   PI3K C2 B-cells had an 
increased population of PI negative cells following 72 hr stimulation with 5g/ml LPS 
and 20ng/ml IL-4. Cells were gated to exclude debris and dead cells, 10,000 events were 
recorded for each plot.  
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FSC 
SS
C
 
FS
C
 
PI 
D 
C 
B 
A 
0hrs 24hrs 72hrs 
0hrs 24hrs 72hrs 
0hrs 24hrs 72hrs 
0hrs 24hrs 72hrs 
Control Control 
Control Control Control 
Control 
PI3K C2 PI3K C2 PI3K C2 
PI3K C2 PI3K C2 PI3K C2 
Appendix 3. Initial assessment of B-cell viability following stimulation 
with 2g/ml LPS and 20ng/ml IL-4. Propidium iodide staining of PI3K 
C2 and control B-Cells at 0, 24 and 72 hr, analysed using flow 
cytometry. A minimum of 10,000 events were recorded per plot. A and B; 
representative plots showing forward scatter and side scatter of control 
and PI3K C2  B-cells  and at 0, 24 and 72 hr respectively. C and D; 
representative dot plots of PI stained control and PI3K C2  B-cells at 0, 
24 and 72 hr respectively, gated to exclude debris, which may result in false 
PI negative results. 
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Appendix 4. Propidium iodide staining of control and PI3K C2 B-cells over 
72 hr. A;  analysis of results (Appendix 3)  showed that following stimulation 
with 2g/ml LPS and 20ng/ml IL-4 there was an increased percentage of live cells  
(PI-ve) in the PI3K C2
 
population compared to the controls at both 24 hr and 
at 72 hr. The results of three separate experiments were analysed by two-way 
ANOVA (P=0.0002).  B and C; representative plots (FSC vs SSC) at 0, 24 and 72 hr 
for control and PI3K C2B-cells respectively. Two distinct populations were 
observed, which were identified as highest viability and mixed viability according 
to the percentage of cells that were PI positive or negative. 10,000 events were 
recorded per plot. 
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Total population (excluding debris/ doublets) 
0 hr Control  PI3K C2  Difference p value 
Sub G0/G1 8.01% ± 0.66  6.61% ± 0.56 1.4± 0.86 p=0.136 
G0/G1 88.27% ± 0.63 89.78% ± 0.60  1.51 ± 0.87 p=0.114 
Synthesis 1.10% ± 0.1 1.08% ± 0.16 0.022 ± 0.19 p=0.912 
G2/M 2.08% ± 0.2  2.24% ± 0.15  0.16 ± 0.25 p=0.545 
24hr 
Sub G0/G1 20.18% ± 2.7 14.37% ± 2.01 5.81 ± 3.37 p=0.116 
G0/G1 75.28% ± 2.79 79.62% ± 2.79 4.34 ± 3.95 p=0.297 
Synthesis 6.24% ± 0.94 7.37% ± 0.51 1.13 ± 1.07 p=0.316 
G2/M 1.23% ± 0.09 2.11% ± 0.42 0.88 ± 0.43 p=0.068 
 72 hr         
Sub G0/G1 67.76% ± 3.44 58.58% ± 1.4 9.18 ± 3.71 p= 0.033 
G0/G1 23.54% ± 3.07 33.66% ± 1.81 10.12 ± 3.56 p= 0.017 
Synthesis 4.81% ± 0.43 3.91% ± 0.32 0.9 ± 0.54 p=0.128 
G2/M 0.46% ± 0.1 0.48% ± 0.05 0.02 ± 0.11 p=0.858 
Highest viability population 
0 hr Control PI3K C2  Difference  p value 
Sub G0/G1 2.74% ± 0.50 2.7% ± 0.29  0.042 ± 0.58 p=0.989 
G0/G1 94.39% ± 0.46  94.30% ± 0.40  0.10 ± 0.61 p=0.973 
Synthesis 2.52% ± 0.73  1.57% ± 0.39  0.94 ± 0.83 p=0.727 
G2/M 2.41% ± 0.23  2.45% ± 0.17 0.4 ± 0.29 p=0.990 
24 hr 
Sub G0/G1 15.90% ± 3.23 8.19% ± 1.75 7.70 ± 3.68 p=0.005 
G0/G1 84.42% ± 2.45 88.62% ± 2.3 4.26 ± 3.36 p=0.117 
Synthesis 2.45% ± 0.28 2.66% ± 0.54 0.21 ± 0.61 p=0.937 
G2/M 1.41% ± 0.088 2.51% ± 0.56 1.10 ± 0.57 p=0.684 
72 hr 
Sub G0/G1 43.51% ± 5.3 31.36% ± 2 12.15 ± 5.65 p=<0.001 
G0/G1 42.95% ± 4.64 57.81% ± 2.46 14.86 ± 5.25 p=<0.001 
Synthesis 7.76% ± 0.99 6.05 ± 0.50  1.70 ± 1.11 P=0.530 
G2/M 0.79% ± 0.19 0.80% ± 0.09 0.015 ± 0.22 p=0.996 
 
Appendix 5. Summary of cell cycle data for each time point. Statistical significance was 
calculated using multiple t-tests, corrected for multiple comparisons using the Sidak-
Bonferroni method. Data represent mean values ± SEM.  
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Appendix 6. Supporting information to explain the gating strategy used in Figure 5.17. A; The top dot 
plots show the highest viability gates, on which further analysis was based. B; The dot plots in the second 
row show the staining pattern for the CD23 and IgM isotype controls. C; shows the results from single 
staining with CD23 or IgM. D; the dot plots on the left show dual staining with CD23 and IgM for control 
(left) and PI3K C2 (right) B-cells. The IgMlow / CD23low gate was determined using results from the 
control B-cells (left). The histograms on the right reveal that a higher proportion of PI3K C2 B-cell 
are both IgMlow and CD23low. This correlates with the increased percentage of PI3K C2 B-cells falling 
within the IgMlow / CD23low gate.  These data are representative of a single experiment using three 
control and three PI3K C2 mice. 
Control. Left; CD23 isotype. Right; IgM isotype PI3K C2. Left; CD23 isotype. Right; IgM isotype 
Control. Left; CD23+ only. Right; IgM+ only PI3K C2. Left; CD23+ only. Right; IgM+ only 
Control. CD23 and IgM PI3K C2. CD23 and IgM Control PI3K C2 
A 
B 
C 
D 
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Appendix 7. Plots showing forward scatter (FSC) versus side scatter (SSC) for B-cells labelled 
with fluorophore conjugated antibodies to IgM and CD23 at 0 hr. Using the gating strategy 
presented in Appendix 6, the FSC was analysed in control and PI3K C2 B-cells. A; CD23+ / 
IgM+ PI3K C2 B-cells were shown to have a consistently higher FSC than CD23+ / IgM+ control 
B-cells. This is in keeping with the previous data that showed both IgM and CD23 appear to be 
down regulated in PI3K C2 B-cells. Activated, differentiating B-cells have a larger FSC than 
naïve B-cells and are typically IgMlow / CD23low. These data are from a single experiment using 
three control and three PI3K C2 mice. 
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Appendix 8. The same gating strategy was used as described in Appendix 6. Freshly 
isolated B-cells were labelled with fluorophore conjugated antibodies to CD23, IgM, CD19, 
relevant isotype controls or all three antibodies. The dot plots show dual staining with 
CD23 and IgM for control (A) and PI3K C2 (B) B-cells. The IgMlow / CD23low gate was 
determined using results from the control B-cells. C; Representative histogram showing 
CD19 expression within the IgM+/ CD23- quadrants. These data are from a single 
experiment using three control and three PI3K C2 mice. 
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PI3K C2 PI3K C2 PI3K C2 
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Appendix 9. Gating strategy to determine FSC of CD19+, sIgMhi/sCD23low B-cells. A; A 
representative dot plot showing the staining pattern for the CD19 isotype control. B; Initially 
cells were gated using the single stained CD19+ B-cells. This allowed identification of a CD19+ 
population with increased forward scatter. C; Using the same plot, the triple stained B-cells CD19 
was analysed within the sIgMhi/sCD23- population (Appendix 8). 
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Appendix 10. Predicted protein interactions generated using PathwayNet (http:// 
pathwaynet.princeton.edu/predictions/gene/?network=human-posttranslational-
regulation&gene=5694). 
